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Abstract 
 
 
1) Extensive deamidation of RNase A limits its 
oligomerization through 3D domain swapping (3D-
DS) 
 
Bovine pancreatic ribonuclease A (RNase A, 13.7 KDa) is the prototype of the 
‘pancreatic-type’ ribonuclease superfamily. When subjected to lyophilization from 
40% acetic acid solutions or to alternative unfolding procedures at high protein 
concentration, natively monomeric RNase A forms oligomers through a mechanism 
named 3D domain swapping (3D-DS). The oligomers form through the swapping 
of the N- and/or C-terminal domain of RNase A monomer. RNase A can undergo 
deamidation, especially of residue N67, to form Asp or isoAsp residues that modify 
both protein net charge and enzymatic activity. Furthermore, it is known that 
deamidation affects, although slightly, also the self-association of RNase B, that is 
one of the glycosylated forms of RNase A. 
In the work described in chapter 3, we report and analyze the strong influence of 
RNase A deamidation on the enzyme tendency to oligomerize through the three-
dimensional domain swapping mechanism. In fact, N67 deamidation decreases the 
yield of RNase A oligomers obtained after lyophilization from 40% acetic acid, and 
the Asp containing RNase A affects less the oligomerization compared to the 
isoAsp-containing protein. On the contrary, deamidation occurring at additional 
Asn or Gln residues nullifies the propensity of RNase A to oligomerize, as well as 
its enzymatic activity. Using 2D and 3D NMR, we identified some residues more 
prone to undergo deamidation, and we studied the difference existing among the 
tertiary structures of native and deamidated RNase A monomer, in combination 
with CD spectroscopy. Finally, the effect induced by deamidated residues on RNase 
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A dimers structures was studied with an in silico approach.  
 
 
2) Different properties of RNase A dimers depend 
on the oligomerization process of the protein 
 
Bovine pancreatic ribonuclease A (RNase A, 13.7 KDa), the ‘pancreatic-type’ 
ribonuclease superfamily prototype, is able to oligomerize through a mechanism 
called 3D domain swapping. RNase A oligomerization takes place when the 
monomeric protein is lyophilized from 40% acetic acid solutions or when it is 
submitted to thermal incubation in various solvents, especially EtOH, at high 
protein concentration.  
Considering that the toxicity of oligomeric species of proteins involved in 
proteopathies often depends on the pathway through which oligomers form, we 
planned to analyze if also RNase A oligomers are affected by the production 
method. Thus, as reported in chapter 4, we analyzed how two different methods 
useful to obtain RNase A oligomers can possibly alter the structure and the function 
of its monomeric and dimeric forms. RNase A monomer and dimers were 
treated/obtained through 40% acetic acid lyophilization or thermal treatments at 60 
°C in 20 or 40% EtOH and they were purified through cation exchange 
chromatography. Their structural differences were studied through cathodic native 
PAGE, far- and near-UV CD, ANS fluorescence and limited proteolysis with 
subtilisin. Tertiary structure differences, related to hydrophobic residues exposure 
and N-terminal region modifications, were confirmed only for the monomer using 
ANS fluorescence. In fact, no significative conformational differences were 
detectable using other analytical approaches. Contrarily, EtOH treatments 
demonstrated to form dimers with higher catalytic activity against ds-RNA 
poly(A):poly(U), with respect to the same species obtained after acid lyophilization. 
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3) Onconase oligomerizes producing a cytotoxic 3D 
domain-swapped dimer 
 
Onconase (ONC, 11.8 KDa) is a protein produced in Rana pipiens oocytes and early 
embryos, belonging to the pancreatic-type RNase superfamily. This protein is 
currently used in Phase II and IIIb clinical trials against human non-small cell lung 
cancer and mesothelioma. In fact, despite its monomeric state, ONC structure 
allows it to avoid the interaction with the cytosolic RNase inhibitor and to exert its 
strong cytotoxicity by cleaving various types of RNA (mRNA, rRNA, tRNA, 
interfering RNA). 
In the work reported in chapter 5, we found for the first time that ONC 
spontaneously forms dimeric trace amounts that increase about four times after acid 
lyophilization of the protein. This dimer was purified from the monomer, together 
with low amounts of ONC larger oligomers, through size exclusion 
chromatography (SEC). We found that dimeric ONC forms through the 3D domain 
swapping of its N-terminal domain, because the C-terminus is blocked by the 
presence of a disulfide involving the last cysteine residue. This was demonstrated 
by cross-linking the dimer with divinyl sulfone (DVS), and by the production of the 
H10A mutant, that resulted unable to oligomerize. Thus, the dimeric ONC has been 
modeled starting from the known structure of the N-swapped RNase A dimer and 
the structures of ONC dimer and monomer were compared using far- and near-UV 
CD and fluorescence. Although no significant differences involving secondary and 
tertiary structures were found, ONC monomer resulted to expose hydrophobic 
residues at a higher extent than the dimer. 
Finally, we noticed that, at low concentrations, ONC dimer is more cytotoxic and 
pro-apoptotic than the monomer against PaCa44 pancreatic cancer cell line, and the 
cytotoxic effect is increased when the ONC species are combined with the 
antitumor drug gemcitabine. 
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1.1 Ribonucleases 
 
The metabolism of ribonucleic acid (RNA), which represents the intermediate step 
in the genetic information transfer from DNA to proteins, is under the control of 
two classes of enzymes: RNA polymerases and RNA depolymerases or 
Ribonucleases (RNases)1. RNA polymerases take part in the synthesis of RNA 
molecules, while their degradation is catalyzed by RNases.  
In living cells, RNA turnover is regulated by more than 20 exo- and 
endoribonucleases (RNases), whose function is to process RNA into mature forms2. 
In this way, RNases participate in RNA metabolism, but are also involved in other 
pathways, such as cell maturation, apoptosis, angiogenesis and defense against 
exogenous RNA viruses3,4. Moreover, some different RNases are also cytotoxic, 
including the wild-type binase from Bacillus intermedius5, RNase Sa from 
Streptomyces aureofaciens6, a-sarcin from Aspergillus giganteus7, ranpirnase (also 
called Onconase) from Rana pipiens8 and bovine seminal RNase (BS-RNase) from 
Bos taurus3,9,10, and also mutants11–15 or chemically modified16,17 or engineered 
forms18,19 of human and bovine pancreatic RNases. 
Hence, it is evident that numerous RNase variants are known, forming a large 
family of enzymes. In non-herbivorous species, an important classification 
addresses the different secretory RNases into two superfamilies: the pancreatic and 
the non-pancreatic-type. The pancreatic-type RNases are present at very low levels 
(with respect to those of bovine pancreas) in secretory organs and body fluids such 
as pancreas, prostate, seminal fluid, milk and saliva20–28. They are characterized by 
sequence, structure and catalytic properties similar to those of bovine or human 
pancreatic RNases and their positive amino acid residues are localized in the 
vicinity of their active site29,30. Instead, the non-pancreatic-type RNases, present in 
spleen, liver, kidney, urine and serum22,23,26,31–35, display sequence and catalytic 
properties similar to those of bovine kidney RNase K2 or human EDN/liver RNase, 
and their basic amino acid residues are distant from the active site29,30. 
 
 
1.	Introduction	
		
6	
	
1.2 RNase A 
 
 
1.2.1 RNase A structure 
 
Bovine pancreatic ribonuclease (RNase A, 13686 Da)36 from Bos taurus is secreted 
in large quantities by the bovine pancreas, possibly due to the large amount or RNA 
produced by the bacteria present in the rumen37. The “A” refers to the most 
abundant isoform of the protein. In fact, other glycosylated isoforms accompany 
RNase A, such as RNase B38–40, which is a mixture of glycoforms in which Man5-
9GlcNAc2 are bound to the side-chain nitrogen of Asn34, and the less abundant 
RNase C and D41,42, even more heterogeneous in their glycosylation profiles. RNase 
A was the first enzyme and the third protein whose amino acid sequence was 
determined43,44, and the third enzyme and fourth protein whose structure was solved 
through X ray diffraction45 (Fig. 1.1). It is a single-domain protein, composed by 
124 amino acids (including all natural amino acids, except tryptophan), which 
originates a three-dimensional structure composed of three a-helices and seven b-
strands: helix I (residues 3–13), helix II (24–34) and helix III (50–60), and an 
antiparallel b-sheet comprising b-strand I (43–49), b-strand II (61–63), b-strand III 
(72–74), b-strand IV (79–87), b-strand V (96–111), and b- strand VI (116–124). 
The structure is stabilized by four disulfide bonds at positions 26-84, 40-95, 58-110 
and 65-72. These disulfide bonds are crucial for the stability of the protein, since 
the mutation of any cysteine in alanine46 or serine47,48 residues decreases its melting 
temperature. The prevalence of basic residues (four Arg, four His and ten Lys) over 
acidic residues (five Asp and five Glu) confers to the protein a positive net charge, 
with a resulting pI of 9.349. The N-terminal domain (residues 1-15), includes the 
first a-helix, and is connected to the protein core through a flexible loop (residues 
16-23). On the contrary, the C-terminal b-hairpin is composed by two b-strands 
(residues 105-124), in which a higher number of hydrophobic residues are present 
with respect to the N-terminus of the protein50.  
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Figure 1.1 – Crystal structure of wild-type bovine pancreatic ribonuclease A (PDB: 5RSA51). The 
N- and C-termini are highlighted in blue and red, respectively. 
 
 
In vivo, RNase A activity is strongly reduced or lost due to the presence of cytosolic 
inhibitors (Fig. 1.2) that inglobate the protein in their structure12,52–54. The most 
potent inhibitor of RNase A is the “ribonuclease inhibitor” (RI), a ~ 50 kDa protein 
present in mammalian cells. The role of RI is very presumably to protect the 
cytosolic RNA from the invasion of external pancreatic ribonucleases, and its 
function has been very well studied (Kd » 10-14 M, Ki » 10-13 M)55,56. The cytotoxic 
properties of other pancreatic-type ribonucleases, such as onconase or BS-RNase, 
seems to be principally due to their ability to evade RI57–59.  
 
 
 
 
 
 
 
 
 
 
N	
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Figure 1.2 – Interaction between RNase A inhibitor (green) and RNase A (light blue)60. 
 
 
1.2.2 Catalytic activity of RNase A 
 
RNase A is active on single-stranded RNA (ss-RNA). Moreover, some experiments 
demonstrated that it is also able to bind one of the two strands of the double-
stranded DNA (ds-DNA) molecule, leading to its destabilization61. The binding 
involves more amino acid residues that take part to different interactions with more 
nucleic acids62,63 (Fig. 1.3). RNase A displays several subsites, three of which (B1, 
B2 and B3) interact with the bases of a bound substrate. The B1 subsite (Thr45, 
Asp83) interacts only with pyrimidine residues64,65, with higher preference for 
cytosine with respect to uracil. In contrast, B2 (Asn71, Glu111) and B3 subsites 
(unknown) are less specific, B2 having a preference for adenine66, while B3 prefers 
purine bases67,68. Subsites P0 (Lys66), P1 (Gln11, His12, Lys41, His119 and 
Asp121) and P2 (Lys7, Arg10) interact with the phosphoryl group of the bound 
substrate63.  
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Figure 1.3 – RNase A residues involved in the interactions with the bound RNA molecule, and 
constituting B1 (Thr45, Asp83), B2 (Asn71, Glu111), B3 (unknown), P0 (Lys66), P1 (Gln11, His12, 
Lys41, His119, Asp121) and P2 (Lys7, Arg10) subsites. Numbers in parentheses refer to the 
conservation of the indicated residues in pancreatic ribonucleases. (Modified from Raines, 199869). 
 
 
The P1 subsite is the active site that catalyzes the cleavage of the bound P-O5’ 
bond70–75. It is composed by Gln11 and His12, located in the N-terminal domain, 
by His119 and Asp121, in the C-terminus, and by Lys41, located in the protein 
core. In the first part of the first reaction, the transphosphorylation, His12 acts as a 
general base, removing a proton from the 2’oxygen of the substrate51,76 (Fig. 1.4A). 
Instead, His119 acts as an electrophile, to allow the protonation of the 5’ oxygen, 
and to favor the cleavage of the P-O bond between two RNA bases. This event leads 
to the formation of a nucleoside 2’,3’-cyclic phosphodiester. In the second reaction 
(Fig. 1.4B), the hydrolysis of the nucleoside 2’,3’-cyclic phosphodiester is induced 
by a nucleophilic attack of a water molecule to the 3’phosphate, facilitated by the 
action of His119 as a general base, with the protonation of the 2’ oxygen and the 
deprotonation of His12 (Fig. 1.4B). 
 
 
 
 
isomerase, tha t ca ta lyze the unscrambling of nonna-
t ive disu lfide bonds.107,108
A more readily t ractable issue in the folding of
reduced RNase A involves the par t icu la r disu lfide
bond between Cys65 and Cys72. Along the polypep-
t ide cha in , Cys58 and Cys72 are equidistan t from
Cys65. According to polymer theory a lone,105,109 the
stability of a disulfide bond between Cys58 and Cys65
should be equa l to tha t of a disu lfide bond between
Cys65 and Cys72. Yet , in the M-pept ide (which
encompasses residues 50-79110), the Cys65-Cys72
disu lfide bond is 3.6-fold more stable than is the
Cys58-Cys65 disu lfide bond.111 This bias is consis-
ten t with the loop st ructure formed by the Cys65-
Cys72 disulfide being a nucleat ion site for the folding
of RNase A under oxidizing condit ions.104,111-114 Un-
der reducing condit ions, however , the Cys65-Cys72
disu lfide bond is vulnerable. Tha t bond and the
Cys40-Cys95 disu lfide bond are the fir st in na t ive
RNase A to suffer reduct ion by dith iothreitol.115
B. Prolyl Peptide Bond Isomerization
RNase A exhibit s a slow kinet ic phase in it s
refolding (tha t is, it s folding with na t ive disu lfide
bonds in tact ).116 The existence of th is second kinet ic
phase is due to the presence of a t least two dist inct
forms of unfolded RNase A.117-120 If the na t ive
enzyme is unfolded rapidly and then allowed to refold
immedia tely, a ll of the molecules refold rapidly. But
if refolding is delayed, ∼80% of the molecules refold
slowly. The simplest kinet ic scheme tha t is consis-
ten t with these da ta is
where N is the na t ive enzyme, Uf are fast refolding
species, and Us are slow refolding species. The t rans
isomer of a typica l pept ide bond is grea t ly favored
over the cis isomer . In cont rast , a t rans bond
preceding a proline residue is only sligh t ly favored,
and its conversion to cis can be slow on the t ime scale
of protein folding. In na t ive RNase A, the pept ide
bonds to Pro42 and Pro117 are t rans and those to
Pro93 and Pro114 are cis. The isomer iza t ion of one
or both of the cis pept ide bonds may be responsible
for the slow kinet ic phase observed dur ing the
refolding of RNase A. The conservat ion of Pro93 and
Pro114 in pancrea t ic r ibonucleases from differen t
vertebrates,20,22 which is part icular ly rare for residues
in a sur face loop,121 cor robora tes the impor tance of a
cis pept ide bond at these posit ions.122
The role of prolyl pept ide bond isomeriza t ion in the
refolding of RNase A has been probed by site-directed
mutagenesis. The refolding ra te of P42A RNase A
is simila r to tha t of the wild-type enzyme, indica t ing
tha t cis-t rans isomer iza t ion of the Pro42 pept ide
bond does not h inder refolding.123,124 Nonetheless, a
hydrogen bond from the side cha in of Tyr97, which
has the least mobile side chain of the six tyrosine and
three phenyla lan ine residues,67 to the Pro42 pept ide
bond enhances stability substan t ia lly.125,126 The re-
folding kinet ics of P93A, P114A, and P117A RNase
A differ sign ifican t ly from tha t of the wild-type
enzyme.124 This difference has a llowed for an elabo-
ra t ion of the scheme in eq 2 to include addit iona l
species.124
A major conclusion from work on the refolding of
RNase A is tha t the Pro93 pept ide bond is t rans in
the slowest refolding species.124,127,128 In other words,
the t rans-to-cis isomer iza t ion of tha t bond is the
slowest step in the refolding of the fu lly dena tured
enzyme. The kinet ics of refolding suggest tha t the
analogous pept ide bond is cis in P93A RNase A.124,129
Yet in the three-dimensiona l st ructure of crysta lline
P93G RNase A, th is bond is t rans because Gly93
a llows the format ion of a type II !-tu rn .130
V. RNABinding
The forces tha t lead to the binding of proteins to
double-st randed DNA are becoming apparen t .131-134
By compar ison , the forces tha t lead to the affin ity
and specificity of proteins for single-st randed RNA
are rela t ively unknown.135 RNase A is being used
to revea l deta iled informat ion on the binding of
proteins to RNA.
A. Subsites
The number of lysine (10) and arginine (4) residues
in RNase A exceeds tha t of aspa r t a t e (5) and
glu tamate (5) residues. Accordingly, RNase A is
ca t ion ic (pI ) 9.3136) a t physiologica l pH. RNase A
has been shown to destabilize double-st randed DNA
by binding to single st rands.137 Moreover , ca t ion
t it ra t ion138 suggests that RNase A can occlude eleven
nucleot ides of a single-st randed nucleic acid139 and
tha t binding involves seven Coulombic in terac-
t ions.140 These resu lt s suggest tha t the in teract ion
between the enzyme and a single-st randed nucleic
acid extends well beyond the scissile bond.
St ructura l74-78 and fu ct iona l (vide infra ) da ta di-
vu lge the existence of severa l enzymic subsites
(F igure 2). The subsites of RNase A have been the
subject of recent reviews.141,142
Us {\}
slow Uf98
fast N (2)
Figure 2. Apparent in teract ions between the subsites in
RNase A and a bound molecule of RNA. The 12 indica ted
residues have been shown by site-directed mutagenesis to
make a cont r ibu t ion to subst ra te binding or turnover (or
both). These residues are Lys7,158,159 Arg10,158,159 Gln11,37
His12,154 Lys41,153,155-157 Thr45,146-148 Lys66,159 Asn71,149
Asp83,148 Glu111,149 His119,154,46 and Asp121.153,270 Phe120
is a lso likely to cont r ibu te to the P1 subsite (via it s mai
cha in) and the B1 subsite (via it s side cha in).164 The
numbers in paren theses refer to the conserva t i n of the
indica ted residues in pancrea t ic r ibonucleases.20,22
1048 Chemical Reviews, 1998, Vol. 98, No. 3 Raines
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Figure 1.4 – Mechanisms of transphosphorylation (A) and hydrolysis (B) reactions catalyzed by 
RNase A. “B:” = His12, “A:” = His119. (Modified from Raines, 199869). 
 
 
RNase A cleaves CpX substrates and hydrolizes C>p (2’,3’-cyclic cytidilate) 2-fold 
faster than the corresponding uridylyl substrates69. Poly(C) is cleaved about 20-fold 
faster than poly(U), while poly(A) is hydrolyzed at a rate that is 103- to 104-fold 
lower with respect to poly(U)29,77. 
 
 
1.2.3 RNase A oligomerizes through 3D Domain Swapping (3D-DS) 
 
In the last two decades, RNase A has become a model to study protein aggregation. 
In fact, under specific conditions such as lyophilization from 40% acetic acid or 
incubation at high protein concentration in various solvents at high 
temperatures50,78,79, monomeric RNase A forms aggregates, some of which have 
been characterized80–82. These species include metastable oligomers ranging from 
dimers, trimers, tetramers and larger oligomers, up to tetradecamers83,84. RNase A 
oligomerizes through 3D domain swapping mechanism85. The term 3D-DS was 
used for the first time by Eisenberg and co-workers86 to describe the structure of a 
diphtheria toxin dimer (DT), but the mechanism was previously proposed in 196278 
Nucleophilic a romat ic subst itu t ion by poly(A) on
1-fluoro-2,4-dinit robenzene yields poly[2′-O-(2,4-dini-
trophenyl)]poly(adenylic acid) [(DNP-poly(A)].211 DNP-
poly(A) of molecular mass 110 kDa and DNP:adenine
ra t io of 1:1.5 is a reversible compet it ive inhibitor but
not a subst ra te of RNase A, RNase B, RNase S (see
sect ion X), and other r ibonucleases.212 The IC50
va lues for inh ibit ion of RNase A, RNase B, and
RNase S by DNP-poly(A) have been repor ted to be
3.20, 0.50, and 0.08 µM, respect ively.212 Encapsula t -
ing DNP-poly(A) with in porous gels213 or a t tach ing
it to acrylic beads212 genera tes affin ity mat r ixes tha t
effect ively remove RNase A from solu t ion . Bound
RNase A can be elu ted from these mat r ixes by
washing with aqueous solutions of high ionic strength.
Specific a ffin ity labels for RNase A exist . 6-Chlo-
ropur ine 9-!-D-r ibofuranosyl 5′-monophospha te (4)
a lkyla tes the R-amino group of Lys1, presumably
after binding to the B3 subsite (F igure 2).150,151 The
st ructure of the crysta lline product of the a lkyla t ion
of RNase A by 4 is known.152 2′-(3′)-O-Bromoacety-
lur idine214,215 and it s amide ana logues 3′-(bromoac-
etamido)-3′-deoxythymidine (5), 3′-(bromoacetamido)-
3′-deoxyuridine, 3′-(bromoacetamido)-3′-deoxyarabino-
furanosyluracil, 2′-(bromoacetamido)-2′-deoxyuridine,
and 2′-(bromoacetamido)-2′-deoxyxylofuranosyl-
uracil216-218 a lkyla te the side cha ins of His12 or
His119. The st ructures of the crysta lline products
of the a lkyla t ion of RNase A by 5 and by 3′-
(bromoacetamido)-3′-deoxyur idine are known.219
F ina lly, RNase A has been the object of mecha-
n ism-based inact iva t ion . The enzyme ca ta lyzes the
conversion of uridine 3′-[4-(fluoromethyl)phenyl] phos-
phate (6) to a quinone methide, which likely alkylates
the side cha in of Lys7, Arg10, Gln69, or Glu111
(Figure 2).220 None of these residues are in the act ive
site, and approximately one-th ird of the ca ta lyt ic
act ivity remains after a lkyla t ion .
VIII. Reaction Mechanism
RNase A cata lyzes the cleavage of the P-O5′ bond
of RNA. Figure 5 depict s a mechanism of ca ta lysis
tha t is consisten t with a ll known data from work on
the enzyme it self.221 Other mechanisms have a lso
been proposed (vide infra ).222-225 In the mechanism
in Figure 5, the side cha in of His12 acts as a base
tha t abst ract s a proton from the 2′-oxygen of a
subst ra te molecule, and thereby facilita tes it s a t tack
on the phosphorus a tom. This a t tack proceeds in-
line to displace a nucleoside.226,227 The side cha in of
His119 acts as an acid tha t protonates the 5′′-oxygen
to facilit a te it s displacement . Both products a re
released to solvent . The slow hydrolysis of the
nucleoside 2′,3′-cyclic phosphodiester occurs in a
separa te process (see sect ion IX), and resembles the
Figure 5. (A) Puta t ive mechanism for the t ransphospho-
ryla t ion react ion ca ta lyzed by RNase A and (B) puta t ive
mechanism for the hydrolysis react ion ca ta lyzed by RNase
A.221 In both mechanisms, “B” is His12 and “A” is His119.
1052 Chemical Reviews, 1998, Vol. 98, No. 3 Raines
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by Crestfield et al., for RNase A. Then, to the end of the past decade, the structures 
of more than sixty domain-swapped protein dimers or oligomers had been solved87. 
3D-DS occurs when one or more domains of a monomeric protein are reciprocally 
exchanged to form a dimer or a larger oligomer (Fig. 1.5). In a monomer, the 
domain(s) involved in the swapping leading to the oligomers formation contacts a 
part of its body, in the so-called closed interface (C-interface)88(Fig. 1.5A). Mildly 
denaturing conditions, such as temperature or pH variation, as well as a high protein 
concentration, allow a monomer to reach the necessary ΔG‡ to switch a domain and 
form an “open” monomer (Fig. 1.5A). Two identical domains are then reciprocally 
exchanged by different monomers, forming a dimer or an oligomer in which the 
interfaces present in the native monomer are re-estabilished. Then, also a new, 
additional, interface not present in the monomer, and referred to as the Open 
interface (O-interface)88 (Fig. 1.5B), forms between the two swapped subunits. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5 – Formation of a 3D domain-swapped metastable (A) and stable (B) dimer. Closed 
monomers are composed by the protein body (square) and the swappable domain (circle), linked 
through a polypeptide linker (hinge loop). The interface between the protein body and the swappable 
domain present in both monomer and dimer is the closed interface (C-interface). The open monomer 
can dimerize through 3D domain swapping, leading to the formation of a new open interface (O-
interface), not present in the monomeric species. The O-interface can involve domains of the same 
subunit (BI) and/or different subunits (BII). Mutations may stabilize the O-interface, and 
consequently the dimeric forms. (Modified from Bennett at al., 199588). 
2456 
Definitions 
The following definitions are helpful in discussing 3D domain 
swapping. 
Swapped  domain 
A swapped domain in a protein oligomer is a globular domain 
(or sometimes one or a few elements of secondary structure) that 
is intertwined with an identical protein chain, with the swapped 
domain having an environment essentially identical to that of 
the same  domain in a protein monomer. 
Hinge loop 
A segment of polypeptide chain that links the swapped domain 
to the rest of its subunit is a hinge loop. Hinge loops have differ- 
ent conformations in monomers and domain-swapped  oligomers. 
C-interface 
A C-interface occurs between domains in a monomeric subunit 
(closed monomer) (Fig. IA, left). 
3D domain-swapped dimer 
A dimer with a two C-interfaces between  two different subunits 
(open monomers) is a 3D domain-swapped dimer (Fig. 1 A, 
right). 
0 interface 
An 0-interface occurs between open monomers in a 3D domain- 
swapped dimer,  NOT present in the closed monomer (Fig. 1 B, 
left). 
Examples of 3D domain swapping in proteins 
We first  described 3D domain swapping as it occurs in metastable 
dimers of diptheria toxin (DT) formed by freezing  in phosphate 
buffer (Bennett et al., 1994b)  (Kinemage  2). However, the struc- 
tures of other proteins that undergo domain swappi g have also 
been reported (Table 1; Fig.  2). These are well-characterized  ex- 
amples of domain swapping; the  structures of  several entries in 
Table I have been determined in both monomeric and dimeric 
states by  X-ray crystallography (DT. CD2 [Kinemage 31, and 
staphylococcal nuclease).  Of the remaining entries, the high  se- 
quence similarity of the RNases ( S O % )  makes it  likely that mo- 
nomeric  BS-RNase and dimeric RNase A  are similar to the X-ray 
structures of monomeric RNase A  and dimeric BS-RNase, re- 
spectively. The CksHs2 monomer was observed in solution and 
its inferred structure is the same as  the crystallographic structure 
of CksHsl (81% identical) (Arvai et al., 1995). The a-spectrin 
dimer structure was determined crystallographically and the 
monomer was observed in solution (Yan et al., 1993).  Single- 
chain Fv molecules form monomers, dimers, and higher oligo- 
mers in solution (Raag & Whitlow, 1995). The hinge loop is 
disordered in the  structure of the anti-sialidase single chain Fv 
molecule, but close interactions between molecules in the crys- 
tal suggest it is a domain-swapped dimer (Kortt et al., 1994). 
Domain-swapped proteins have a C-interface (see Defini- 
tions), generally with many specific interactions. Each pair of 
M.J.  Bennett  et al. 
A Closed Monomers  Domain-swapped  dimer 
Hingle loop C interface 
B Stable  domain- Domain-swapped  dimer  swapped  dimer 
0 interface 
c h 
Fig. 1. 3D  domain  swapping  definitions. A: Closed monomers  are  com- 
prised of tertiary  or  secondary  structural  domains  (represented by a  cir- 
cle and  square) linked by polypeptide linkers (hinge loops). The interface 
between domains in the closed monomer is r ferred to  as the  C-  (closed) 
interface.  Closed  monomers  may  be  opened  by mildly denaturing  con- 
ditions  or by mutations  that  destabilize  the  closed  monomer  (see  text). 
Open monomers may dimerize by domain swapping. The domain- 
swapped dimer has two C-interfaces identical to those in the closed 
monomer,  however,  each is form d  betw en  a  domain  from  one  sub- 
unit  (black)  and  a  domain  from  the  other  subunit  (gray).  The  only res- 
idues  whose  conformations  significantly  differ  between  the  closed  and 
open  monomers  are in the hinge loop.  Domain-swapped  dimers  that are 
only  metastable  (e&, DT, CD2,  RNase A) may  convert to monomers, 
as  indicated  by the  backward  arrow. B:Over  time, amino cid  substi- 
tutions  may  stabilize  an  interface  that  does  not exist in the closed mono- 
mers.  This  interface  formed  between  open  monomers is referred  to  as 
the 0- (open)  interface.  The  0-interface  can  involve  domains  within  a 
single  subunit ( I )  and/or  between  subunits (11). 
proteins in  Table 1 has an identical C-interface in the monomeric 
and dimeric states (Fig. 2), formed between domains linked by 
a hinge loop. The length of the swapped domains varies greatly 
from a 150-residue globular domain in DT, to four P-strands in 
CD2, to a single a-helix of only 15 residues  in  BS-RNase.  How- 
ever, the buried areas and polar interactions in the C-interfaces 
are more uniform and extensive, from 850 A' to 3,800 A' and 
involving 8-19 hydrogen bonds and/or salt bridges. 
In addition to illustrating that  domain swapping occurs in a 
variety of unrelated proteins, Table 1 includes domain-swapped 
dimers with functions altered from their monomers, consistent 
with the hypothesis that domain swapping can be a means  of  reg- 
ulating activity. We discuss two of these proteins in the following. 
RNase A and  BS-RNase 
RNase (Kinemage 3)  is a 124-residue protein isolated from the 
pancreas of animals, and from bovine  seminal  plasma.  BS-RNase 
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When the DG°oligomerization is positive, metastable oligomers (such as RNase A 
oligomers, DT dimer) are generated, whereas stable oligomers form when 
DG°oligomerization is negative (such as BS-RNase, IL-5 or bB2-crystallin dimers)88 
(Fig. 1.6). Three factors contribute to the Gibbs free energy difference among 
monomers and 3D-swapped oligomers: the oligomerization entropy makes the 
monomer more thermodynamically favored, while the new contacts generated in 
the swapped oligomers by the hinge loops and/or the new O-interface interactions 
make the domain-swapped oligomer more favorable80,89–91. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6 – Free energy in the formation of a domain-swapped dimer form two DT monomers. The 
difference in Gibbs free energy is positive, according to the metastable nature of the dimer formed. 
The dashed line refers to the formation of a stable domain-swapped dimer, favored by a negative 
difference in Gibbs free energy. (Modified from Bennett at al., 199588). 
 
 
The swapping domain may have different secondary structures: one a-helix, one b-
strand, several a-helices, several b-strands, or a mixture of a-helices and b-strands. 
This demonstrates that 3D-DS does not need a particular type of primary or 
secondary structure85. Also the very flexible loop connecting the swapping domain 
to the protein body, the so-called hinge loop, can adopt a variety of secondary 
structures. Some hinge loops are coils, some a-helices and other form b-strands81. 
The stabilization of the swapped oligomers depends on various conditions, such as 
Domain swapping 246  1 
Closed monomer 
Open monomer 
Domain-swapped 
dimer 
Association Pathway 
Fig. 3. Free  energy  relationships in the  formation of domain-swapped 
dimeric DT (right-hand  minimum)  from  monomeric DT (left-hand min- 
imum)  as  estimated  from  experiments  and  calculations.  The  Gibbs  free 
energy of formation, AG&,,Cr,,ifl,U,,, is positive as  shown by the  obser- 
vation  that 5-10’70 of  dimer  dissociates to monomer  over several weeks 
(Carroll et al., 1986). We calculate  a  value of 9 k 2  kcal/mol of mono- 
mer  for AG&,l.r,l~,l,o,l as  a  sum of two  terms: - TAS” + AG~,l,,,,i,,,, , 
in which AS” is the entropy change of rotation and translation and 
AG&l,,,,,,, is the free-en rgy  change  of  solvation  of  the  surfaces in the 
dimer.  Following  Erickson  (1989), we estimate TAS” = -10 i 1 kcal/ 
mol  of  monomer  at 277 K ,  and  from  atomic  solvation  energies  (Eisen- 
berg & McLachlan,  1986), we estimate AG~,,,.,,,,,,, = -1 ? 1 kcal/mol 
of monomer.  The free-energy barrier between monomer  and  dimer  can 
be estimated  from  experimental  rates  of  dimer  dissociation. We estimate 
;1 value for Act, the activation energy of converting dimer to open 
monomer, of 27 t 1 kcal/mol  of  dimer  from  the  measured  rate  of  di- 
mer  dissociation to  monomers  (Carroll  et  al., 1986) and  the  Eyring  ate 
equation,  assuming  first-order  kinetics  and  that  the  transmission  coef- 
ficient is unity.  Reprinted in modified  form  from Bennett et al. (1994b). 
does  not  dimerize  an   dimeric  DT  dissociates  only slowly, in- 
dicating that the activation barrier, AGS, is large. Thus, al- 
though  the  domain-swapped  DT  dimer is thermodynamically 
unstable,  the large activation  barrier  endows it  with  a long life- 
time.  The  dotted-line  right-hand well in Figure  3,  with a  nega- 
tive AGdq,,,Crila,ion, represents the case of stable  domain-swapped 
dimers, such  as IL-5 and 0 B2-crystallin. A metastable  domain- 
swapped  dimer  could evolve int  a stable  dimer  by  the  accumu- 
lation of stabilizing  amino  acid  replacements  at  the 0 interface 
as  shown in Figure  IB. Alternatively, a stable  domain-swapped 
dimer  could be formed by a mutation in the hinge loop  that de- 
stabilized  the  monomer (discussed  below). 
Mechanisms for domain swapping in vivo 
Although  the  observation  of  domain  swapping  under  transient 
denaturing  conditions in vitro  can  be considered an experimen- 
tal  artifact, it is consistent with the possibility that  stable  mo- 
nomeric  proteins  might  undergo  3D  domain  swapping in  vivo. 
This  could  occur if association of folded  domains is slow  rela- 
tive to  domain  folding or if proteins  encountered  transient  de- 
naturing  conditions,  for  example in an acidic compartment. As 
an example  of  dimerization  during  folding,  the  N-terminal  do- 
main of the cell adhesion molecule CD2 undergoes domain 
swapping when it is expressed as a fusion protein with GST 
(Murray et al., 1995). The  tethering  of  two  CD2 molecules to  
a GST dimer during folding  permits domain swapping, perhaps 
mimicking  interactions between folding  intermediates  at high 
concentrations in the cell. That is, 3D  domain  swapping might 
occur in the  folding  pathways  of  proteins if intermediates ac- 
cumulate  that  have  folded  but  unassociated  domains. 
Finally, we note  that  domain  swapping  may play a role in 
amyloidosis, a set of diseases characterized by the  deposition of 
protein aggregates. Often,  the  proteins involved  in amyloid ag- 
gregates are stable in both  monomeric  and oligomeric forms,  as 
are  domain-swapped proteins. Domain swapping was proposed 
to be involved  in the  formation of amyloid-like  fibrils in vitro 
from a  Bence-Jones protein  (Klafki et al., 1993). The  mecha- 
nism for  forming  amyloid fibrils is not yet well understood, but 
partial  denaturation was shown to be sufficient for amyloid for- 
mation of transthyretin in vitro  (Colon & Kelly, 1992). 
Evolution of oligomers 
We have  documented in Table 1 that  domain  swapping  occurs 
in  a  several different  proteins,  leading in some cases to oligo- 
mers with diff rent activities from  the  monomers.  Thus  far, we 
have limited our discussion of domain swapping to  dimerlmono- 
mer pairs  having the  same  amino acid sequence (Table I ) .  Now, 
we will describe  two  models  for  oligomer  evolution  and  extend 
the discussion to  include  dimer/monomer  pairs having differ- 
ent  sequences  and a common  ancestor,  to  support  the idea that 
domain swapping  may play a  role  in  oligomer  evolution (Table 2; 
Fig. 4). 
Two models for oligomer evolution 
What  are  the  characteristics of a stable  oligomer  interface  and 
how  might such an interface evolve? For  simplicity, we focus 
on dimers in the  following  discussion.  Dimer  interfaces  are ex- 
tensive (700-5,000 A2/subunit), close-packed, and generally in- 
clude several hydrogen  bonds  (Janin et al., 1988). A primitive 
dimer would  have  required a stable  interface  that yielded a  free 
energy  of interaction  at least equal  to  the  free energy  associated 
with the loss of  rotational  and  translational  entropy  upon di- 
merization, which has been estimated as  approximately 15 kcal/ 
mol (Erickson, 1989; Finkelstein & Janin, 1989). In  the follow- 
ing, we outline  two possible models  for evolving such a prim- 
itive dimer interface, which we call the “sticky billiard ball 
model”  and  the  “3D  domain  swapping  model.” 
The simplest view of dimer formation  can be termed  the sticky 
billiard  ball  model:  a  primitive dimer might arise  from  the gen- 
esis of an  interface  on  the  monomer  surface by the replacement 
of residues via random  mutations.  These  amino  acid replace- 
ments  must have the correct  chemical structure  to  bind residues 
in the  other  subunit  and  must  be fully  accessible at  the  subunit 
surface  to  bind  productively  upon collision with another  sub- 
unit.  However,  the  occurrence of  several amino  acid  substitu- 
tions on the  monomer surface that  form a dimer  interface is  very 
unlikely in a single generation. Thus, the sticky billiard ball 
model  can  account easily for  only  those  dimerizations  in which 
a single mutation  produces a stable  dimer.  However, a  single 
mutation is unlikely to  provide  the  large  surface  area  and  mul- 
tiple specific interactions  that  characterize  stable  interfaces. In 
spite of this  seeming  contradiction,  some  intracellular  dimers 
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buffer type, buffer concentration and pH, temperature, time and/or mutation of key 
residues84,92–97. 
3D-DS may also occur as a consequence of multiple mutations, causing monomer 
destabilization, such as the hinge loop shortening (for example in Staphylococcal 
nuclease)98–101, or mutation(s) causing electrostatic repulsions between the 
swapping domain and the protein body (bB2-crystallin)102. On the other hand, 
amino acid substitution could form new contacts between the subunits of the same 
or different monomers constituting the oligomer and stabilize the O-interface88.  
3D-DS is also implicated in protein evolution. In fact, some proteins may acquire 
different activity with respect to the monomeric forms upon oligomerization, and if 
it confers an advantage to the organism, the oligomers will be selected in the process 
of natural evolution88. 
 
 
1.2.4 RNase A 3D domain-swapped N- and C-dimers 
 
The most abundant species obtained through the induced oligomerization of RNase 
A are two different dimers. The crystallographic structures of both dimers were 
solved80,81. The first dimer forms through the swapping of the N-terminal domain 
(residues 1-15) of two RNase A monomers, and for this reason has been called N-
dimer (ND, PDB entry 1A2W), while the swapping of the C-terminus (residues 116-
124) leads to the formation of the so-called C-dimer (CD, PDB entry 1F0V), as 
shown in figure 1.7. The active site is reconstituted in both dimers, and the 
enzymatic activity is hence maintained78,103. 
RNase A constitutively forms traces of N-dimer79,104. In the ND (Fig. 1.7A), the 
swapped N-terminus of each monomer contacts the major domain (residues 23-124) 
of the other. The two subunits interact through their three-stranded b-sheets, 
forming a six-stranded b-sheet through an O-interface stabilized by six H-bonds81. 
These specific stabilizing contacts are warranted by the two subunits disposed at 
approximately 160 degrees81,105, because the two hinge loops acquire a different 
conformation: one forms a coil, whereas the other forms a helix. 
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In the CD (Fig. 1.7B), the C-terminus of each monomer accommodates to the core 
of the other, forming a dimer that is larger in size with respect to the ND, due to its 
different conformation, with a surface area of 13411 Å2, instead of the 12236 Å2 of 
the ND80. In the C-terminal domain of the two subunits two b-strands form a b-
hairpin richer in hydrophobic residues with respect to the N-terminus, and 
molecular dynamics simulations suggest that CD is more flexible than ND105,106. 
Moreover, the CD conformation allows this isoform to expose a higher positive 
charge than ND. The different sizes and charge exposition of N- and C-dimers allow 
to separate these two isoforms through size exclusion or cation exchange 
chromatographies103,107.  
 
 
 
Figure 1.7 – A) N-terminal (blue) and C-terminal (red) opening of RNase A monomer, with B) the 
formation of the N-dimer (left PDB: 1A2W81) and the C-dimer (right, PDB: 1F0V80), respectively. 
(Modified from Libonati and Gotte, 200450). 
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Figure 7 Linear models of the two RNase A tetramers
(A) NCN-tetramer (N=NC=CN=N swapped). Its structure can be envisaged as being formed by a central C-dimer, each of the two subunits of which swaps its N-terminus with that of another RNase
A monomer. (B) CNC-tetramer (C=CN=NC=C swapped). Its structure is envisaged as being formed by a central N-dimer, each of the two subunits of which swaps its C-terminus with that of another
RNase A monomer. Modified, with permission, from Liu, Y. and Eisenberg, D. (2002) Protein Science 11, 1285–1299. c⃝ Cold Spring Harbor Laboratory Press.
RNase A tetramers
NCN-tetramer
This tetramer comprises one swapped C-terminus and two
swapped N-termini. The relatively small amount of this and the
next tetrameric conformer of RNase A has made their character-
ization difficult. However, on the basis of their dissociation ki-
netics, cross-linking experiments and susceptibility to digestion
by subtilisin, two linear models were proposed [20], each of which
involves two types of 3D domain swapping. The tetramer once
called the minor or less basic tetramer [3,16] contains two N-
terminal types and one (central) C-terminal type of domain
swapping. On this basis it was named the NCN-tetramer [35]
(Figure 7A). Its linear structure can be envisaged as being
formed by a central C-dimer, each monomer of which swaps its
N-terminus with the N-terminus of another monomer. The NCN-,
minor tetramer has a total density of positive charges lower than
that of the more abundant CNC-tetramer, and therefore shows
different ion-exchange chromatographic behaviour (Figure 2B).
CNC-tetramer
The CNC-tetramer contains one swapped N-terminus and two
swapped C-termini. The linear model for this second type of tetra-
meric RNase A, previously called the major or more basic tetramer
[15,20], can be pictured as a central N-dimer whose monomers
have exchanged their C-termini with the C-terminus of another
RNase A monomer (Figure 7B). Since an N-terminal swapping
links the central pair of monomers that swap their C-termini to join
the exterior monomers, this tetramer has been named the CNC-
tetramer [35]. Due to the greater exposure of positive charges
characteristic of the C-dimer in comparison with the N-dimer
[15,19,20] (Figure 5), the CNC-tetramer has a positive charge
density higher than that of the NCN-tetramer, which explains
the greater retention of the former by the cation-exchange resin
(Figure 2B). Also, the CNC-tetramer is slightly larger, because
of the presence of two C-dimers, than the NCN-tetramer, which
accounts for the clear separation of the two oligomers on gel
filtration (Figure 2A). The stability of the quaternary structure
of the CNC-tetramer appears to be lower than that of the
NCN-tetramer under a particular set of defined conditions [20].
However, as for the trimers (see above), this result might not be
general, as the quaternary structure stability of RNase A oligo-
mers in general, and of the tetramers in particular, is highly de-
pendent on the environmental conditions, including buffer, pH,
ionic strength and temperature [20,39].
The NCN- and the CNC-tetramers might be also respectively
considered as an NC-trimer with the addition of an N-swapping
monomer on one end or of a C-swapping monomer on the
other end of the molecule. By adding additional monomers on
the ends of either linear tetramer, long linear oligomers with alter-
nating N- and C-swapped termini could theoretically form.
Other models of tetrameric RNase A
Two linear models for the tetramers of RNase A, identical to
those described and discussed above, were also proposed by Liu
and Eisenberg [14], but in addition these authors advanced two
c⃝ 2004 Biochemical Society
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Figure 8 Models for additional possible tetrameric structures of RNase A
(A) Propeller-like, NCCC-tetramer (N=NC–C–C swapped). This tetramer can be envisaged as a C-trimer, one of the subunits of which swaps its N-terminus with that of an RNase A monomer.
(B) Cyclic, flower cup-like tetramer (C–C–C–C swapped). Modified, with permission, from Liu, Y. and Eisenberg, D. (2002) Protein Science 11, 1285–1299. c⃝ Cold Spring Harbor Laboratory
Press.
additional, quite different tetrameric models [14]. One of them
is a combination of a cyclic, propeller-like molecule and a linear
structure, containing both types of swapping (Figure 8A). The
other is the model of a cyclic flower cup-like tetramer, formed by
the swapping of the C-terminus of each monomer, and with the
four subunits s o ing a reciprocal symmetry of 90◦ (Figure 8B).
Other cyclic or composite (cyclic plus linear) tetrameric structures
could exist, and future experimental work might confirm these
predictions. A final observation: cyclic trimers or tetramers could
be considered as a first nucleus from which branches of linear
oligomers might protrude and develop to form further, more com-
plex structures. Moreover, the picture could be made more compli-
cated by assuming that linear and/or cyclic oligomers with an
identical typ of domain swapping could have different structures
because of diff ent reciprocal o ientations of their subunits (see
the model and the real structure of the C-trimer; Figures 6B–6E).
RNase A pentamers
The xistence f these higher-order multimers has been deduced
from the pres nce of two sm ll protein peaks eluting after the
two etramers, at a higher salt concentration, in cation-exchange
chromatograms (Figure 2B), and of two discrete, unique bands
appearing in cation gel electrophoresis analyses performed under
non-denaturing conditions [16]. Moreover, a third piece of evi-
dence is a peak (P) eluting before the two tetramers in the gel
filtration chromatogram shown in Figure 2(A), that could reason-
ably be interpreted as a pentameric RNase A species. Theor-
etically, there could be several pentamers of RNase A. Their
quaternary structures can be imagined on the basis of the linear
or composite oligomers described above (see Figures 7 and 8).
The first of the two putative pentameric species eluted from
the ion-exchange chromatographic column (P in Figure 2B) was
assayed for its enzyme activity on dsRNAs, and was shown to
be endowed with the highest depolymerizing activity measured
[16]. This is consistent (see below) with the charge properties
of an RNase A pentamer. However, the difficulty in obtaining
these higher-order oligomers in sufficient amounts for their
characterization does not allow us to describe them in more detail.
Implications of the C-dimer structure for amyloid formation
One point deserves further comment; namely, the implications
of the C-dimer structure for amyloid formation [3]. This has to
be regarded as one facet of the general hypothesis [3,18,40,41]
that proposes the involvement of 3D domain swapping in the
production of the large aggregates of cross-β structure that have
been found in neurons of people suffering from many neuro-
degenerative diseases, and that therefore have been linked to the
development of these diseases.
Although the solubility and functional properties of all RNase
A oligomers, and the C-dimer in particular, differentiate them
from insoluble protein aggregates in general, and especially from
amyloid, some interesting structural details highlight the utility
of the RNase A multimers as models for interpreting the fea-
tures of pathological aggregates. Moreover, the recent finding
that early aggregates of native non-disease-associated proteins can
become inherently highly cytotoxic [42] greatly increases interest
in the first event(s) that cause protein aggregation and in the
mechanism(s) that adjust the formation of these early aggregates.
3D domain swapping, a mechanism for oligomer assembly [36],
has also been proposed as a mechanism for amyloid formation,
since oligomer assembly and amyloid formation share common
features: both events are characterized by high specificity; both
result in two stable forms, separated by a high energy barrier; and
both can lead to the formation of linear aggregates [14]. The idea
that every protein, provided that its concentration is high and the
environmental conditions are such as to partially destabilize its
native structure, can aggregate to form amyloid fibrils [4] could
be extended by saying that every protein under the conditions
mentioned above can oligomerize by 3D domain swapping [3].
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Figure 6 The two RNase A trimers
(A) Linear model for the RNase A NC-trimer (N=NC=C swapped). Modifi d with permission from Liu, Y., Gotte, G., Libonati, M. and Eisenberg, D. (2001) Nat. Struct. Biol. 8, 211–214. c⃝ (2001)
Nature Publishing Group and from Liu, Y., Gotte, G., Libonati, M. and Eisenberg, D. (2002) Protein Science 11, 371–380. c⃝ Cold Spring Harbor Laboratory Press. (B–D) Flower cup-like model of
the cyclic trimer. (E) Structure of the propeller-like C-trimer (C–C–C swapped) at 2.2 A˚´ (PDB code 1JS0). Modified with permission from Liu, Y., Gotte, G., Libonati, M. and Eisenberg, D. (2002)
Protein Science 11, 371–380. c⃝ Cold Spring Harbor Laboratory Press.
been derived from data obtained by studying the spontaneous
dissociation of the oligomer, its cross-linkage with 1,5-difluoro-
2,4-dinitrobenzene, and its susceptibility to digestion with
subtilisin [19,20]. On this basis, a linear model for th trim r,
the more abundant of the two trimeric conformers, was proposed
[3,19] (Figu e 6A), with the two types of domain swapping
contributing t its formation. Therefore it was later named the
NC-trimer [35]. It can be envisaged either as a N-dimer, ne
subunit of which swaps its C-terminus with the C-terminus of a
third monom r, or as a C-dimer swapping the N-terminus of one
of its two subunits with the N-terminus of a third subunit. The
linear trimeric molecule is obviously longer than both RNase A
dimers. In fact, in gel-filtration experiments it elutes before the
C-dimer, which in turn elutes before the N-dimer (Figure 2A).
Moreover, the density of positive charges in its structure is higher
t n th t of both imers (see Figure 5), whi h explains its cation-
exchange chromatographic properties. The NC-trimer is indeed
retained by the resin more strongly than the two dimers, and
elutes after the C-dimer in the typical ion-exchange chromatogram
shown in Figure 2(B).
C-trimer
In this case each of the three monomers swaps its C-terminus
(PDB entry, 1JS0). On the basis of spontaneo s dissociation
experiments with the less abundant trimeric conformer, indicating
the formation of only the C-dimer and the RNase A monomer
as intermediate products, a cyclic ‘flower cup-like’ model was
initi ll constructed for this RNase A oligomer (Figures 6B–6D),
with th C-ter inal strands swapped and the three subunits
placed with a reciprocal symmetry of 120◦ [19]. The model was
found to be similar but not identical to the real cyclic structure
of the trimer derived from X-ray analyses of its crystals [19] that
i shown in Figure 6(E). The stability of the quaternary structure
of the C-trimer appears to be lower than that of the NC-trimer
under a particular set of defined conditions [20]. The shape of
this interesting structure is rather compact and looks similar to
a propeller. Oligome ization occurs by the swapping of the C-
terminus of each monomer into the body of the next monomer;
thus this trimer, once called the minor and more basic trimer
[3,16,19], was renamed the C-trimer [35]. The composite active
site of each subuni is therefore made by His-12 and Lys-41
belonging to one RNas A monomer, and His-119 belonging to
another monomer. The density of positive charges of this trimer
(see Figure 5) explains its elution position in the ion-exchange
chromatography shown in Figure 2(B). The production of this
type of oligomer indicates once more the peculiar nature of the
RNase A protein, which is not only able to swap both its N-
terminus and C-terminus, but is also able to form linear as well as
cyclic oligomeric structures because of the high flexibility of the
C-ter inal hinge loop (Figures 6A–6E). In both instances RNase
A appears to be a unique protein.
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(A) Linear model for the RNase A NC-trimer (N=NC=C swapped). Modified with permission fro Liu, Y., Gotte, G., Libonati, M. and Eisenberg, D. (2001) Nat. Struct. Biol. 8, 211–214. c⃝ (2001)
Nature Publishing Group and from Liu, Y., Gotte, G., Libonati, M. and Eisenberg, D. (2002) Protein Science 11, 371–380. c⃝ Cold Spring Harbor Laboratory Press. (B–D) Flower cup-like model of
the cyclic trimer. (E) Structure of the propeller-like C-trimer (C–C–C swapped) at 2.2 A˚´ (PDB code 1JS0). Modified with permission from Liu, Y., Gotte, G., Libonati, M. and Eisenberg, D. (2002)
Protein Science 11, 371–380. c⃝ Cold Spring Harbor Laboratory Press.
been derived from data obtained by studying the spontaneous
dissociation of the oligomer, its cross-linkage with 1,5-difluoro-
2,4-dinitrobenzene, and its susceptibility to digestion with
subtilisin [19,20]. On this basis, a linear model for the trimer,
the more abundant of the two trimeric conformers, was proposed
[3,19] (Figure 6A), with the two types of domain swapping
contributing to its formation. Therefore it was later named the
NC-trimer [35]. It can be envisaged either as an N-dimer, one
subunit of which swaps its C-terminus with the C-ter inus of a
third monomer, or as a C-dimer swapping the N-terminus of one
of its two subunits with the N-terminus of a third subunit. The
linear trimeric molecule is obviously longer than both RNase A
dimers. In fact, in gel-filtration experiments it elutes before the
C-dimer, which in turn elutes before the N-dimer (Figure 2A).
Moreover, the density of positive charges in its structure is higher
than that of both dimers (see Figure 5), which explains its cation-
exchange chromatographic properties. The NC-trimer is indeed
retained by the resin more strongly than the two dimers, and
elutes after the C-dimer in the typical ion-exchange chromatogram
shown in Figure 2(B).
C-trimer
In this case each of the three monomers swaps its C-terminus
(PDB entry, 1JS0). On the basis of spontaneous dissociation
experiments with the less abundant trimeric conformer, indicating
the formation of only the C-dimer and the RNase A monomer
as intermediate products, a cyclic ‘flower cup-like’ model was
initially constructed for this RNase A olig mer (Figures 6B–6D),
with the C-terminal strands swapped and the three subunits
placed with a reciprocal symmetry of 120◦ [19]. The model was
found to be similar but not identical to the real cyclic structure
of the trimer derived from X-ray analyses of its crystals [19] that
is shown in Figure 6(E). The stability of the quaternary structure
of the C-trimer appears to be lower than that of the NC-trimer
under a particular set of defined conditions [20]. The shape of
this interesting structure is rather compact and looks similar to
a propeller. Oligomerization occurs by the swapping of the C-
terminus of each monomer into the body of the next ono er;
thu this trimer, once called the minor and more basic trime
[3,16,19], was renamed the C-trimer [35]. The composite active
site of each subunit is therefore made by His-12 and Lys-41
belonging to one RNase A monomer, and His-119 belonging to
another m nomer. The density of positive charges of this trimer
(see Figure 5) explains its elution position in the ion- xchange
chromatography shown in Figure 2(B). The production of his
type of oligomer indicates once more the peculiar nature of the
RNase A protein, which is not only able to swap both its N-
terminus and C-terminus, but is also able to form linear as w ll as
cyclic oligo eric structures becaus of the high flexibility of the
C-terminal hinge loop (Figures 6A–6E). In both instances RNase
A appears to be a unique protein.
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Figure 3 Structures of the two dimeric conformers of RNase A
(A) ‘Opening’ of the N-terminus or C-terminus of RNase A as the first step in the formation of 3D domain-swapped oligomers. N, N-terminal α-helix; C, C-terminal β-strand. (B) The two dimers of
RNase A. The N-dimer (N=N swapped) is shown at 2.1 A˚ resolution (PDB code 1A2W). Modified, with permission, from Liu, Y., Hart, P. J., Schlunegger, M. P. and Eisenberg, D. (1998) Proc. Natl.
Acad. Sci. U.S.A. 95, 3437–3442. c⃝ (1998) National Academy of Sciences, U.S.A. The C-dimer (C=C swapped) is shown at 1.75 A˚ resolution (PDB code 1F0V). Modified, with permission, from
Liu, Y., Gotte, G., Libonati, M. and Eisenberg, D. (2001) Nat. Struct. Biol. 8, 211–214. c⃝ Nature Publishing Group.
is physiologically meaningful. The stability of the aggregates,
which is quite good in 0.2 M sodium phosphate buffer, pH 6.7
[11,20], decreases going from dimers to the larger oligomers. All
of them dissociate over time, with the larger oligomers forming
intermediate, smaller oligomers before complete dissociation.
The stability of RNase A oligomers depends closely on temper-
ature, protein concentration and ionic strength [20]. Moreover,
as would be expected theoretically, the stability of the RNase A
oligomers increases when they form a complex with a nucleic
acid. This has been demonstrated with the C-trimer and the CNC-
tetramer, whose structures exposed to a temperature of 45 ◦C
for 2.5 min were definitely stabilized by the presence of double-
stranded poly(dA-dT) · poly(dA-dT) [20]. It is worth noting here
that among the most important features of the RNase A oligomers
are the arrangement and density of their basic charges (which
of course change on going from smaller to larger oligomers), to
which their biological actions appear to be related, as we shall see
later.
The two RNase A dimers
As mentioned above, dimerization, or the oligomerization of
RNase A generally, may occur by the swapping of only its N-
terminus (residues 1–15) or C-terminus (residues 116–124) (Fig-
ure 3), or both. In each case the integrity and functionality of the
active site (His-12, His-119 and Lys-41) is maintained because of
its composite nature. By swapping, the N-terminal or C-terminal
domains adhere to their new partner in such a way that His-12 or
His-119 can find their proper location and correctly reconstitute
the enzyme active site [3,11–14,18–20].
N-dimer
This is formed by the swapping of the N-termini of each monomer
(PDB entry 1A2W). Figure 3 shows the minor, less basic RNase
A dimer, recently named the N-dimer [17,35], for which crystals
were obtained and the structure solved in 1998 by Liu, Hart,
Schlunegger and Eisenberg [18]. The N-terminal helix (residues
1–15) of each monomer is swapped into the major domain
(residues 23–124) of the second monomer. The two subunits of
this dimer interact through their three-stranded β-sheets, forming
a six-stranded sheet across the interface of the dimer. This is the
new interface (the ‘open interface’ in the terminology introduced
by Eisenberg; see [14,18,36]) between the two subunits of the
dimer, and is not present in the monomer of RNase A. This
structure is remarkably different from that of BS-RNase (bovine
seminal RNase) [37] (see Figure 4), the only natural ribonuclease
dimer known so far [38], in which the interface between the two
subunits (the ‘open interface’) is formed by the two N-terminal
α-helices (residues 24–33), and is stabilized by two disulphide
bonds existing between Cys-31 and Cys-32 of each subunit.
Interestingly, and with important functional consequences, there is
a conformational equilibrium between the helices and the protein
cores, with the helices being swapped two-thirds of the time [38].
c⃝ 2004 Biochemical Society
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1.2.5 RNase A 3D domain-swapped trimers, tetramers and larger 
oligomers  
 
RNase A forms also oligomers larger than dimers; in fact, there are two types of 
trimers: the NC-trimer (Fig. 1.8B), whose structure has been modeled as a linear 
trimer82,94, and the C-trimer (Fig. 1.8A), whose structure has been solved82 (PDB 
entry, 1JS0). 
According to the proposed model, whose validity has been experimentally 
confirmed, the NC-trimer forms when a central monomer simultaneously swaps 
both its N-and C termini with two other monomers. It can be envisaged as a N-
dimer, one subunit of which swaps the C-terminus with another monomer or, 
alternatively, as a C-dimer swapping the N-terminus of one subunit with a third 
monomer.  
Instead, the structure of the C-trimer shows that the molecule generates through the 
swapping of the C-terminal domain of three monomers. Each monomer swaps its 
C-terminus into the core of the next monomer, forming a structure similar to a 
propeller whose surface is richer in basic charges with respect to NC-trimer. 
The possibility to simultaneously swap both termini enlarges the oligomerization 
potential of RNase A: in fact, fewer amounts of different tetrameric isoform 
generate80,82,83,85,94,107,108. Four of them have been partially characterized and 
modeled (Fig. 1.8). Finally, also traces of pentamers, hexamers and larger 
oligomers have been detected and partially characterized84,107,109,110. 
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Figure 1.8 – Structure of A) C-trimer, and models of B) NC-trimer, C) NCN-tetramer, D) CNC-
tetramer, E) NCCC-tetramer, F) C-tetramer. (Modified from Libonati and Gotte, 200450). 
 
 
1.2.6 Enzymatic activity of RNase A oligomers 
 
Due to the reconstitution of a composite active site, RNase A oligomers are 
enzymatically active78,80,81,88,103. There is no difference among monomer and 
oligomers activity against 2’,3’-cyclic cytidylate78,103,111, while using single 
stranded (ss) yeast RNA as substrate, oligomers display a ribonucleolytic activity 
between 40 and 80% of monomeric RNase A79,83,107,112. In this case, the larger the 
oligomer, the lower the catalytic activity. With polyuridylate (polyU) and 
polycytidylate (polyC) as substrates, the activity of the oligomers falls between 70 
and 90% of that of RNase A monomer83,107. The activities of the oligomers have to 
be considered per mole of oligomeric molecule, as the activity expressed per mole 
of species is about 60% of the activity of the monomer. In fact, when more subunits 
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Figure 7 Linear models of the two RNase A tetramers
(A) NCN-tetramer (N=NC=CN=N swapped). Its structure can be envisaged as being formed by a central C-dimer, each of the two subunits of which swaps its N-terminus with that of another RNase
A monomer. (B) CNC-tetramer (C=CN=NC=C swapped). Its structure is envisaged as being formed by a central N-dimer, each of the two subunits of which swaps its C-terminus with that of another
RNase A monomer. Modified, with permission, from Liu, Y. and Eisenberg, D. (2002) Protein Science 11, 1285–1299. c⃝ Cold Spring Harbor Laboratory Press.
RNase A tetramers
NCN-tetramer
This tetramer comprises one swapped C-terminus and two
swapped N-termini. The relatively small amount of this and the
next tetrameric conformer of RNase A has made their character-
ization difficult. However, on the basis of their dissociation ki-
netics, cross-linking experiments and susceptibility to digestion
by subtilisin, two linear models were proposed [20], each of which
involves two types of 3D domain swapping. The tetramer once
called the minor or less basic tetramer [3,16] contains two N-
terminal types and one (central) C-terminal type of domain
swapping. On this basis it was named the NCN-tetramer [35]
(Figure 7A). Its linear structure can be envisaged as being
formed by a central C-dimer, each monomer of which swaps its
N-terminus with the N-terminus of another monomer. The NCN-,
minor tetramer has a total density of positive charges lower than
that of the more abundant CNC-tetramer, and therefore shows
different ion-exchange chromatographic behaviour (Figure 2B).
CNC-tetramer
The CNC-tetramer contains one swapped N-terminus and two
swapped C-termini. The linear model for this second type of tetra-
meric RNase A, previously called the major or more basic tetramer
[15,20], can be pictured as a central N-dimer whose monomers
have exchanged their C-termini with the C-terminus of another
RNase A monomer (Figure 7B). Since an N-terminal sw pping
links the central pair of monomers that swap their C-termini to join
the exterior monomers, this tetramer has been named the CNC-
tetramer [35]. Due to the greater exposure of positive charges
characteristic of the C-dimer in comparison with the N-dimer
[15,19,20] (Figure 5), the CNC-tetramer has a positive charge
density higher than that of the NCN-tetramer, which explains
the greater retention of the former by the cation-exchange resin
(Figure 2B). Also, the CNC-tetramer is slightly larger, because
of the presence of two C-dimers, than the NCN-tetramer, which
accounts for the clear separation of the two oligomers on gel
filtration (Figure 2A). The stability of the quaternary structure
of the CNC-tetramer appears to be lower than that of the
NCN-tetramer under a particular set of defined conditions [20].
However, as for the trimers (see above), this result might n t be
general, as the quaternary structure stability of RNase A oligo-
mers in general, and of the tetramers in particular, is highly de-
pendent on the environmental conditions, including buffer, pH,
ionic strength and temperature [20,39].
The NCN- and the CNC-tetramers might be also respectively
considered as an NC-trimer with the addition of an N-swapping
monomer on one end or of a C-swapping monomer on the
other end of the molecule. By adding additional monomers on
the ends of either linear tetramer, long linear oligomers with alter-
nating N- and C-swapped termini could theoretically form.
Other models of tetrameric RNase A
Two linear models for the tetramers of RNase A, identical to
those described and discussed above, were also proposed by Liu
and Eisenberg [14], but in addition these authors advanced two
c⃝ 2004 Biochemical Society
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Figure 8 Models for additional possible tetrameric structures of RNase A
(A) Propeller-like, NCCC-tetramer (N=NC–C–C swapped). This tetramer can be envisaged as a C-trimer, one of the subunits of which swaps its N-terminus with that of an RNase A monomer.
(B) Cyclic, flower cup-like tetramer (C–C–C–C swapped). Modified, with permission, from Liu, Y. and Eisenberg, D. (2002) Protein Science 11, 1285–1299. c⃝ Cold Spring Harbor Laboratory
Press.
additional, quite different tetrameric models [14]. One of them
is a combination of a cyclic, propeller-like molecule and a linear
structure, containing both types of swapping (Figure 8A). The
other is the model of a cyclic flower cup-like tetramer, formed by
the swapping of the C-terminus of each monomer, and with the
four subunits s o ing a reciprocal symmetry of 90◦ (Figure 8B).
Other cyclic or composite (cyclic plus linear) tetrameric structures
could exist and future exp rimental work might confirm these
predictions. A final observation: cyclic trimers or tetramers could
be considered as a first nucleus from which branches of linear
oligomers might protrude and develop to for further, more com-
plex structures. Moreover, the picture could be made more compli-
cated by assuming that linear and/or cyclic oligomers with an
identical typ of domain swapping could have different structures
because of diff ent reciprocal o ientations of their subunits (see
the model and the real structure of the C-trimer; Figures 6B–6E).
RNase A pentamers
The xistence f these higher-order multimers has been deduced
from the pres nce of two sm ll protein peaks eluting after the
two etramers, at a higher salt concentration, in cation-exchange
chromatograms (Figure 2B), and of two discrete, unique bands
appearing in cation gel electrophoresis analyses performed under
non-denaturing conditions [16]. Moreover, a third piece of evi-
dence is a peak (P) eluting before the two tetramers in the gel
filtration chromatogram shown in Figure 2(A), that could reason-
ably be interpreted as a pentameric RNase A species. Theor-
etically, there could be several pentamers of RNase A. Their
quaternary structures can be imagi ed on the basis of the linear
or composite oligomers described above (see Figures 7 and 8).
The first of the two putative pentameric species eluted from
the ion-exchange chromatographic column (P in Figure 2B) was
assayed for its enzyme activity on dsRNAs, and was shown to
be endowed with the highest depolymerizing activity measured
[16]. This is consistent (see below) with the charge properties
of an RNase A pentamer. However, the difficulty in obtaining
these higher-order oligomers in sufficient amounts for their
characterization does not allow us to describe them in more detail.
Implications of the C-dimer structure for amyloid formation
One point deserves further comment; namely, the implications
of the C-dimer structure for amyloid formation [3]. This has to
be regarded as one facet of the general hypothesis [3,18,40,41]
that proposes the involvement of 3D domain swapping in the
production of the large aggregates of cross-β structure that have
been found in neurons of people suffering from many neuro-
degenerative diseases, and that therefore have been linked to the
development of these diseases.
Although the solubility and functional properties of all RNase
A oligomers, and the C-dimer in particular, differentiate them
from insoluble protein aggregates in general, and especially from
amyloid, some interesting structural details highlight the utility
of the RNase A multimers as models for interpreting the fea-
tures of pathological aggregates. Moreover, the recent finding
that early aggregates of native non-disease-associated proteins can
become inherently highly cytotoxic [42] greatly increases interest
in the first event(s) that cause protein aggregation and in the
mechanism(s) that adjust the formation of these early aggregates.
3D domain swapping, a mechanism for oligomer assembly [36],
has also been proposed as a mechanism for amyloid formation,
ince oligomer assembly and amyloid formation share common
features: both events are characterized by high specificity; both
result in two stable forms, separated by a high energy barrier; and
both can lead to the f r ation of linear aggregates [14]. The idea
that every protein, provided that its concentration is high and the
environmental conditions are such as to partially destabilize its
native structure, can aggregate to form amyloid fibrils [4] could
be extended by saying that every protein under the conditions
mentioned above can oligomerize by 3D domain swapping [3].
c⃝ 2004 Biochemical Society
316 M. Libonati and G. Gotte
Figure 6 The two RNase A trimers
(A) Linear model for the RNase A NC-trimer (N=NC=C swapped). Modifi d with permission from Liu, Y., Gotte, G., Libonati, M. and Eisenberg, D. (2001) Nat. Struct. Biol. 8, 211–214. c⃝ (2001)
Natur Publishing Group and from Liu, Y., Gotte, G., Libonati, M. a d Eisenberg, D. (2002) Protein Science 11, 371–380. c⃝ Cold Spring Harbor Laboratory Press. (B–D) Flower cup-like model of
the cyclic trimer. (E) Structure of the propeller-like C-trimer (C–C–C swapped) at 2.2 A˚´ (PDB code 1JS0). Modified with permission from Liu, Y., Gotte, G., Libonati, M. and Eisenberg, D. (2002)
Protein Science 11, 371–380. c⃝ Cold Spring Harbor Laboratory Press.
been derived from data obtained by studying the spontaneous
dissociation of the oligomer, its cross-linkage with 1,5-difluoro-
2,4-dinitr benzen , and its susceptibility to digestion with
subtilisin [19,20]. On this basis, a linear model for th trim ,
the more abundant of the two trimeric conformers, was proposed
[3,19] (Figure 6A), with the two types of domain swapping
contributing t its formation. Therefore it was later named the
NC-trimer [35]. It can be envisaged either as a N-dimer, ne
subunit of which swaps its C-terminus with the C-terminus of a
third monomer, or as a C-dimer swapping the N-terminus of one
of its two subuni s with the N-terminus of a third subunit. The
linear trimeric molecule is obviously longer than both RNase A
dimers. In fact, in gel-filtration experiments it elutes before the
C-dimer, which in turn elutes before the N-dimer (Figure 2A).
Moreover, the density of positive charges in its structure is higher
than that of both imers (see Figure 5), which explains its cation-
exchange chromatographic propertie . The NC-trimer i indeed
retained by the resin more strongly than the two dimers, and
elutes after the C-dimer in the typical ion-exchange chromatogram
shown i Figure 2(B).
C-trimer
In this case each of the three monomers swaps its C-terminus
(PDB entry, 1JS0). On the basis of spontaneo s dissociation
exp riments with the less abundant trimeric conformer, ind cating
the formation of only the C-dimer and the RNase A monomer
as intermediate products, a cyclic ‘flower cup-like’ model was
initi ll constructed for this RNase A oligomer (Figures 6B–6D),
with th C-ter inal strands swapped and the three subunits
placed with a reciprocal symmetry of 120◦ [19]. The model was
found to be similar but not identical to the real cyclic structure
of the trimer derived from X-ray analyses of its crystals [19] that
i shown in Figure 6(E). The stability of the quaternary structure
of the C-trimer appears to be lower than that of the NC-trimer
under a particular set of defined conditions [20]. The shape of
this interesting structure is rather compact and looks similar to
a propeller. Oligomerization occurs by the swapping of the C-
terminus of each monomer into the body of the next monomer;
thus this trimer, once called the minor and more basic trimer
[3,16,19], was renamed the C-trimer [35]. The composite active
site of each subunit is therefore made by His-12 and Lys-41
belonging to one RNas A monomer, and His-119 belonging to
another monomer. The density of positive charges of this trimer
(see Figure 5) explains its elution position in the ion-exchange
chromatography shown in Figure 2(B). The production of this
type of oligomer indicates once more the peculiar nature of the
RN se A protein, which is not only able to swap both its N-
terminus and C-terminus, but is also able to form linear as well as
cyclic oligomeric structures because of the high flexibility of the
C-ter inal hinge loop (Figures 6A–6E). In both instances RNase
A appears to b a unique protein.
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(A) Linear model for the RNase A NC-trimer (N=NC=C swapped). Modified with permission from Liu, Y., Gotte, G., Libonati, M. and Eisenberg, D. (2001) Nat. Struct. Biol. 8, 211–214. c⃝ (2001)
Nature Publishing Group and from Liu, Y., Gotte, G., Libonati, M. and Eisenberg, D. (2002) Protein Science 11, 371–380. c⃝ Cold Spring Harbor Laboratory Press. (B–D) Flower cup-like model of
the cyclic trimer. (E) Structure of the propeller-like C-trimer (C–C–C swapped) at 2.2 A˚´ (PDB code 1JS0). Modified with permission from Liu, Y., Gotte, G., Libonati, M. and Eisenberg, D. (2002)
Protein Science 11, 371–380. c⃝ Cold Spring Harbor Laboratory Press.
been derived from data obtained by studying the spontaneous
dissociation of the oligomer, its cross-linkage with 1,5-difluoro-
2,4-dinitrobenzene, and its susceptibility to digestion with
subtilisin [19,20]. On this basis, a linear model for the trimer,
the more abundant of the two trimeric conformers, was proposed
[3,19] (Figure 6A), with the two types of domain swapping
contributing to its formation. Therefore it was later named the
NC-trimer [35]. It can be envisaged either as an N-dimer, one
subunit of which swaps its C-terminus with the C-ter inus of a
third monomer, or as a C-dimer swapping the N-terminus of one
of its two subunits with the N-terminus of a third subunit. The
linear trimeric molecule is obviously longer than both RNase A
dimers. In fact, in gel-filtration experiments it elutes before the
C-dimer, which in turn elutes before the N-dimer (Figure 2A).
Moreover, the density of positive charges in its structure is higher
than that of both dimers (see Figure 5), which explains its cation-
exchange chromatographic properties. The NC-trimer is indeed
retained by the resin more strongly than the two dimers, and
elutes after the C-dimer in the typical ion-excha ge chromatogram
shown in Figure 2(B).
C-trimer
In this case each of the three monomers swaps its C-terminus
(PDB entry, 1JS0). On the basis of spontaneous dissociation
experiments with the less abundant trimeric conformer, indicating
the formation of only the C-dimer and the RNase A monomer
as intermediate products, a cyclic ‘flower cup-like’ model was
initially constructed for this RNase A oligomer (Figures 6B–6D),
with the C-terminal strands swapped and the three subunits
placed with a reciprocal symmetry of 120◦ [19]. The model was
found to be similar but not identical to the real cyclic structure
of the trimer derived from X-ray analyses of its crystals [19] that
is shown in Figure 6(E). The stability of the quaternary structure
of the C-trimer appears to be lower than that of the NC-trimer
under a particular set of defined conditions [20]. The shape of
this interesting structure is rather compact and looks similar to
a propeller. Oligomerization occurs by the swapping of the C-
terminus of each monomer into the body of the next ono er;
thu this trimer, once called the minor and more basic trime
[3,16,19], was renamed the C-trimer [35]. The composite active
site of each subunit is therefore made by His-12 and Lys-41
belonging to one RNase A monomer, and His-119 belonging to
another m nomer. The density of positive charges of this trimer
(see Figure 5) explains its elution position in the ion- xchange
chromatography shown in Figure 2(B). The production of his
type of oligomer indicates once more the peculiar nature of the
RNase A protein, which is not only able to swap both its N-
terminus and C-terminus, but is also able to form linear as w ll as
cyclic oligo eric structures becaus of the high flexibility of the
C-terminal hinge loop (Figures 6A–6E). In both instances RNase
A appears to be a unique protein.
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are bound together, they are unable to simultaneously bind the substrate, but only a 
fraction of them can attack the substrate, reducing in this way the catalytic activity 
per mg of oligomer50. The higher catalytic activity that oligomers display against 
poly(U) and poly(C) with respect to yeast RNA could be due to the greater length 
and homogeneity of these substrates, that allow a better binding to the RNase A 
subsites69,113,114. Moreover, because of its heterogeneous sequence, the folding of 
yeast RNA leads to a complicated structure, which RNase A can attack less 
efficiently.  
On the contrary, double stranded-RNA (ds-RNA) is degraded less efficiently by 
RNase A, due to the difficult enzyme-substrate interactions115. However, RNase A 
oligomerization leads to the gain of depolymerization activity against double-
stranded RNA, such as the synthetic polyribonucleotide poly(A):poly(U). This 
activity increases with the size of oligomers, augmenting from dimers to trimers to 
tetramers, and so on82,83,107,112. Moreover, the activity varies among the oligomers 
with the same size, with the one exposing more positive charge being more 
active107. Thus, the C-swapped oligomers are generally more active than the N-
swapped ones. This is due to the different basicity localized by the active sites of 
the oligomers, with a consequent different interaction with the negative charges of 
RNA phosphate groups. 
RNase A is not highly active against poly(A), likely because purine bases can only 
bind the B2 and B3 subsites, but not the B169. On the contrary, its oligomers become 
more active, and this activity increases with the size of the oligomers, probably due 
to the stronger electrostatic interaction83,107,116. 
 
 
1.2.7 Cytotoxic activity of RNase A oligomers  
 
The catalytic activity of RNase A is responsible of its cytotoxicity against some 
types of cancer cells117. RNase A, in fact,  demonstrated to display weak antitumor 
activity at high doses against Ehrlich carcinoma in mice (above 10 mg/Kg)118,119. 
On the contrary, RNase A oligomers are characterized by an in vitro and in vivo 
cytotoxic activity against some types of cancer cells such as ML-2 (human myeloid 
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leukemia) and HL-60 (human promyelocytic leukemia cells), as well by an 
aspermatogenic action, that generally increases with the increasing size, catalytic 
activity and, consequently, basic charge of RNase A oligomers108. Experimental 
evidence of these points is supported by the acidic, non-cytotoxic RNase Sa from 
Streptomyces aurefaciens, that becomes cytotoxic against NIH3T3 and v-ras 
transformed NIH3T3 cells after the replacement of five acidic residues with 
lysines120 and by the decreased cytotoxicity of the ribotoxin a-sarcin against human 
rhabdomyosarcoma cells after the removal of a highly positively charged b-hairpin 
belonging to its N-terminus121. It was supposed that the cytotoxicity of RNase A 
oligomers is principally ascribed to their ability to evade the cytosolic RNase A 
inhibitor (cRI)12,122. Their structure, in fact, does not allow the cRI to retain them, 
contrarily to RNase A monomer, for which it shows high affinity123,124. Supporting 
this hypothesis, it was demonstrated that RNase A monomer acquires significant 
antitumor activity when conjugated with PEG125 and is cytotoxic against k-562 cells 
when submitted to site directed mutagenesis in order to decrease the interaction 
with cRI126. However, the mechanism of RNase A oligomers endocytosis has not 
been clarified yet, but it has been hypothesized that the high positive charges 
exposed allow them to interact with the negative surfaces of the target cells, that 
successively incorporate them through endocytosis108. Once inside the cell, 
oligomers are allowed to attack various type of RNA, such as mRNA, tRNA, rRNA, 
siRNA, and DNA:RNA hybrid molecules. Putative targets of RNase A are also 
RNAs circulating in the blood plasma, including pre-miRNAs and miRNAs 
implicated in the control of oncogenesis and invasion127. 
The cytotoxic activity of RNase A oligomers depends on their stability, that is 
difficult to be analyzed during in vitro or in vivo experiments. In general, the higher 
the oligomer size, the lower its stability94. However, when tested in very complex 
environments composed by a huge number of different molecules, such as cell 
cultures or in vivo tissues, it is impossible to predict the stability of these species. 
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1.2.8 RNase A as a model to study the mechanism through which 
amyloid fibers form 
 
The mechanism of 3D domain swapping has been found to be involved in the 
formation of amyloid fibers. Amyloid deposits are formed by proteins that are 
otherwise soluble in their physiological role. All amyloids fibers share three 
specific characteristics: i) they can be stained by organic dyes, such as the bis-diazo 
Congo Red128, ii) they appear composed by uniform, straight and rigid fibers, of 
about 100 Å diameter129,130, and iii) they are formed by the so-called repetitive 
cross-b structure131, in which b-strands are perpendicular to the fiber axis. Some 
human diseases are caused by the accumulation of localized amyloid deposits. 
Amyloid b-protein, a-synuclein, and prion protein, for example, are able to form 
amyloid fibrils, causing the known pathologies of Alzheimer, Parkinson and prion 
diseases (such as spongiform encephalopathies and scrapie), respectively132. Then, 
human cystatin C (HCC, a cysteine protease inhibitor), that can generate amyloid 
fibrils that accumulate in the brain arteries of elderly patients suffering from 
cerebral amyloid angiopathy, and b2-microglobulin (the invariant light chain of the 
class I major histocompatibility antigens), that forms dialysis related amyloid 
fibers, are examples of proteins able to form oligomers through 3D-DS133–135. In 
these contexts, 3D-DS, the mechanism shared by RNase A, has been proposed as a 
possible mechanism responsible for amyloid fibers formation. Anyway, the only 
pancreatic-type RNase that is able to form amyloid fibrils is the eosinophil cationic 
protein (ECP)136. RNase A does not form amyloid fibrils in its wild-type (wt) form, 
but produces amyloid type fibrils when modified through the addition of 10 Gln 
residues in the proximity of the C-terminal domain, or by the addition of some Gly 
residues before its N-terminus137,138. Moreover, it has been demonstrated that fibrils 
are not the direct cause of toxicity that is rather related to the presence of smaller 
oligomers that are the fibril precursors139. It was recently demonstrated that these 
oligomers may be toxic or not depending on the way they form139.  
In this context, RNase A can be taken as a model to study and understand the 
mechanism of self-association of amyloid precursors, although the wt protein does 
not form fibrils (Chapter 4).  
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1.2.9 RNase A deamidation 
 
3D-DS self-association is quantitatively affected by several factors, such as 
molecular crowding96, glycosylation140, mutations affecting the polarity of N- and 
C-swapping termini93, or mutations of key-residues92,95. These parameters affect the 
relative proportions of RNase A N-swapped or C-swapped oligomers92,93,140,141. 
Another factor that limits RNase A oligomerization may be deamidation, although 
this link has been only investigated for RNase B107,140.  
Protein deamidation principally involves Asn but also Gln residues. Asn 
deamidation starts with a nucleophilic attack on its amide carbonyl performed by 
the nitrogen of the peptide group linking the Asn to the following residue, generally 
a Gly. The result of this reaction is the formation of a cyclic succinimidyl 
intermediate that can undergo hydrolysis at both the sides of the imide nitrogen, 
forming either a normal aspartic derivative (D) or an isoaspartic one (D)142,143 (Fig. 
1.9). On the other hand, Gln deamidation leads to the formation of a Glu residue 
and a slower forming g-Glu product144,145. 
 
 
 
 
 
 
 
 
 
Figure 1.9 – Asn deamidation proceeds through a cyclic succinimidyl intermediate that can be 
hydrolyzed at both sides of the imide nitrogen, producing either an aspartate (a-derivative) or an 
isoaspartate (b-derivative) residue. 
 
 
Protein deamidation occurs during purification or long-time storage of a protein, 
thus it has been proposed to occur during protein aging144,146,147. Deamidation, in 
Fig. 4. Puriﬁcation and aggregation tendency of the N67D-Asp/IsoAsp RNase A isoforms A) Asn deamidation reaction scheme: a preliminary cyclic intermediate forms with NH3
elimination; then, the resulting imide can be hydrolyzed through two different pathways, to form linear α- and β-derivatives, i.e. Asp (D) and isoAsp (D), respectively. B) Separation of
N67D- from N67D-RNase A injecting the unresolved N67-deamidated mixture onto a Capto-Phenyl Sepharose Hydrophobic Interaction Column (HIC), in line with what reported in
[35]. C) Aggregation proﬁles of the N67D and N67D derivatives separately induced to oligomerize by lyophilizing the protein from 40% HAc solutions [2]. Products were analyzed with
SEC in a Superdex 75 10/300 column equilibrated with 0.4 M NaPi, pH 6.7. Each curve is representative of three to four independent experiments per species. The relative average
yields of the oligomers are reported in Table 2.
82 A. Fagagnini et al. / Biochimica et Biophysica Acta 1865 (2017) 76–87
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fact, spontaneously affects several proteins144,145,148,149. 
The deamidation of specific residues of some proteins can alter their propensity to 
aggregate, with opposite effects. For example, the natural structural variant D76N 
of b2-microglobulin increases its fibrillogenic capacity with respect to the wt 
protein150, while deamidation is able to induce the aggregation of other proteins 
such as gD-crystallin, amylin and SOD1151–153. In addition, it has to be underlined 
that Asn263 deamidation in the fibronectin type I repeat (FN-I5) is able to increase 
endothelial cell adhesion and proliferation154. 
In the case of BS-RNase, the deamidation of Asn67 of both subunits occurs as a 
post-translational modification146,155. In its native structure RNase A is very 
resistant to deamidation, probably due to the rigidity of the backbone of the loop 
between Cys65 and Cys72, that is stabilized by a disulfide bond between these two 
residues and by the b-turn at residues 66-68, which could hinder the formation of 
the cyclic imide156. It is possible to selectively deamidate the Asn67 of RNase A, 
and this modification results in both a reduction of its catalytic activity against yeast 
ss-RNA for both the isoAsp and Asp derivatives, and a reduction in the folding rate 
of the isoAsp derivative157. 
The influence of deamidation on the oligomerization of RNase A is deeply analyzed 
in chapter 3.  
 
 
 
1.3 Onconase 
 
 
1.3.1 Onconase structure 
 
Onconase (ONC) (Fig. 1.10A), also known as P30 protein158 or Ranpirnase, is a 
small basic protein (11.8 kDa). It is the smallest member of the pancreatic-type 
RNase super-family159, despite a sequence identity of only 30% with RNase A, and 
it is isolated from oocytes and early embryos of Rana pipiens, the northern leopard 
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frog158,160,161. ONC extracted from oocytes is polymorphic at positions 11, 20, 25, 
85 and 103, and R. pipiens genome seems to contain four or more genes coding for 
ONC variants160–163. ONC shares common structural elements with RNase A, 
particularly the position of the three α-helices, the two 3-stranded anti-parallel β-
sheets, the active sites residues, the hydrophobic clusters, and three out of four 
disulfide bonds (Cys19-Cys68, Cys30-Cys75, Cys48-Cys90)164 (Fig.1.10B). 
Nevertheless, ONC differs from RNase A for the presence of a N-terminal 
pyroglutamate residue161,164, formed by the spontaneous cyclization of the amino-
terminal glutamine residue or as a product of glutaminyl cyclase, which tethers the 
N-terminus to the protein body, and of a disulfide bond involving the C-terminal 
cysteine (Cys87-Cys104). Both features contribute to the high thermal stability of 
ONC, whose melting temperature is of about 90 °C, that is 25-30 °C higher than 
that of RNase A165,166. In fact, hindering the formation of the N-terminal 
pyroglutamyl bond by retaining the N-terminal Met results in a decrease of ONC 
Tm of about 5 °C, and in a ~40-fold reduction of its catalytic activity against yeast 
RNA, measured in the presence of 0.05 M NaCl. This demonstrates that the 
pyroglutamate takes part also in the catalytic mechanism166. On the other hand, the 
loss of the C-terminal disulfide bond results to a decreasing of the melting 
temperature of about 19 °C, but it does not affect the catalytic activity166. 
 
 
 
Figure 1.10 – A) Crystal structure of wild type onconase (ONC, PDB entry, 1ONC164) and B) 
schematic representation of the disulfide bonds present in ONC tertiary structure. The secondary 
structural context of each half-cystine is indicated by H (helix), S (sheet), or L (loop). (Modified 
from Lee and Raines, 2003167 and from Leland and Raines, 2001168). 
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Little is known about catalysis by ONC. The few previous
studies have employed heterogeneous substrates and variants
of ONC having an additional N-terminal methionine residue,
which lies near the active site and precludes the cyclization
of Gln1 to form Pca1 (26, 27). Here, we have produced
active-site variants of ONC without any additional residues
at the N-terminus. We have also developed a novel homo-
geneous substrate for ONC that has allowed us to measure
kinetic parameters accurately, even for ONC variants of low
catalytic activity. We use these tools to address the following
mechanistic issues: (1) How do the active-site lysine residues
of ONC contribute to transition-state and ground-state
binding? (2) What is the role in catalysis of the hydrogen
bond between Pca1 and Lys9? (3) What is the origin of the
low ribonucleolytic activity of ONC?
EXPERIMENTAL PROCEDURES
Materials. Human RI (as RNasin) was from Promega
(Madison, WI). 6-Carboxyfluorescein-dArUdAdA-6-carboxy-
tetramethylrhodamine (6-FAM-dArUdAdA-6-TAMRA), 6-
FAM-dArUdGdA-6-TAMRA, and 6-FAM-dAdUdGdA were
from Integrated DNA Technology (Coralville, IA). 2-(N-
Morpholino)ethanesulfonic acid (MES) was from Sigma
Chemical (St. Louis, MO). MES was purified further by
anion-exchange chromatography prior to its use so as to
eliminate oligo(vinylsulfonic acid), which is a potent inhibitor
of ribonucleases (28). [methyl-3H]Thymidine was from
PerkinElmer Life Sciences (Boston, MA). Phosphate-
buffered saline (PBS) contained (in 1 L) 0.20 g of KCl, 0.20
g of KH2PO4, 8.0 g of NaCl, and 2.16 g of Na2HPO4‚7H2O.
All other chemicals and reagents were of commercial grade
or better and were used without further purification.
K-562 cells, which derive from a continuous human
chronic myelogenous leukemia line, were from the American
Type Culture Collection (Manassas, VA). The cell culture
medium and supplements were from Invitrogen (Carlsbad,
CA).
Instruments. Mass was measured by matrix-assisted laser
desorption ionization-time-of-flight (MALDI-TOF) mass
spectrometry using a Voyager-DE-PRO Biospectrometry
Workstation (Applied Biosystems, Foster City, CA) and a
3,5-dimethoxy-4-hydroxycinnamic acid (sinapinic acid) ma-
trix (Sigma Chemical). Fluorescence measurements were
performed with a QuantaMaster 1 photon counting fluorom-
eter equipped with sample stirring (Photon Technology
FIGURE 1: Structure and function of Onconase. (A) Three-dimensional structure of ONC (PDB entry 1ONC (11)). (B) Three-dimensional
structure of RNase A (PDB entry 7RSA (24)), which is a homologue of ONC. (C) Active-site residues of ONC. His10, Lys31, and His97
are conserved in the RNase A superfamily (18). Pca1 and Lys9 are absent from RNase A and its mammalian homologues (19). Images
were created with the program MOLSCRIPT and rendered with the program RASTER3D (25). (D) Putative mechanism of catalysis of
RNA cleavage by ONC.
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1.3.2 ONC enzymatic activity 
 
The catalytic residues of RNase A (His12, Lys41, His119) are conserved in ONC, 
and are His10, Lys31, His97161 (Fig. 1.11). The B1 subsite of ONC is composed by 
Thr35, Asp67 and Phe98, while the B2 subsite is supposed to be formed by Thr89 
and Glu91169. 
 
 
 
 
 
 
 
 
 
Figure 1.11 – Active-site residues of ONC. His10, Lys31, and His97 are conserved in the RNase A 
superfamily. (Modified from Lee and Raines, 2003167). 
 
 
The catalytic activity of ONC toward the synthetic substrate 6-FAM-dArUdGdA-
6-TAMRA is three-five orders of magnitude lower than that of RNase A167. While 
RNase A homologs bind a pyrimidine residue on the 5’ side of the phosphodiester 
bond51,67,77,170, ONC prefers to bind a guanine on the 3’ side167. This preference is 
typical of frog ribonucleases, but not of mammalian homologs. The ONC target is 
the intracellular RNA, and some experiments demonstrated that it is able to cleave 
tRNA171. In this case, the cleavage sequence for ONC is the guanosine-guanosine 
phosphodiester bond in the variable loop of the D-arm of t-RNA172. ONC is 100-
fold more active against polyuridylic than polycytidilyc acids and 10-fold more 
active against uridylyl 3’,5’ guanosine than cytidilyl 3’,5’ guanosine173. Hence, 
somewhat surprisingly, ONC displays a different base specificity when interacting 
with synthetic substrates or tRNA molecules172,174.  
 
 
Little is known about catalysis by ONC. The few previous
studies have employed heterogeneous substrates and variants
of ONC having an additional N-terminal methionine residue,
which lies near the active site and precludes the cyclization
of Gln1 to form Pca1 (26, 27). Here w have produc d
active-site variants of ONC without any additional residues
at the N-terminus. We have also developed a novel homo-
geneous substrate for ONC that has allowed us to measure
kinetic parameters accurately, even for ONC variants of low
catalytic activity. We use these tools to address the following
mechanistic issues: (1) How do the active-site lysine residues
of ONC contribute to transition-state and ground-state
binding? (2) What is the role in catalysis of the hydrogen
bond between Pca1 and Lys9? (3) Wha i the origin of the
low ribonucleolytic activity of ONC?
EXPERIMENTAL PROCEDURES
Materials. Human RI (as RNasin) was from Promega
(Madison, WI). 6-Carboxyfluorescein-dArUdAdA-6-carboxy-
tetramethylrhodamine (6-FAM-dArUdAdA-6-TAMRA), 6-
FAM-dArUdGdA-6-TAMRA, and 6-FAM-dAdUdGdA were
from Integrated DNA Technology (Coralville, IA). 2-(N-
Morpholino)ethanesulfonic acid (MES) was from Sigma
Chemical (St. Louis, MO). MES was purified further by
anion-exchange chromatography prior to its use so as to
eliminate oligo(vinylsulfonic acid), which is a potent inhibitor
of ribonucleases (28). [methyl-3H]Thym dine was from
PerkinElmer Life Sciences (Boston, MA). Phosphate-
buffered saline (PBS) contained (in 1 L) 0.20 g of KCl, 0.20
g of KH2PO4, 8.0 g of NaCl, and 2.16 g of Na2HPO4‚7H2O.
All other chemicals and reagents were of commercial grade
or better and were used without further purification.
K-562 cells, which derive from a continuous human
chronic myelogenous leukemia line, were from the American
Type Culture Collection (Manassas, VA). The cell culture
medium and supplements were from Invitrogen (Carlsbad,
CA).
Instruments. Mass was measured by matrix-assisted laser
desorption ionization-time-of-flight (MALDI-TOF) mass
spectrometry using a Voyager-DE-PRO Biospectrometry
Workstation (Applied Biosystems, Foster City, CA) and a
3,5-dimethoxy-4-hydroxycinnamic acid (sinapinic acid) ma-
trix (Sigma Chemical). Fluorescence measurements were
performed with a QuantaMaster 1 photon counting fluorom-
eter equipped with sample stirring (Photon Technology
FIGURE 1: Structure and function of Onconase. (A) Three-dimensional structure of ONC (PDB entry 1ONC (11)). (B) Three-dimensional
structure of RNase A (PDB entry 7RSA (24)), which is a homologue of ONC. (C) Active-site residues of ONC. His10, Lys31, and His97
are conserved in the RNase A superfamily (18). Pca1 and Lys9 are absent from RNase A and its mammalian homologues (19). Images
were created with the program MOLSCRIPT and rendered with the program RASTER3D (25). (D) Putative mechanism of catalysis of
RNA cleavage by ONC.
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1.3.3 ONC cytotoxicity  
 
Onconase is both cytotoxic and cytostatic towards several tumor cell lines. Its 
action is explicated by arresting the cell cycle in the G1 phase8,58. Its LC50 in vitro 
is about 10-7 M, but it depends on the type of cancer cell. It is used in Phase II and 
Phase IIIb clinical trials against non-small cell lung cancer and unresectable 
malignant mesothelioma, respectively175. Recently, ONC showed to be remarkably 
active against other several human cancer cell types, such as glioma cells and 
lymphoma B cells176,177 or, finally, against human pancreatic adenocarcinoma cell 
lines through an autophagy-mediated and ROS-dependent pathway178. Some 
studies demonstrated that it is an effective chemotherapeutic agent in mice179. 
Moreover, ONC is able to inhibit human immunodeficiency virus type 1 
replication174,180. Renal toxicity is dose-limiting, but it can be overcome by 
discontinuing treatments. 
Like the other cytotoxic RNases, except for the RNases from Rana catesbeiana 
(RC-RNase) and Rana japonica (RJ-RNase), which lead to cell death through their 
binding to the cell membrane181, ONC explicates its cytotoxicity after its cellular 
internalization, that occurs through endocytosis9. The cell membrane receptors 
involved in ONC internalization are still elusive. After the releasing from the 
endosome to the cytoplasm, ONC and RNases in general are free to meet the target 
RNA, but they must resist to the attack of proteases.  
The degradation of rRNA was proposed to be the reason for ONC cytostatic and 
cytotoxic activity, due to the inhibition of protein synthesis58. Subsequently, the 
cleavage of tRNA induced by this protein was supposed to lead to the activation of 
the caspase cascade in mammalian cells, resulting in apoptosis182. Another 
proposed mechanism for ONC action is the generation of intracellular interfering 
RNA (RNAi), whose final result is also the induction of apoptosis183.  
ONC cytotoxicity, like that of BS-RNase and RNase A oligomers (Section 1.2.7), 
is principally ascribed to its ability to evade the cytosolic RNase inhibitor, a ~ 50 
kDa protein. Although being monomeric, the low sensitivity of ONC to the inhibitor 
(Ki ³ 10-6 M) seems to be related to the lack of many of the residues present in 
RNase A sequence that are known to mediate the interaction with the inhibitor19,57.  
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1.3.4 ONC oligomerization 
 
At the time of this study, no data reporting the capacity of ONC to self-associate 
were available. Since RNase A oligomerization greatly enhances its activity and 
cytotoxicity, we wished to assess whether ONC oligomerization could lead to 
similar improvements in the therapeutic potential, and simultaneously reduce the 
side effects associated with the treatment. 
It is well known that RNase A, when lyophilized from 40% acetic acid solution and 
redissolved in sodium-phosphate buffer (section 1.2.3), produces oligomers with an 
increasing cytotoxic activity as a function of the molecular weight. So far, no 
oligomers of ONC have been reported or characterized in their cytotoxic activity. 
In the work reported in chapter 5, we obtained a ONC dimer and traces of larger 
oligomers through lyophilization from 40% acetic acid. We studied the structural 
and functional properties of the dimer and we tested its cytotoxic effects induced 
on a pancreatic cancer cell line, PaCa44. 
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Chapter 2  
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The main intent of this PhD thesis was to deepen the investigation of the structural 
determinants that affect the self-association tendency of pancreatic-type 
RNases50,79,95,184. 
In particular, I started to study the effect played by deamidation on the aggregation 
propensity of RNase A, an aspect that was only marginally mentioned in the past107. 
Then, I analysed the differences detectable between RNase A oligomers obtained 
after acid lyophilization78 or, alternatively, through the thermal treatment of 
concentrated solutions of the protein dissolved in various solvents79. 
Finally, I focused my attention on the oligomerization process of onconase, the 
amphibian pancreatic-type RNase variant already known to be cytotoxic in its 
native form. 
 
 
1) Extensive deamidation of RNAse A limits its 
oligomerization through 3D domain swapping 
 
Protein deamidation is ascribable to processes taking part during the protein 
purification steps, but also to protein storage. Moreover, some studies 
demonstraded that it also occurs as a consequence of protein aging144,146,147. When 
a protein undergoes deamidation, some of its structural and/or functional properties 
can be altered in different ways. For example, when the Asp present in position 76 
of b2-microglobulin is replaced by Asn, the protein increases its fibrillogenic 
propensity150, while the deamidation of proteins such as gD-crystalline, amylin and 
SOD1 promotes their aggregation151–153. 
The cation exchange chromatography pattern of a commercial type of RNase A 
(RNase A-type IA, Sigma-Aldrich) is consistent with the presence of deamidated 
species, as judged from the comparison with RNase B, previously studied107. 
Moreover, with respect to the purer RNase A (Type XIIA, Sigma-Aldrich), RNase 
A-IA produced less oligomers after lyophilization from 40% acetic acid solution. 
Our hypothesis was that RNase A deamidation could influence its propensity to 
oligomerize. RNase A deamidation was hence induced to study the oligomerization 
2.	Aim	of	the	thesis	
	
		
28	
	
ability of the resulting deamidated species, following the protocol of Di Donato et 
al.157. N67D-RNase A, a deamidated derivative previously deeply characterized, as 
well as its two subspecies, Asp and isoAsp derivatives, and other poly-deamidated 
species that were chromatographically isolated, were induced to oligomerize. In 
order to study how extensive deamidation of RNase A inhibits its oligomerization 
ability and alters its enzymatic activity, CD spectroscopy, 2D and 3D NMR, 
immunoblotting, in silico structural analyses and Kunitz enzymatic assays were 
used (Chapter 3).  
 
 
2) Different properties of RNase A dimers depend 
on the oligomerization process of the protein 
 
Natively monomeric RNase A (13.7 KDa) can oligomerize under determined 
conditions, such as lyophilization from 30-50% acetic acid78 or thermal treatments 
in various solvents79, producing dimers, trimers, tetramers and larger 
oligomers50,84,110, through a mechanism named three-dimensional domain 
swapping (3D-DS)88. This mechanism had also been unveiled to lead to the 
formation of cross-β spine aggregates and fibrils involved in deposition diseases185. 
It is known that, in the context of amyloid deposition diseases, the toxicity is not 
due to fibrils, but rather to early oligomeric aggregates. Again, more recently, some 
studies demonstrated that these oligomers can be toxic or not toxic, as a function of 
possibly different aggregation pathways139. 
Considering that RNase A forms the same type of oligomers following two different 
protocols, in the work reported in chapter 4 we aimed to evaluate if the process of 
production of RNase A oligomers could somehow affect their functional properties. 
To do so, we focused our attention on RNase A N-dimer(s)81 and C-dimer(s)80 
obtained through the two different methods mentioned above: 1) lyophilization 
from 40% acetic acid78 and 2) thermal treatment of highly concentrated solution of 
the protein in 20% and 40% EtOH79. We measured and analyzed the differences in 
the enzymatic activities of monomer and dimers treated/obtained with the 
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mentioned conditions and, using CD spectroscopy, ANS fluorescence, and limited 
proteolysis with subtilisin, we analyzed their structural and stability differences. 
 
 
3) Onconase oligomerizes producing a cytotoxic 3D 
domain-swapped dimer 
 
Onconase (ONC), a small member of the pancreatic-type RNases superfamily, is a 
cytotoxic and cytostatic protein expressed in oocytes and early embryos of Rana 
pipiens158,160,161. This protein is used in Phase II and Phase IIIb clinical trials against 
non-small cell lung cancer and unresectable malignant mesothelioma175, 
respectively, and it is also active against other several human cancer cell types176–
178, as well as against human immunodeficiency virus type 1174,180. 
Because of the structural similarity existing among ONC and RNase A despite the 
low sequence identity (about 30%), we attempted to induce ONC oligomerization 
by lyophilizing it from 40% acetic acid, in order to investigate if ONC could be able 
to produce 3D domain-swapped oligomers, similarly to the prototype RNase 
A50,78,79, even if the C-terminus of ONC is blocked by a disulfide bond involving 
the last C-terminal cysteine (Cys104). For this reason, we hypothesized that the C-
terminal domain could not be available to take part in the swapping process. In fact, 
after acid lyophilization, only one peak eluting before the ONC monomer was 
detected in size exclusion chromatography. The species eluted in this peak was 
deeply characterized using CD spectroscopy, fluorescence, Kunitz assays and in 
silico analysis. To confirm that the ONC dimer formed through N-terminal domain 
swapping, a cross-linking reaction with divinyl sulfone was performed and a H10A 
mutant was produced and analyzed. Finally, since RNases generally increase their 
biological activities upon oligomerization50,186, the cytotoxic activity and the 
apoptosis induction of ONC dimer was tested against a pancreatic cancer cell line, 
and compared to the already known cytotoxicity of ONC monomer178. The whole 
work performed is described and discussed in chapter 5.
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3.1 Materials 
 
RNase A from bovine pancreas (Type IA-S and XII-A) and poly(A):poly(U) were 
purchased from Sigma-Aldrich. Yeast RNA (ss-RNA) was from Boehringer. All 
other chemicals were used at the highest purity available. ONC cDNA was kindly 
provided by prof. Delia Picone and dr. Eugenio Notomista (University of Naples, 
Federico II).  
 
 
 
3.2 Methods 
 
 
3.2.1 Quantification of the various RNase A species 
 
The concentration of the RNase A monomeric and oligomeric species was 
determined measuring the sample absorbance at 280 nm, e1%280 = 7.3 M-1cm-1, with 
a Jasco V-650 spectrophotometer. Oligomerization does not affect the molar 
extinction coefficient value (unpublished data). 
 
 
3.2.2 Induction of RNase A deamidation  
 
Deamidation of RNase type XII-A was carried out incubating the protein at a 
concentration of 2 mg/ml in 1% NH4HCO3, at 37 °C, following the procedure of Di 
Donato & coll.157. 500 µg aliquots of the protein were withdrawn at different times 
(0-48-134-256 h) and the reaction was stopped by adding 0.2 M 
NaH2PO4/Na2HPO4 (NaPi) buffer, pH 6.7. Then, the NaPi concentration of the 
aliquots was lowered to 50 mM with Amicon Plus and Amicon Mini ultrafilters (3 
kDa or 10 kDa cut-off, Merck-Millipore) for subsequent cation exchange 
chromatography analyses.  
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3.2.3 Purification of RNase type IA-S, deamidated RNase type XII-
A and RNase A oligomers 
 
Each species deriving from RNase type IA-S or from the deamidation reaction of 
RNase type XII-A was purified through cation exchange chromatography, with a 
Source 15S HR 10/10 column attached to an ÄKTA-FPLC system (GE-
Healthcare), and equilibrated with 60 mM NaPi buffer, pH 6.7, at a flow rate of 1 
ml/min.  
RNase A oligomers were purified at a flow rate of 2 ml/min, with a 70 mM NaPi 
concentration to elute the monomer, 90 mM to elute the N-dimer, and a 1h gradient 
from 90 to 200 mM to elute the C-dimer and the larger oligomers107. 
To better resolve the polydeamidated species, the same column was equilibrated 
with 0.1 M sodium acetate-acetic acid buffer, pH 5.0, and 0.05 M NaCl, and a 120 
min NaCl gradient was applied from 0.05 M to 0.35 M to elute samples. The flow 
rate was of 1 ml/min. 
Chromatographic patterns and areas of the resulting peaks were analyzed with the 
Unicorn 5.01 Software (GE Healthcare).  
 
 
3.2.4 Purification of Aspartic and IsoAspartic derivatives through 
hydrophobic interaction chromatography (HIC) 
 
One peak resulting from the deamidation reaction corresponds to the 
monodeamidated species at Asn67157. To better resolve the Asp (N67D) and IsoAsp 
(N67D) derivatives, the peak corresponding to N67D/N67D was collected after 
cation exchange chromatography, dyalized against ddH2O and lyophilized. The 
resulting powder was redissolved in 2.0 M (NH4)2SO4/0.1 M NaPi, pH 6.0, and 
injected onto a Phenyl Sepharose column equilibrated with the same buffer. The 
samples were eluted with a gradient from 2.0 M to 0.5 M (NH4)2SO4, in 90 min, an 
elution strategy that resembles the one described by Di Donato et al.157. 
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3.2.5 Enzymatic activity on single strand (ss-) RNA  
 
Kunitz assays187 were performed on 0.6 mg/ml yeast RNA (A300 » 0.6) solubilized 
in 0.1 M sodium acetate buffer, pH 5.0, using a Jasco V-650 spectrophotometer. 
Enzymes’ concentration was 0.75 ng/µl. The decrease of A300 was recorded for 300 
seconds, in the linearity range. The blank measure was performed acquiring the 
absorbance of 0.1 M sodium acetate buffer, pH 5.0. Negative controls were 
performed by measuring the absorbance of the yeast-RNA solution without the 
addition of the enzyme, in order to exclude the presence of contaminant RNases. 
The enzymatic activities of the protein samples were calculated as DA/(Dmin×µg).  
 
 
3.2.6 RNase A oligomers production and purification 
 
Each species purified by cation exchange chromatography and/or by HIC was 
dialyzed against 2x distilled water (ddH2O), and then lyophilized from 40% 
aqueous acetic acid solutions at the concentration of 50 mg/ml, following the 
procedure of Crestfield & coll78. The resulting powder was then suspended at 
different concentrations, ranging from 1 to 10 mg/ml, in 0.4 M NaPi buffer, pH 6.7, 
and analyzed by size exclusion chromatography (SEC), with a Superdex 75 HR 
10/300 column attached to an ÄKTA-FPLC system (GE-Healthcare). The column 
was equilibrated with the same NaPi buffer and the mixtures were eluted at a flow 
rate of 0.10-0.15 ml/min. Chromatographic patterns and areas of the resulting peaks 
were analyzed with the Unicorn 5.01 Software (GE Healthcare).  
 
 
3.2.7 SDS-PAGE and immunoblotting analysis 
 
SDS-PAGE was performed using a 12.5% acrylamide gel and Tris/glycine buffer, 
pH 8.3. Five µg of each sample were run at 200 V, for 60 min.  
The transfer of each protein sample on a PVDF (Immobilon-P) membrane, was 
carried out in ice bath, using a constant amperage of 300 mA, for 1 h. The 
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membrane was then transferred in a 5% BSA in TBST solution (50 mM Tris-HCl, 
pH 7.5, 0.9% NaCl, 0.1% Tween20), for 1 h. IgG anti-HP-RNase (IgTech, Salerno, 
Italy), kindly provided by Dr. E. Pizzo (University of Naples, Federico II), was 
added in a 1:1000 (antibody stock:TBST solution) ratio, and the membrane was 
transferred at 4 °C, overnigth. After TBST washing, the membrane was developed 
with anti-rabbit IgG peroxidase-conjugate antibody (1:2000, Cell Signaling Tech, 
Danvers, MA, USA) and detected with a chemiluminescent detection system 
(Immun-Star WesternC Kit, Bio-Rad, Hercules, CA). Blotted proteins were then 
detected with ChemiDoc XRS Imaging System (Bio-Rad).  
 
   
3.2.8 Nondenaturing cathodic PAGE 
 
Nondenaturing cathodic PAGE188 was performed using a 12.5-15% acrylamide gel, 
in β-alanine (0.35%)/acetic acid buffer, pH 4.0. Samples were electrophoresed with 
a constant voltage of 200 V, for 90 min, in ice. Gels were subsequently transferred 
in 12.5% 2,2,2-trichloroacetic acid for 90 min, stained with 0.1% Coomassie 
Brilliant Blue, and destained in 10% CH3COOH, 20% EtOH solution.  
 
 
3.2.9 Circular dichroism and thermal unfolding analyses 
 
A Jasco J-810 spectropolarimeter was used to measure far-UV CD spectra. Spectra 
of native and deamidated monomeric RNase A (Sigma, type XII-A) were recorded 
at 25 °C using the following parameters: bandwidth = 1.2 nm, scan speed = 20 
nm/min, number of scans = 6, substracting the spectrum of the 5 mM 
K2HPO4/KH2PO4
 
buffer recorded using the same parameters. 
The thermal denaturation of RNase A species was carried out with a protein 
concentration ranging from 0.25 to 0.5 mg/ml, diluted in 10 mM NaPi buffer, pH 
6.7, and submitting the protein to a thermal gradient of 1.5 °C/min, from 25 to 90 
°C. The reaction was monitored in the far-UV, at 218 nm, with a Jasco J-810 
spectropolarimeter equipped with a programmable Peltier device for the 
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temperature control. The signal was recorded every 0.5 °C, with a bandwidth of 2 
nm. The Tm of each monomer was hence derived from the 50% far-UV CD signal. 
 
 
3.2.10 NMR experiments 
 
NMR spectra were recorded in collaboration with prof. D. V. Laurents (CSIC, 
Madrid) at 25 °C in buffer containing 10% D2O, 10 mM NaPi (pH 6.65) and 0.5 
mM 4,4-dimethyl-4-silapentane-1-sulfonic acid (DSS) as the internal chemical shift 
reference. NMR spectra were acquired on a Bruker Advance Spectrometer, 
operating at 800 MHz (1H) and equipped with a triple resonance cryoprobe and z-
gradients. The mixing time of the 1H NOESY was 150 ms, 2024 × 320 pt. matrix 
(132 scans per increment) and a 12.0 × 12.0 ppm sweep width. Spectra were 
processed and analyzed with the TOPSPIN 2.1 program and peaks were assigned 
with the aid of the Sparky program. In order to identify which Asn and Gln residues 
actually suffer deamidation in 1H homonuclear NMR spectra, 3 mg of 13C, 15N- 
labeled RNase A were dissolved in 20 mM NaH2PO4 buffer (pH 4.6) with 15% D2O 
and a series of 1D 1H, 2D 1H-15N HSQC and 3D HN(CO)CA and HNCACB NMR 
spectra were recorded at 35 °C. On the basis of the correlations observed in the 2D 
and 3D spectra, and of the comparison with previous assignments under similar 
conditions48,189 the chemical shifts of the 1HN, 15N, 13Cα and 13Cβ of the Asn and 
Gln residues and their sequential neighbors were corroborated. Next, to afford 
deamidation, 1% NH4HCO3 was added, the sample's pH was increased to 8.2 and 
the sample incubated for seven days at 37 °C. Afterwards, the sample was 
transferred by a short gel filtration step back into 20 mM NaH2PO4 buffer (pH 4.6) 
with 15% D2O, concentrated by ultrafiltration and a second series of 1D 
1H, 2D 1H-
15N HSQC and 3D HN(CO)CA and HNCACB NMR spectra were recorded. The 
identification of deamidated peaks was performed by the quantitative integration of 
their signals in 2D HSQC spectra or by visual inspection for weak or missing peaks 
in 3D spectra, or both. Whereas side chain Asn/Gln H2N-resonances will be 
sensitive probes of deamidation, we used backbone HN-signals to identify residues 
undergoing deamidation, since they are more disperse, have been previously 
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assigned and give rise to peaks with superior signal/noise ratios in standard 13C, 15N 
3D NMR spectra.  
 
 
3.2.11 Molecular Modeling  
 
The coordinate files of the RNase A N-dimer (PDB ID: 1A2W81) and C-dimer 
(PDB ID: 1F0V80) were used as templates for in silico mutational analysis, 
performed in collaboration with doctor R. Montioli. Mutations AsnàAsp and 
GluàGln were constructed via in silico amino acid substitution using the 
Molecular Operating Environment (MOE) software provided by Chemical 
Computing Group Inc. (Montreal, Quebec, Canada) mutagenesis tool. The 
AsnàisoAsp substitution was carried out by the modeling tool of MOE software 
using the available structure of N67D mutant (PDB ID: 1DY5190) as the source for 
the isoAsp residue structure. The protonation state was calculated by setting the 
parameters that reflect physiological conditions (37°C, ionic strength given by 
NaCl 0.15 M, pH 7.4), using the Protonate 3D application of MOE. All mutated 
structures were refined by potential energy minimization applying the CHARM27 
force field in implicit solvent. The structure alignment and non-covalent 
interactions prediction were carried out using the MOE software. Local changes of 
the secondary structure, and/or side chains orientation, and contact(s) detection 
were analyzed by visual inspection.  
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3.3 Results 
 
 
3.3.1 The yield of oligomerization of less pure RNase A is lower than 
that of the purer one 
 
RNase type IA and XIIA powders were separately lyophilized from 40% acetic acid 
solution and then redissolved in 50 mM NaPi buffer, pH 6.7. RNase A oligomers 
were purified through cation exchange chromatography, by increasing the 
concentration of NaPi buffer, pH 6.7. The result is that the lower the purity of 
RNase A, the lower the oligomerization yield, as it is visible in figure 3.1, where 
the pattern of oligomerization of RNase A type IA (black dashed curve) is compared 
with the one of the purest type XIIA (continuous curve). 
Figure 3.1 – Cation exchange of RNase type IA (dashed curve) and type XII A (continuous curve) 
performed with a Source 15S HR 10/10 after lyophilization from 40% acetic acid solution and 
resuspension in 50 mM NaPi buffer. X = unknown, probably polydeamidated species, M = 
monomer, ND = N-terminal domain swapped dimer, CD = C-terminal domain swapped dimer, NCT 
= N- and C-terminal domain swapped trimer, CT = C-terminal domain swapped trimer. The 
structures of each known species are reported next to their corresponding elution peak. Patterns were 
normalized on the monomer area with the Unicorn 5.01 Software (GE Healthcare).  
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Both the reduced oligomerization yield and the position of the impurities (identified 
with “X” in figure 3.1) recall previous results displayed by RNase A when 
oligomerization was affected by impurities attributed to deamidated variants of the 
protein107.  
 
 
3.3.2 Induction of deamidation of RNase A and purification and 
preliminar characterization of the obtained species 
 
To assess if the X species were deamidated RNase A products, deamidation was 
induced on the purer RNase A XIIA, by incubating the monomer at a concentration 
of 2 mg/ml in a 1% ammonium bicarbonate buffer, following the procedure 
described by Di Donato & coll.157. 1 mg aliquots of the protein were withdrawn at 
0, 48, 134 and 256 h and analyzed through cation exchange chromatography, using 
a constant NaPi buffer concentration of 60 mM, pH 6.7.  
The described reaction promotes the formation of new peaks whose area increases 
with time, until 256 h, in line with the decreasing quantity of native RNase A 
monomer. The two main peaks, called dd and N67D, elute at about 10 and 17 ml, 
respectively (Fig. 3.2). The position of the former is the same of the peaks 
corresponding to the unknown impurities found in RNase type IA (dotted black 
line), while the latter resembles the characteristics of RNase A deamidated at 
position 67 (N67D), previously studied by Di Donato & coll.157.  
A nondenaturing cathodic PAGE188 (Fig. 3.2, upper inset) displays that X and dd 
are a qualitatively similar mix of more species, less basic than native RNase A and 
N67D. For this reason, they are probably deamidated at different and/or various 
residues157. N67D shows a lower mobility than monomeric RNase A, according to 
the presence of Asp67 carboxyl group in spite of the Asn67 amide.  
To confirm that all RNase type IA impurities and all the species formed by the 
deamidation reaction of RNase type XIIA were RNase A derivatives, a Western 
blot analysis was performed on X, dd (1 and 2), N67D and monomeric RNase A. 
Each species can be recognized by the IgG anti-HP-RNase, definitely confirming 
that the species analyzed are RNase A derivatives (Fig 3.2, lower inset). 
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Figure 3.2 – Pattern of RNase XIIA deamidated species purified through cation exchange 
chromatography performed on a Source 15S HR 10/10 equilibrated with 60 mM NaPi buffer, pH 
6.7. Four aliquots of 1 mg each have been withdrawn at different times from the deamidation 
reaction and chromatographed (blue curve-0h, green curve-48h, red curve-134h, violet curve-256h). 
dd = polydeamidated RNase A species, N67D = deamidated RNase A at residue 67. The pattern of 
RNase A-IA is superimposed as a black dashed curve. The results of RNase A derivatives submitted 
to a 15% native cathodic PAGE and to Western blot analysis performed on a 12.5% SDS-PAGE are 
shown in the central insets.  
 
 
Moreover, each peak eluting from the cation exchange chromatography was 
separately collected and analyzed through SEC, onto a Superdex 75 HR 10/300 
column and in a 12.5% SDS-PAGE (Fig. 3.3). Figure 3.3 shows that samples elute 
at the same volume (about 14 ml) and migrate with the same mobility of native 
RNase A.  
  
(dashed line) oligomerizes to an extent only slightly lower than native
RNase A (Tables 1 and 2), the N67D derivative oligomers' yield is re-
markably lower, especially the C-dimer (dot-dash line). It isworthmen-
tioning that the oligomerization yield of the unresolved N67D + N67D
mixture (solid line) is similar to the one shown by the isoAsp-
derivative, and that is not equal to the average of the two isolated iso-
forms. This suggests that a unique deamidated residue (N67) cannot
"per se" strongly limit the RNase A ability to self-associate, but, instead,
that RNaseA oligomerization is affected at a higher extent by the change
of the peptide backbone's length or conformation induced by the D67
derivative [36].
3.6. Native-like structure of the ‘dd’ species and NMR deamidation sites
detection
Since multiple deamidation completely inhibits RNase A aggrega-
tion, we further characterized the heavily deamidated species. Hence,
we collected two fractions of the dd species, named “1” and “2”, which
are not retained by cation exchange chromatography (see Fig. 2A),
and we analyzed them with CD and NMR techniques.
Far UV-CD shows that the spectra of native and deamidated (dd)mo-
nomeric RNase A are very similar to each other (Fig. S2), suggesting that
deamidation does not affect the protein's tertiary fold.We alsomeasured
Fig. 2. Puriﬁcation and analysis of the products obtained after RNase A deamidation A) Type XII-A RNase A deamidation kinetics obtained following the protocol of Di Donato et al. [35].
Four aliquots, 1 mg each, withdrawn at times indicated by different colors and analyzed by cation-exchange chromatography performed on a Source 15S HR 10/10 column equilibrated
with 60mMNaPi, pH6.7,with no gradient applied [6]. Symbols refer to:M, native RNase A, (bars ↓ fromblue-t0 to pink-256 h); N67D, Asn67 deamidated-RNase A, eluted as in [35] (bars ↑
from blue to pink); dd (1 and 2), poly-deamidated RNase A derivatives, also increasing with time. The chromatogram relative to type IA-S RNase A not subjected to 40% HAc incubation/
lyophilization is superimposed as a dashed black line to compare the of the “X” species with the “dd” ones deriving from type XII-A RNase A deamidation. In the upper inset, non-
denaturing cathodic PAGE [46] of the indicated RNase A derivatives. In the lower black/white inset, Western blot analysis of the RNase A derivatives after being run in 12.5% SDS-PAGE.
For both insets, see Mat. and Meth. for details. B) SEC and 12.5% SDS-PAGE (inset) analysis of RNase A derivatives, N67D, dd, and X, compared with native RNase A. SEC was performed
with a Superdex 75 10/300 column equilibrated with 0.2 M NaPi, pH 6.7.
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Figure 3.3 – SEC separation in a Superdex 75 HR 10/300 column of native, monomeric RNase A 
(blue curve), N67D (red curve), impurities of RNase type IA (X, green curve) and polydeamidated 
species obtained from the deamidation reaction of RNase type XIIA (dd, violet curve), performed 
with 0.4 M NaPi buffer, pH 6.7. A 12.5% SDS-PAGE of each species is reported as an inset.  
 
 
3.3.3 Comparison of the enzymatic activities of the obtained species 
against yeast ss-RNA  
 
The enzymatic activity against yeast ss-RNA of each RNase A purified species was 
measured by Kunitz assays187. Activities were calculated as the decrease of 
absorbance with respect to time, per mg of protein. The obtained data demonstrate 
that N67D retains about 74% of RNase A activity, while X and dd species maintain 
about 4 and 6% of it, respectively (Tab. 3.1). The values, despite the very low X 
and dd activities, further confirm that they all are RNase A derivatives. The 
decreased activity could be due to Asn71 and Gln11 deamidation, which affect 
RNase A B2 and P1 binding subsites, respectively70,191. Moreover, the deamidation 
of other Asn/Gln residues could increase the net negative charge, that would 
interfere with the binding of the substrate. 
 
(dashed line) oligomerizes to an extent only slightly lower than native
RNase A (Tables 1 and 2), the N67D derivative oligomers' yield is re-
markably lower, especially the C-dimer (dot-dash line). It isworthmen-
tioning that the oligomerization yield of the unresolved N67D + N67D
mixture (solid line) is similar to the one shown by the isoAsp-
derivative, and that is not equal to the average of the two isolated iso-
forms. This suggests that a unique deamidated residue (N67) cannot
"per se" strongly limit the RNase A ability to self-associate, but, instead,
that RNaseA oligomerization is affected at a higher extent by the change
of the peptide backbone's length or conformation induced by the D67
derivative [36].
3.6. Native-like structure of the ‘dd’ species and NMR deamidation sites
detection
Since multiple deamidation completely inhibits RNase A aggrega-
tion, we further characterized the heavily deamidated species. Hence,
we collected two fractions of the dd species, named “1” and “2”, which
are not retained by cation exchange chromatography (see Fig. 2A),
and we analyzed them with CD and NMR techniques.
Far UV-CD shows that the spectra of native and deamidated (dd)mo-
nomeric RNase A are very similar to each other (Fig. S2), suggesting that
deamidation does not affect the protein's tertiary fold.We alsomeasured
Fig. 2. Puriﬁcation and analysis of the products obtained after RNase A deamidation A) Type XII-A RNase A deamidation kinetics obtained following the protocol of Di Donato et al. [35].
Four aliquots, 1 mg each, withdrawn at times indicated by different colors and analyzed by cation-exchange chromatography performed on a Source 15S HR 10/10 column equilibrated
with 60mMNaPi, pH6.7,with no gradient applied [6]. Symbols refer to:M, native RNase A, (bars ↓ fromblue-t0 to pink-256 h); N67D, Asn67 deamidated-RNase A, eluted as in [35] (bars ↑
from blue to pink); dd (1 and 2), poly-deamidated RNase A derivatives, also increasing with time. The chromatogram relative to type IA-S RNase A not subjected to 40% HAc incubation/
lyophilization is superimposed as a dashed black line to compare the of the “X” species with the “dd” ones deriving from type XII-A RNase A deamidation. In the upper inset, non-
denaturing cathodic PAGE [46] of the indicated RNase A derivatives. In the lower black/white inset, Western blot analysis of the RNase A derivatives after being run in 12.5% SDS-PAGE.
For both insets, see Mat. and Meth. for details. B) SEC and 12.5% SDS-PAGE (inset) analysis of RNase A derivatives, N67D, dd, and X, compared with native RNase A. SEC was performed
with a Superdex 75 10/300 column equilibrated with 0.2 M NaPi, pH 6.7.
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Table 3.1 – Kunitz activity and mean percentages of the residual monomer after lyophilization from 
40% acetic acid of RNase A monomer, N67D, X, dd species and 1:1 RNase A:dd mix. The activities 
of all the species are reported as percentages of the RNase A monomer activity (100%). All 
percentages were calculated from three or more different experiments. 
 
 
3.3.4 Oligomerization of the variously deamidated RNase A 
derivatives  
 
Each peak eluted from the cation exchange was desalted, lyophilized, and submitted 
to another lyophilization step from 40% acetic acid (40 mg/ml), in order to obtain 
RNase A oligomers. Each lyophilized sample was then resuspended in 0.4 M NaPi 
buffer, pH 6.7, at a concentration of 10 mg/ml, and immediately injected onto a 
SEC Superdex 75 HR 10/300 column. The obtained patterns are superimposed in 
figure 3.4.  
 
 
 
 
 
 
 
 
RNase A 
species 
% residual 
Kunitz 
activity 
% residual 
monomer 
RNase A 100.0 62.4 ± 0.6 
N67D 73.9 71.8 ± 1.7 
X 4.0 97.0 ± 1.1 
dd 5.7 98.1 ± 0.6 
1:1 dd:native 
RNase A mix - 89.6 ± 1.0 
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Figure 3.4 – SEC chromatography of the obtained oligomers of RNase A (continuous line), N67D 
(dashed-dotted line), dd (dashed line), X (dotted line) and 1:1 RNase A:dd mix (grey line). The 
chromatographic purification was performed with a Superdex 75 HR 10/300 equilibrated with 0.4 
M NaPi buffer, pH 6.7. M = monomer, ND = N-terminal domain swapped dimer, CD = C-terminal 
domain swapped dimer, T = trimer. Vertical bars represent the elution positions of M.W. standards: 
Ovalbumin (44 kDa), Carbonic Anhydrase (29 kDa) Cytochrome C (12.3 kDa). Patterns were 
normalized on the monomer area with the Unicorn 5.01 Software (GE Healthcare). 
 
 
Contrarily to RNase A, that forms about 38% oligomers (residual monomer 62.4%, 
Table 3.1), dd and X do not oligomerize at all. In fact, since the percentage of 
oligomers obtained from dd and X is about 2% and 3%, respectively, and 
considering that RNase A constitutively forms 1-2% of ND, the aggregation 
propensity of dd and X derivatives is actually reduced to zero by extensive protein 
deamidation. The aggregation is instead only partially compromised by 
deamidation of Asn67, since only 28% oligomers are obtained from N67D (Table 
3.1). Moreover, the aggregation propensity of native RNase A is lowered by the 
presence of equal amounts of impurities (1:1 mix of RNase type XIIA:X, 10% 
obtained oligomers), in line with the lowered aggregation yield obtained with 
the melting temperatures (Tm) of X, dd, N67D and native RNase A in
0.010MNaPi, pH 6.7, detecting only a limited decrease of this parameter
with the increase of deamidation (Table 1). This indicates, once again,
that deamidation does not induce a strong unfolding effect on RNase A.
The 2D 1H NOESY NMR spectra recorded on the poly-deamidated
species reveal hundreds of cross-peaks characteristic of native RNase
A, which is consistent with the maintainance of a folded structure
(Fig. 5). In addition, some cross-peaks which in RNase A are known to
arise from side chain amide\\CO\\NH2 resonances are absent, which
conﬁrms that some Gln and/or Asn residues have become deamidated.
One of the cross-peaks whose signal intensity decreases can be tenta-
tively assigned to Asn67. Two additional cross-peaks also lose signal
strength and are very probably due to deamidation of two more Asn/
Gln side chains. It is interesting that the HN signal of Lys66 is split into
at least two or (more probably) three peaks. Based on similar ﬁndings
previously reported by D'Ursi et al. [56] and on three distinct NOESY
cross-peaks visible between Lys66 HN and HN signals of Asn67, at
10.28 × 7.51, 10.31 × 7.49 and 10.41 × 7.61 ppm, respectively, we pro-
pose that Asn67, Asp67, and isoAsp67 species are simultaneously pres-
ent. Considering i) the heterogeneous nature of the poly-deamidated
sample [35,54], thus containing multiple derivatives even after chang-
ing chromatographic conditions (Fig. S1A), ii) the overlapping of
relevant cross-peaks, and iii) the slight differences in the pH and buffer
compositionbetween these samples and those used to assignRNase A, it
was not possible to unambiguously identify, from these data, which
Asn/Gln residues deﬁnitely suffered deamidation. Moreover, it is also
possible that deamidation at one site could alter the conformation of
nearby Asn or Gln residues enough to shift their NMR peaks.
To further investigate which Asn and Gln residues suffer
deamidation, we recorded and analyzed 2D 1H-15 N HSQC and 3D
1H-13C-15N HN(CO)CA and HNCACB NMR spectra on a 13C,15N-RNase
A labeled sample before and after a week-incubation under
deamidation conditions [35]. The comparison of the two sets of spectra
shows that 13C,15N-RNase A largely retains its folded conformation after
deamidation since many signals readily assignable to the native state
are observed (Fig. 5D) [49,50]. However, the appearance of additional
broad signals between 7.9 and 8.5 ppm (1H) is indicative of an increased
population of unfolded conformers following the incubation. Despite
the peak overlap in the 2D 1H-15N HSQC spectra, it was possible to as-
sign and verify the native backbone resonances of the Asn and Gln res-
idues, as well as adjacent residues in the 3D spectra in the sample prior
to treatment (Table S1). After incubation under deamidation conditions,
many of these signals remain strong, indicating that Gln11, Asn24,
Asn27, Gln28, Gln55, Gln60, Asn103 and Asn113 were not signiﬁcantly
deamidated (Table S2). In contrast, signal displacement, broadening, or
loss of intensity, which are hallmarks of conformational diversity that
would arise from partial or complete deamidation, were observed for
Asn34, Asn44, Asn67, Gln69, Asn71, Gln74, and Gln101 (Table S2). It
was not possible to clearly assess changes in Asn62 due to signal over-
lap. Finally, Asn94 displays to be not extensively deamidated (see
Table S2).
When the HN of the residue following Asn or Gln participates in sec-
ondary structure and/or is protected against H/D exchange, the rigidity
afforded is expected to prevent this HN from attacking its neighbor's
side chain amide. In this regard, we recall that all the Asn and Gln resi-
dues which are not deamidated meet these conditions [49], except for
Asn113, which is followed by Pro114, but is even resistant to
deamidation [31]. Instead, the Asn and Gln residues that suffer
deamidation, Asn34, Asn67 and Gln69 are not bordered by HN in sec-
ondary structure or protected against exchange, which leaves them
open to be deamidated. Interestingly, although Asn71 and Gln74’s
neighbors are in secondary structure and protected against H/D ex-
change, these residues do suffer deamidation, although the extent of
Gln74's deamidation seems less complete than other residues [37].
This strongly suggests that the early deamidation of Asn67 and possibly
Gln69 could cause the local structure to breakdown, leaving Asn71 and
Gln74 open to be attacked.
Besides Asn and Gln residues, the deamidation conditions strongly
weaken the 1H-15N resonances of Lys66 (adjacent to Asn67), Lys41
and His119 (catalytic residues) as well as Phe120, Asp121 and Ala122
(Fig. 5D). The remaining catalytic residue, His12, retains instead its
native-like signal. Recently, certain RNase A 1H-15N signals have been
Table 1
Enzymatic activity, aggregation tendency, and stability of RNase A derivatives.
RNase A species Native
RNase A
N67Da X dd 1/1
dd/nativeb
“Kunitz” activity %c 100 73.9 4.0 5.7 N.D.
Residual monomer %d 62.4 ± 0.6 71.8 ± 1.7 97.0 ± 1.1 98.1 ± 0.6 89.6 ± 1.0
Tm (melting temperature)e 64.6 ± 0.5 62.5 ± 0.7 59.0 ± 0.5 59.7 ± 0.6 N.D.
a It refers here to N67D + N67D, i.e., to the Asp + IsoAsp mixture.
b Equimolar mixture of native RNase A and dd (polydeamidated RNase A).
c % refers to the activity ratio RNase A species / native RNase A × 100. Native RNase A displayed an activity of about 105 Kunitz units/mg protein.
d The % of residual monomer is calculated bymeasuring the peak area of RNase Amonomer divided by the sum of the areas of the peaks of all species eluted from the SEC column after
inducing the aggregation through lyophilization of 40% HAc protein solutions [2].
e Thermal denaturation of native RNase A and derivatives monitored with CD at 218 nm in 10 mM NaPi, pH 6.7, as described in the Mat. & Meth. section. Results are means of three
independent measurements ± S.D. The slight decrease of the N67D Tm with respect to the native RNase A reﬂects the isoAsp derivative contribution.
Fig. 3. SEC of the RNase A deamidated derivatives aggregation proﬁles RNase A X, dd, and
N67D deamidated species [35] separately duced to s lf-associate by ly philization from
40% aqueous HAc solutions [2] and analyzed with a Superdex 75 10/300 column. The
relative dotted, dashed, and dash-dotted curves are superimposed with the one of
native RNase A (solid line) and with the one relative to the oligomerization of a 1/1
native RNase A/ddmix (grey line). Vertical bars represent the elution positions of M.W.
standards: Ovalbumin (44 kDa), Carbonic Anhydrase (29 kDa) Cytochrome C
(12.3 kDa). Each curve is representative of four to six independent experiments, whose
yields are reported in Table 1.
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RNase A type IA (Fig. 3.1). It is interesting to note that the yield of oligomers 
(especially CD and trimers) obtained from this mix is lower with respect to the 
expected average calculated as the average of the oligomers obtained from the pure 
native RNase A monomer and X or dd. 
 
 
3.3.5 Purification and induced oligomerization of N67D and N67D 
RNase A derivatives 
 
When an asparagine residue undergoes deamidation, it passes through a cyclic 
succinimidyl intermediate that can successively generate either an aspartic or a b-
aspartic residue, depending on the position (a or b) in which hydrolysis takes place 
(Introduction, Fig. 1.9). Also glutamine residues are susceptible to deamidation 
reaction, that leads to the formation of either glutammic or g-glutammic acid. Also 
racemization, producing D-Asp and D-isoAsp or D-Glu and D-g-Glu, may occur, 
but it has never been so far detected in RNase A. 
It had been demonstrated that N67D is a mix of two isoforms; one characterized by 
the presence of an aspartic acid in position 67 (N67D), and another with an 
isoaspartic acid occupying the same position (N67D)157. In order to study the 
differences in the oligomerization propensity among these two species, we 
separated the two isoforms through HIC. Fig. 3.5 shows the result of the purification 
of N67D from N67D. The former elutes at about 48 ml, while the latter elutes 4 ml 
before, at a volume of about 44 ml. The ratio N67D:N67D, calculated as the area 
of the eluting peaks, was about 55:45, confirming previous results and indicating 
that the slightly predominant isoform is the isoAsp derivative157. To avoid the 
reciprocal contamination of the two species, only the ascending fraction of N67D 
peak and the descending fraction of N67D were collected. 
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Figure 3.5 – HIC purification of N67D from N67D. The purification was performed using a Phenyl 
Sepharose column, starting from 100% 2 M (NH4)2SO4, 0.1 M NaPi, pH 6.0, and applying a linear 
gradient in 90 min, until reaching 100% 0.5 M (NH4)2SO4, 0.1 M NaPi, pH 6.0.  
 
 
After their purification, N67D and N67D were separately lyophilized from ddH2O, 
redissolved in 40% acetic acid, resubmittet to lyophilization and finally 
resuspended in 0.4 M NaPi buffer, pH 6.7, at a concentration of 10 mg/ml. The two 
samples obtained were then separately analyzed through size exclusion 
chromatography, in parallel with a 1:1 mix of them (Fig. 3.6). Both N67D and 
N67D are able to oligomerize, producing the same oligomers as native RNase A. 
However, the oligomeric yields obtained, about 31% for N67D and 21% for N67D, 
are lower than the 38% obtained from monomeric RNase A (Table 3.1). Moreover, 
the yield of the oligomers obtained from N67D are lower than N67D, and the mix 
of the two isoforms produces a quantity of oligomers (about 24%) that is similar to 
that of N67D, but lower than the expected yield calculated from the average 
quantity of the oligomers obtained by separate N67D and N67D. The difference in 
oligomers’ yield is mainly due to the high difference in the amount of CD produced. 
 
 
Fig. 4. Puriﬁcation and aggregation tendency of the N67D-Asp/IsoAsp RNase A isoforms A) Asn deamidation reaction scheme: a preliminary cyclic intermediate forms with NH3
elimination; then, the resulting imide can be hydrolyzed through two different pathways, to form linear α- and β-derivatives, i.e. Asp (D) and isoAsp (D), respectively. B) Separation of
N67D- from N67D-RNase A injecting the unresolved N67-deamidated mixture onto a Capto-Phenyl Sepharose Hydrophobic Interaction Column (HIC), in line with what reported in
[35]. C) Aggregation proﬁles of the N67D and N67D derivatives separately induced to oligomerize by lyophilizing the protein from 40% HAc solutions [2]. Products were analyzed with
SEC in a Superdex 75 10/300 column equilibrated with 0.4 M NaPi, pH 6.7. Each curve is representative of three to four independent experiments per species. The relative average
yields of the oligomers are reported in Table 2.
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Figure 3.6 – SEC purification through a Superdex 75 HR 10/300 column equilibrated with 0.4 M 
NaPi buffer, pH 6.7, of the oligomers obtained from 40% acetic acid lyophilization of N67D (dashed 
line), N67D (dash-dot line) and a 1/1 mix of N67D/N67D (continuous line). M = monomer, ND = 
N-terminal domain swapped dimer, CD = C-terminal domain swapped dimer, T = trimer, TT = 
tetramers. The table reports the mean percentages of each species calculated from three or four 
different experiments. Patterns were normalized on the monomer area with the Unicorn 5.01 
Software (GE Healthcare). 
 
 
3.3.6 Extensively polydeamidated RNase A derivatives lose their 
propensity to oligomerize  
 
A more in-depth analysis was performed also on the dd species. As being 
polydeamidated species, X and dd are indeed a mixture of differently charged 
isoforms. By changing the chromatography conditions equilibrating the cation 
exchange column with 0.1 M acetic acid/sodium acetate, pH 5.0, NaCl 0.05 M, then 
performing a linear gradient from 0.05 to 0.35 NaCl in 90 min, it was possible to 
split the dd and X corresponding peaks in further four peaks (Fig. 3.7A). Each peak 
was collected, lyophilized from ddH2O, and then from 40% acetic acid. After 
resuspension in 0.4 M NaPi buffer pH 6.7, each sample was analyzed through SEC 
(Fig. 3.7B-E). In line with the results obtained from the whole mix of these species, 
Fig. 4. Puriﬁcation and aggregation tendency of the N67D-Asp/IsoAsp RNase A isoforms A) Asn deamidation reaction scheme: a preliminary cyclic intermediate forms with NH3
elimination; then, the resulting imide can be hydrolyzed through two different pathways, to form linear α- and β-derivatives, i.e. Asp (D) and isoAsp (D), respectively. B) Separation of
N67D- from N67D-RNase A injecting the unresolved N67-deamidated mixture onto a Capto-Phenyl Sepharose Hydrophobic Interaction Column (HIC), in line with what reported in
[35]. C) Aggregation proﬁles of the N67D and N67D derivatives separately induced to oligomerize by lyophilizing the protein from 40% HAc solutions [2]. Products were analyzed with
SEC in a Superdex 75 10/300 column equilibrated with 0.4 M NaPi, pH 6.7. Each curve is representative of three to four independent experiments per species. The relative average
yields of the oligomers are reported in Table 2.
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RNase A 
species 
% residual 
monomer % ND % CD % trimers 
% large 
oligomers 
N67D + N67D 75.7 ± 2.1 5.5 ± 0.7 14.2 ± 1.1 3.0 ± 0.3 1.6 ± 0.2 
N67D (Asp) 68.5 ± 2.0 5.8 ± 0.8 19.2 ± 1.4 4.0 ± 0.4 2.5 ± 0.3 
N67D (isoAsp) 78.7 ± 1.2 4.9 ± 0.4 13.1 ± 0.8 2.1 ± 0.2 1.3 ± 0.1 
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no oligomers are visible from any peak. This indicates again that polydeamidation 
of different and/or more sites inhibits the oligomerization propensity of RNase A at 
all. Traces of aggregates eluting at the void volume are detectable for peak 3 (Fig. 
3.7D). 
 
Figure 3.7 – A) dd analysis through cation exchange chromatography after the equilibration of a 
Source 15S 10/10 column with 0.1 M acetic acid/sodium acetate, pH 5.0, NaCl 0.05 M, with the 
application of a linear gradient from 0.05 to 0.35 NaCl in 90 min. B, C, D, E) SEC analysis of the 
four peaks eluted from cation exchange chromatography and lyophilized from 40% acetic acid. 
 
 
3.3.7 Far-UV CD and melting temperatures analysis of the dd 
species 
 
The characterization of peaks 1 (dd1) and 2 (dd2) of the dd species purified through 
cation exchange chromatography with the NaCl gradient (Fig. 3.7A) was deepened 
through far-UV CD analysis. The spectra of native and polydeamidated (dd) 
3 
 
 
 
 
Figur  S1  Aggregation profiles of the dd subspecies 
A) Cation-exch nge chromatography of poly-deamidated dd RNase A derivatives. Peaks dd1 and 2 
eluted as in Figure 2A were collected and concentrated in 0.1 M HAc/sodium acetate, pH 5.0. Source 
15S HR 10/10 column (GE-Healthcare) was equilibrated with the same buffer supplemented with 
NaCl 0.05M. After 15 mL, a linear gradient was applied to increase NaCl from 0.05 to 0.35 M in 90 
min and elute the subspecies named 1, 2, 3, and 4. The distinct elution behavior of these species can 
be ascribed to putative differences in the number or location of the deamidation sites. 
B), C), D), E) SEC of the RNase A species 1, 2, 3, 4, respectively, after inducing their oligomerization 
by lyophilizing from 40% HAc solutions [2] and injecting each mixture onto a Superdex 75 HR 
10/300 column (GE-Healthcare). Each derivative displays one single peak at about 14 mL; this peak 
corresponds to monomeric RNase A, and in icates that no aggregation occurs. 
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monomeric RNase A (Fig. 3.8) are very similar to each other, suggesting that 
deamidation does not affect the protein’s secondary fold.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8 – Far-UV CD spectra of native monomeric RNase A (blue) and dd2 (red) eluting from 
cation exchange chromatography (Figure 3.7). The concentration of each sample is reported in the 
Materials and Methods section. 
 
 
Thermal denaturations were followed with CD at 218 nm, in 10 mM NaPi buffer, 
pH 6.7 (Fig. 3.9). The calculated Tm of N67D mix (N67D + N67D) is slightly lower 
that of the native RNase A monomer, while the Tm of X and dd species are about 
5.6 and 4.9 °C lower. These results indicate that the stability of RNase A monomer 
is minimally affected in case of N67 deamidation, while when the deamidation 
affects more residues, its stability is more largely compromised, even if 
deamidation does not induce a dramatic unfolding on the protein. 
 
 
4 
 
 
Figure S2  Circular Dichroism of RNase A dd species 
Far UV-CD spectra were recorded on a Jasco model J-810 spectropolarimeter at 25.0 °C. The 
spectrum of the deamidated sample was registered employing the following parameters: 
bandwidth=1.2 nm, scan speed=20 nm per min, number of scans=6. A reference spectrum of the 
buffer (5 mM K2HPO4/KH2PO4) was recorded using the same set of parameters and subtracted. For 
comparison, a far UV CD spectrum of RNase A (Sigma type XII-A) recorded under similar conditions 
is shown for comparison. Though not identical, the spectra do resemble each other and this is a further 
evidence that the deamidated sample retains the native tertiary fold. 
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Figure 3.9 – Denaturation curves of native RNase A monomer (blue curve), N67D (N67D/N67D 
mix, red curve), X (green curve) and dd (violet curve). The thermal denaturation experiments were 
followed with CD at 218 nm, in 10 mM NaPi buffer, pH 6.7, from 25 to 90 °C. The calculated Tm 
are reported in the table. The concentration of the samples is reported in the Material and Methods 
section. The displayed values are the means of three experiments. 
 
 
3.3.8 NMR analysis of the dd species 
 
The 2D 1H NOESY NMR spectra recorded show hundreds of cross-peaks, 
characteristic of native RNase A, suggesting once again that the folding is not lost 
upon polydeamidation (Fig. 3.10). Some cross-peaks previously assigned to the 
side chain amide ¾CO¾NH2 of some Gln and/or Asn residues in native RNase A, 
are not detectable, demonstrating that these residues undergo deamidation. One of 
the cross-peaks whose signal intensity decreases can be tentatively assigned to 
Asn67. Two additional cross-peaks also lose signal intensity and are very probably 
due to deamidation of two more Asn/ Gln side chains. Interestingly, the HN signal 
of Lys66 is split into at least two or, more probably, three parts. Based on similar 
findings previously reported by D'Ursi et al.192 and on three distinct NOESY cross-
peaks visible between Lys66 HN and HN signals of Asn67, at 10.28 × 7.51, 10.31 
× 7.49 and 10.41 × 7.61 ppm, respectively, it could be that Asn67, Asp67, and 
isoAsp67 species are simultaneously present. However, due to the heterogeneity of 
the poly-deamidated sample, the overlapping of relevant cross-peaks, and the slight 
differences in the pH and buffer composition between these samples and those used 
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Introduction 
 
 
 
 
 
RNase A species % residual  monomer 
RNase A  62.4 ± 0.6 
N67D 71.8 ± 1.7 
X 97.0 ± 1.1 
dd 98.1 ± 0.6 
1/1 dd/native 
RNase A 89.6 ± 1.0 
RNase A species Tm °C 
RNase A 64.6 ± 0.5 
N67D 62.5 ± 0.7 
X 59.0 ± 0.5 
dd 59.7 ± 0.6 
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to assign RNase A, it was not possible to unambiguously identify which Asn or Gln 
residues suffer deamidation. Moreover, Asn and Gln peaks could be shifted by the 
deamidation of a nearby site, because it could alter their conformation. Hence, to 
further analyze the residues affected by deamidation, a 2D 1H-15N HSQC and a 3D 
1H-13C-15N HN(CO)CA and HNCACB NMR spectra were recorded on a 13C,15N- 
RNase A labeled sample before and after the incubation under deamidation 
conditions (Section 3.2.2). The comparison of the two sets of spectra shows that 
13C,15N-RNase A maintains its folded structure after deamidation, since many 
signals readily assignable to the native state are observed (Fig. 3.10D)48,189. 
However, deamidation produces a part of unfolded conformers, as notable from the 
additional broad signals between 7.9 and 8.5 ppM in the 1H dimension. Despite the 
peak overlap in the 2D 1H-15N HSQC spectra, it was possible to assign and verify 
the native backbone resonances of Asn and Gln residues, as well as adjacent 
residues in the 3D spectra in the sample prior to the reaction inducing deamidation. 
Many of these signals remain strong after deamidation, indicating that Gln11, 
Asn24, Asn27, Gln28, Gln55, Gln60, Asn103 and Asn113 were not significantly 
deamidated. On the contrary, signal displacement, broadening or loss of intensity 
were detected for Asn34, Asn44, Asn67, Gln69, Asn71, Gln74 and Gln101, 
indicating the reason of possible conformational diversity that would arise from 
partial or complete deamidation.  
All Asn and Gln residues that did not suffer deamidation, except for Asn113 that is 
resistant because is followed by Pro114145, are followed by residues whose NH 
partecipates to the secondary structure and/or is protected against H/D exchange189. 
In these situations, the rigidity afforded is expected to prevent this HN from 
attacking its neighbor’s side chain amide. Conversely, Asn34, Asn67 and Gln69, 
that suffer deamidation, are not bordered by HN in secondary structure or protected 
against exchange. Nevertheless, Asn71 and, partly, Gln74 undergo deamidation, 
even if their neighbors are protected by secondary structure. This strongly suggests 
that the deamidation of Asn67 and possibly Gln69 may produce a local 
conformational change, facilitating Asn71 and Gln74 deamidation.  
Besides Asn and Gln residues, the 1H-15N signals of Lys66 (adjacent to Asn67), 
Lys41, His119 (catalytic residue), Phe120, Asp121 and Ala122 were strongly 
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weakened by deamidation conditions (Fig. 3.10D). On the contrary His12, the other 
catalytic residue, retains its native-like signal. It has recently been shown that 
certain RNase A 1H-15N signals are weakened when the protein is not fully bound 
to phosphate193. Considering this, conformational changes in the P0 subsite (Lys66) 
may cause the spectral changes described. These, like the perturbations at the B2 
(Gln69 and Asn71) and the B1 subsites (Phe120)194, could be involved in the loss 
of enzymatic activity observed when RNase A undergoes deamidation (Table 3.1).  
 
Figure 3.10 – NMR analysis of the poly-
deamidated RNase A species. A) 1D 1H 
Spectrum of RNase A dd2 recorded at 25 °C in 
10 mM NaPi buffer, pH 6.65 with 0.5 mM DSS 
as the internal chemical shift reference. B) 
Downfield region of the 2D 1H NOESY 
spectrum of dd2, showing hundreds of peaks 
typical of native RNase A. The crosspeaks circled in red can be putatively assigned to Gln74. The 
arrowheads in the left of the panel mark distinct HN-Lys66 resonances, which putatively arise from 
Asn67 deamidation. C) Zoom of the NOESY spectrum showing some Asn and Gln -NH2 side-chain 
cross peaks. The signal putatively assigned to Asn67 (circle) appears weaker than two other probable 
Asn/Gln-NH2 cross peaks (solid boxes). Additional peaks (dashed boxes) are putatively assigned to 
additional partially deamidated Asn/Gln -NH2 groups. D) 2D 
1H, 15N HSQC NMR spectra of 13C, 
15N- labeled RNase A prior to (blue signals) and after (red peaks) incubation under deamidation 
conditions, recorded at pH 4.6, 35 °C in 20 mM NaH2PO4 buffer. Selected resonances are labeled. 
Signals that do not substantially change peak width or chemical shift are colored black, while the 
ones that change are blue or red depending on whether the signal corresponds to the spectrum 
acquired before or after incubation under deamidation conditions, respectively.  
shown toweakenwhen the protein is not fully bound to phosphate [57].
Considering this, the spectral changes observed here could reﬂect con-
formational alterations in RNase A P0 subsite (Lys66). This change, as
well as perturbations at the B2 (Gln69 & Asn71) and the B1 subsites
(Phe120) [58], couldwell contribute to the loss of enzymatic activity ob-
served for deamidated RNase A (Table 1).
3.7. Analysis of RNase A dimers' interface sites containing Asn and/or Gln
residues
To obtain more insight on the role of the Asn/Gln residues resulting
as to be deamidated in NMR, we carried out an in silico inspection of
both RNase A N-dimer (ND, PDB ID: 1A2W [4]) and C-dimer (CD, PDB
ID: 1F0V [5]) crystal structures to map the Asn or Gln residues whose
deamidation could affect stability and, although indirectly, to possibly
explain the incapability of the polydeamidated derivatives to
oligomerize.
RNase A displays nine additional Asn and seven Gln residues beside
Asn67. Among them, Gln11, Asn24, Asn27, Asn44 andGln101 inND, and
Asn67, Gln69, Asn71 and Asn113 in CD are directly involved in inter-
chain contacts contributing to the stabilizing interactions of the open in-
terface [59] of the swapped dimers [4,5]. Fig. 6A shows the N-dimer
(ND) with residues belonging to the green subunit marked with an as-
terisk. In this dimer, three hot-spot regions comprising (i) Gln11* and
Asn44, (ii) Asn24, Asn27 and Asn103*, and (iii) Gln101 and Gln101*
can be found. In the C-dimer (CD), two hot-spot regions involving
(i) Asn67, Gln69, Asn71 belonging to the 65–72 loop, and (ii) Asn113
and 113*are visible (Fig. 7A). On the basis of NMR results, only Asn44,
Gln101, and Asn67, Gln69 and Asn71 certainly underwent deamidation.
The in silico analysis of the latter residues positions and contacts
revealed that, in ND, Gln11* and Asn44 are involved in two interchain
contacts, assisted also by the Lys41 side chain (Fig. 6B). Such a contact
cluster is symmetrically present in both ND subunits, importantly to an-
chor both N-swapping-termini. Moreover, Gln101 and 101* are
Table 2
Oligomerization % yielda of N67D-RNase A derivatives.
RNase A species Large oligomers Trimers C-dimer N-dimer Residual monomer
N67D + N67D 1.6 ± 0.2 3.0 ± 0.3 14.2 ± 1.1 5.5 ± 0.7 75.7 ± 2.1
N67D (isoAsp) 1.3 ± 0.1 2.1 ± 0.2 13.1 ± 0.8 4.9 ± 0.4 78.7 ± 1.2
N67D (Asp) 2.5 ± 0.3 4.0 ± 0.4 19.2 ± 1.4 5.8 ± 0.8 68.5 ± 2.0
a Each value reported is the mean of three or four independent experiments. Values are the % ratio of the area of each peak area relative to the total area of thewhole peaks eluted (see
Fig. 3).
Fig. 5. NMR Analysis of the poly-deamidated RNase A species dd. A) 1D 1H Spectrum of
RNase A dd2 recorded at 25 °C in 10 mM NaPi buffer, pH 6.65 with 0.5 mM DSS as the
internal chemical shift reference. The spectrum shows broad chemical shift dispersion
typical of native RNase A. Some signals characteristic of folded RNase A [48] with Val63
γ-methyl H near 0.40 ppm are labeled. B) Downﬁeld region of the 2D 1H NOESY
spectrum of dd2, showing a hundreds of peaks typical of native RNase A. The crosspeaks
circled in red can be putatively assigned to Gln74. The arrowheads in the left of the
panel mark distinct HN-Lys66 resonances, which putatively arise from Asn67
deamidation. Left INSET: zoomed view of the NOESY 1H-1H NMR spectrum was
prepared using Bruker 2.1 TOPSPIN software; 27,000 as the value of the lowest contour
and 1.1 as the multiplication factor between contours. C) Zoom of the NOESY spectrum
showing some Asn and Gln -NH2 side-chain cross peaks. The signal putatively assigned
to Asn67 (circle) appears weaker than two other probable Asn/Gln-NH2 cross peaks
(solid oxes). Additional peaks (dashed boxes) are putatively assigned to additional
partially deamidated Asn/Gln -NH2 groups. D) 2D 1H,15N HSQC NMR spectra of 13C,15N-
labeled RNase A prior to (blue signals) and after (red peaks) incubation under
deamidation conditions [35], recorded at pH 4.6, 35 °C in 20 mM NaH2PO4 buffer.
Selected resonances are labeled. Signals that do not substantially change peak width or
chemical shift are colored black, while the ones that change are blue or red depending
on whether the signal corresponds to the spectrum acquired before or after incubation
under deamidation conditions, r spectively.
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shown toweakenwhen the protein is not fully bound to phosphate [57].
Considering this, the spectral changes observed here could reﬂect con-
formational alterations in RNase A P0 subsite (Lys66). This change, as
well as perturbations at the B2 (Gln69 & Asn71) and the B1 subsites
(Phe120) [58], couldwell contribute to the loss of enzymatic activity ob-
served for deamidated RNase A (Table 1).
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residues
To obtain more insight on the role of the Asn/Gln residues resulting
as to be deamidated in NMR, we carried out an in silico inspection of
both RNase A N-dimer (ND, PDB ID: 1A2W [4]) and C-dimer (CD, PDB
ID: 1F0V [5]) crystal structures to map the Asn or Gln residues whose
deamidation could affect stability and, although indirectly, to possibly
explain the incapability of the polydeamidated derivatives to
oligomerize.
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can be found. In the C-dimer (CD), two hot-spot regions involving
(i) Asn67, Gln69, Asn71 belonging to the 65–72 loop, and (ii) Asn113
and 113*are visible (Fig. 7A). On the basis of NMR results, only Asn44,
Gln101, and Asn67, Gln69 and Asn71 certainly underwent deamidation.
The in silico analysis of the latter residues positions and contacts
revealed that, in ND, Gln11* and Asn44 are involved in two interchain
contacts, assisted also by the Lys41 side chain (Fig. 6B). Such a contact
cluster is symmetrically present in both ND subunits, importantly to an-
chor both N-swapping-termini. Moreover, Gln101 and 101* are
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prepared using Bruker 2.1 TOPSPIN software; 27,000 as the value of the lowest contour
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showing some Asn and Gln -NH2 side-chain cross peaks. The signal putatively assigned
to Asn67 (circle) appears weaker than two other probable Asn/Gln-NH2 cross peaks
(solid boxes). Additional peaks (dashed boxes) are putatively assigned to additional
partially deamidated Asn/Gln -NH2 groups. D) 2D 1H,15N HSQC NMR spectra of 13C,15N-
labeled RNase A prior to (blue signals) and after (red peaks) incubation under
deamidation conditions [35], recorded at pH 4.6, 35 °C in 20 mM NaH2PO4 buffer.
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3.3.9 Analysis of RNase A dimers’ interface sites containing Asn 
and/or Gln residues 
 
An in silico analysis of both N-dimer (PDB ID:1A2W81) and C-dimer (PDB ID: 
1F0V80) structures was performed in order to obtain more information on the way 
in which deamidated residues affect RNase A stability and oligomerization 
tendency. In ND, three hot-spot regions can be found: 1) Gln11* (*refers to the 
second subunit in the dimer) and Asn44, 2) Asn24, Asn27 and Asn103*, and 3) 
Gln101 and Gln101* (Fig. 3.11). In CD, two hot-spot regions involving 1) Asn67, 
Gln69, Asn71 belonging to the 65–72 loop, and 2) Asn113 and 113* are visible (Fig 
3.11). NMR results demonstrated that only Asn44, Asn67, Gln69, Asn71 and 
Gln101 underwent extensive deamidation. In N-dimer, the in silico analysis shows 
that Gln11* and Asn44 are involved in two interchain contacts, where also Lys41 
side chain takes part (Fig. 3.11B). These contacts are symmetrically present in both 
ND subunits, and tether the N-swapping termini. Moreover, Gln101 and Gln101* 
are asymmetrically positioned81,105, and form inter-chain H-bonds with Ser21* and 
Ser22, respectively (Fig. 3.11C). The in silico substitution Asn44* ® Asp/isoAsp, 
followed by local energy minimization, does not allow the formation of the H-bond 
connecting Asn44 d-amide group to the peptide oxygen of Gln11* (Fig. 3.11D,E), 
while Gln101/Gln101* ® Glu substitution affects the H-bond with Ser21* and 
Ser22105 (Fig. 3.11F).  
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Figure 3.11 – RNase A deamidation sites possibly affecting N-dimer stability. A) Ribbon 
representation of RNase A whole ND structure (PDB ID: 1A2W), with the two protomers in green 
and grey and the relative position of the three deamidation hot-spot residues clusters shown as 
yellow, orange and magenta sticks, respectively. B, C) Detailed representation of the interaction 
network of N44 and Q101. D, E and F) Superimposition of the wild-type (dark colors) and the 
structures of N44D, N44D and E101Q mutants (light colors) respectively. Images built using the 
MOE software (CCG Group). 
 
 
The loop formed by Cys65 and Cys72 is a crucial nucleation and folding site of 
RNase A195. It generates a symmetrical interaction network present in both CD 
subunits, involving Asn67, Gln69, Asn71 and Lys66, which contacts the neighbor 
Asp121* (Fig. 3.12B). The composition and/or conformation of the 65-72 loop, 
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tethered to the antiparallel b-strand that connects the two protomers through an H-
bond between Asn71 side chain and Cys110, can alter two strong contacts between 
Lys66 and Asp121*. Moreover, Gln69 side chain interacts with both Asn67 and, 
through a water molecule, Asn71 (Fig. 3.12B). The Asn71 ® Asp deamidation 
could abolish the contact with Cys110, while the Gln69 ® Glu conversion is 
expected to break the interactions with Asn67 and Asn71. In any case, it is difficult 
to predict how the conversion Asp ® isoAsp could alter the structure of the 65-72 
loop, but previous studies showed how this loop affects the stability of RNase A 
dimers105,106, and a concomitant deamidation of Asn67, Gln69 and Asn71 could be  
a deleterious event for the formation of such oligomers. 
 
 
Figure 3.12 – RNase A deamidation sites predicted to affect C-dimer stability. A) RNase A C-dimer 
structure with the two protomers represented in grey and green (residues marked with *). The two 
hot-spot clusters are shown as orange and yellow sticks. B) Zoom on the interaction network 
between N67, Q69, K66 and D121*. The images were produced with MOE software (CCG Group). 
 
 
 
 
asymmetrically position d [4,60] and fo m direct ter-cha n H-bond
with Ser21* and Ser22, respectively (Fig. 6C). In silicomutational analy-
sis and local energy minimization predicted that Asn44*➔ Asp/isoAsp
substitution prevents the formation of the H-bond connecting Asn44
δ-amide group to the peptide oxygen of Gln11*, while Gln101/
Gln101*➔ Glu substitution affects the H-bond with Ser21* and Ser22
[60]. In the C-dimer (CD) the 65–72 loop is an important nucleation
and folding site of RNase A [61] that gen rates an interaction network
symmetrically present in both CD ubunits and involving Asn67,
Gln69, Asn71, and Lys66 that contacts the neighbor Asp121* (Fig. 7B).
Two strong contacts involving Lys66 and Asp121* (Fig. 7B) could be af-
fected by the composition and/or conformation of the 65–72 loop that is
anchored to the antiparallel β-strand connecting the two protomers
through an H-bond forming between the Asn71 side chain and
Cys110. Furthermore, the Gln69 side chain interacts with both Asn67
and 71, th latter through a water molecule (Fig. 7B). The
Fig. 6. RNase A deamidation sites possibly affecting N-dimer stability. A) Ribbon representation of RNase A whole ND structure (PDB ID: 1A2W [4]), with the two protomers in green and
grey and the relative position of the three deamidation hot-spot residues clusters shown as yellow, orange andmagenta sticks, respectively. B, C) Detailed representation of the interaction
network of N44 and Q101. Images built using the MOE software (CCG group) [51].
Fig. 7. RNase A deamidation sites possibly affecting C-dimer stability. A) Ribbon representation of the RNase Awhole CD structure (PDB ID: 1F0V [5]) with the two protomers in green and
grey and the relative position of the two deamidation hot-spot residues clusters shown as yellow and orange sticks, respectively. B) Detailed representation of the interaction network
existing between N67, Q69, N71, K66 and D121*. Images built using the MOE software (CCG group) [51].
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3.4 Discussion 
 
In this work we report that extensive deamidation of Asn/Gln residues almost 
nullifies RNase A oligomerization through 3D-DS. Recent papers indicate that non-
natural aminoacids, as well as small interference molecules, can inhibit amyloid 
fibril formation, thus blocking or slowing the onset of neurodegenerative 
pathologies196–198. Certain point mutation(s) can protect proteins against undesired 
and pathological aggregation199, whereas others enhance oligomerization and 
disease200. Since deamidation exerts an effect comparable to that induced by a point 
mutation, it is not surprising that it can affect protein oligomerization. 
RNase A deamidation starts with N67, the residue most prone to undergo 
deamidation, since it is followed by G68, which does not hinder the formation of 
the cyclic intermediate imide145,201. Our studies demonstrated how RNase A N67D, 
the mixture of N67D and N67D157, deamidation slightly limits the yield of 
oligomers obtained through its lyophilization from 40% acetic acid (Fig. 3.4 and 
3.6), similarly to the effect of deamidation in RNase B140. In particular, while the 
oligomers’ yield produced by N67D is similar to that of the native enzyme, N67D 
derivative hinders the oligomerization propensity to a higher extent. This could be 
due to the extension of the 65-72 loop in the isoAsp derivative, because of the 
additional –CH2– in the backbone, or/and by the increased proximity of the 
carboxylate group to the backbone. This insertion causes the loss of two H-bonds 
(N67-Od–N-Q69 and C65-O–N-G68), with the consequent shift of the 65-72 loop 
toward the main protein body190. In presence of N67D, CD production is more 
affected than that of ND, likely because of the altered interactions between 65-72 
loop and Asp121*, which favor the C-terminal swapping.  
When deamidation is extended to other Asn or Gln residues besides N67, RNase A 
does not oligomerize at all (Fig. 3.4 and 3.7). In the 2D and 3D heteronuclear NMR 
spectra (Fig. 3.10) Asn34, Asn44, Gln69, Asn71, Gln74, and Gln101 resulted to be 
deamidated after a week incubation at pH 8.2, at 37 °C. This is in line with an earlier 
work in which is described how Q69, N71 and and Q74 are the best candidate to 
suffer this modification202. N67, Q69, N71 and Q74 are all residues located in the 
65-72 loop, or in its proximity. This loop, delimited by 65-72 disulfide bond, is one 
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of the first folding nuclei of the protein, and is a dynamically “breathing” loop both 
in monomeric and oligomeric RNase A105,106,203. The influence of this loop on the 
stability of the CD106 was not contradicted by the in silico inspection (Fig. 3.12). 
Furthermore, N67 deamidation may increase the loop flexibility and facilitate the 
deamidation of other Asn/Gln residues of this short domain202, in line with the 
results emerging from 13C, 15N spectra. 
2D 1H NOESY NMR (Fig. 3.10) and far-UV CD spectra (Fig. 3.8) indicate that the 
poly-deamidated derivatives are correctly folded. Hence, the reduced capacity of 
RNase A to oligomerize may be ascribed to three reasons: 1) the monomer and the 
oligomers could be destabilized by a remarkable structural modification of 65-72 
loop. The oligomers stably form only if the native closed interface is 
reconstituded88; 2) poly-deamidation increases the negative charge density, 
especially in the 65-72 loop, with a consequent electrostatic repulsion between the 
subunits84; 3) the Asp (Glu) or isoAsp isomers of each deamidated residue may 
produce a mixture of differently deamidated protomers, that would eliminate the 
correct complementarity necessary for 3D-DS. This third point is supported by the 
fact that 1:1 N67D/N67D and especially 1:1 dd/native RNase mixtures produce a 
lower amount of oligomers with respect to the predicted yield calculated as the 
mean obtained from each separate species (Fig. 3.4). This behavior resembles that 
of other 3D-DS proteins, such as human prion protein, which struggles to form 
hetero-oligomers199. 
According to molecular modeling (Fig. 3.11), N44 and Q101 deamidation detected 
by NMR would reduce ND stability. On the other hand, CD stability could be 
theoretically destabilized by the deamidation of N113. However, this residue is 
resistant to deamidation, because it is followed by a Pro that prevents the formation 
of the cyclic imide145, in line with our 2D and 3D heteronuclear NMR results, which 
demonstrate that N113 does not suffer deamidation. Consequently, the key residues 
that may hinder CD formation upon deamidation should be N67, Q69 and N71 (Fig. 
3.12). 
Overall, deamidation of RNase A seems to inhibit its ability to oligomerize by: 1) 
modifications of the protein structure and of the approach dynamics of the subunits, 
in particular when isoAsp derivative is present, or also when racemization with the 
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consequent formation of D-derivatives may occur204; 2) variation of the charge 
density and/or exposure of the approaching protomers; 3) key H-bonds and contacts 
depletion affecting the dimers. 
In conclusion, the deamidation event, which is naturally linked to protein aging, 
could be a protective mechanism against self-association of RNase A. In fact, since 
several neurodegenerative pathologies are related to protein aging that leads to 
protein self-association, with the consequent formation of toxic oligomers, we 
could propose, considering RNase A as a protein model, that deamidation may 
become an aging strategy of proteins to avoid or limit pathological aggregation. 
This would be in line with the fact that D76N b2-microglobulin increases its 
propensity to aggregate, with respect to wt150. However, an opposite behavior was 
demonstrated for other proteins, such as gD-crystalline, amylin and SOD1151–153, 
whose aggregation propensity is enhanced by deamidation. So, it is difficult to 
generally predict the effect of the deamidation on the aggregation propensity of a 
protein, and further investigations are needed to withdraw general conclusion.
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4.1 Materials 
 
RNase A type XII-A (highest purity available), polyadenylic acid-polyuridylic acid 
[poly(A):poly(U)] and Subtilisin “Carlsberg” were purchased from Sigma. Yeast 
RNA was purchased from Boheringer, and ANS from Molecular Probes. All other 
chemicals were of the highest purity available.  
 
 
 
4.2 Methods 
 
 
4.2.1 RNase A oligomerization 
 
a) Lyophilization from acetic acid 
 
Oligomerization of monomeric RNase A was induced by lyophilizing a solution of 
the protein dissolved in 40% acetic acid at a concentration of about 50 mg/ml78. 
The powder was then resuspended at a concentration of 10 mg/ml in 50 mM 
phosphate buffer (NaPi), pH 6.7.  
 
 
b) Thermally-induced oligomerization  
 
RNase A oligomers were obtained also by incubating the protein dissolved at about 
200-250 mg/ml at 60 °C for 2 hours in 20% or 40% EtOH79. Thereafter, 1 ml of 0.2 
M NaPi buffer, pH 6.7, (preheated at 60 °C) was added to the sample. Once the 
resulting mixture spontaneously cooled to 25 °C, it was put in an ice-bath till further 
analyses.  
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4.2.2 Monomers and dimers purification 
 
Samples that underwent the treatments described were separately purified through 
cation exchange chromatography, using a Source 15S 10/10 column connected to 
an ÄKTA-FPLC system (GE Healthcare). The separation of the different species 
was carried out starting with NaPi, pH 6.7, at a concentration of 70 mM to elute 
RNase A monomer, then increasing it to 90 mM to elute the N-dimer, and 
subsequently performing a 1h linear gradient from 90 mM to 200 mM to elute the 
C-dimer and to purify it from higher order-oligomers107. Hence, RNase A 
monomer, N-dimer and C-dimer were separately collected and used for further 
analyses in parallel with the native, untreated, monomer. 
The NaPi concentration was lowered to 50 mM in each sample, and then protein 
concentration was concentrated to 0.7/0.8 mg/ml, with Amicon plus or Amicon 
mini ultrafilters (3 kDa or 10 kDa c.o.), until use. 
 
 
4.2.3 Enzymatic activity 
 
a) Single strand (ss-)RNA activity  
 
The activity of RNase A monomers was tested using yeast ss-RNA as substrate, 
following the protocol of Kunitz187. Assays were performed with a substrate 
concentration of 0.6 mg/ml (A300 » 0.6), in 0.10 M sodium acetate/acetic acid 
buffer, pH 5.0. Enzyme concentration was 0.75 ng/µl, in each reaction. The 
catalytic activity was determined at 300 nm in the linearity range, measuring the 
absorbance decrease over time per µg of enzyme. The blank measure was 
performed measuring the absorbance of 0.1 M sodium acetate buffer pH 5.0. 
Negative controls were performed by measuring the absorbance of the yeast-RNA 
solution without the addition of the enzyme, in order to exclude the presence of 
contaminant RNases. 
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b) Double stranded (ds-)RNA activity  
 
Activity was tested on synthetic poly(A):poly(U) diluted to 0.045 mg/ml in 400 µl 
of 0.150 M NaCl/ 0.015 M sodium citrate, pH 7.0116. In each assay, 12 µg of RNase 
A monomer(s) or 5 µg of dimer(s) were added. The reaction was followed at 260 
nm, for 300s, in the linearity range. Blank was determined measuring the 
absorbance of 0.150 M NaCl/ 0.015 M sodium citrate solution, pH 7.0. To confirm 
the absence of contaminant RNases, negative controls were performed measuring 
the absorbance of poly(A):poly(U) solution, without the addition of the enzyme. 
The catalytic activity was calculated as the absorbance increase per min and per µg 
of enzyme. 
 
 
4.2.4 Nondenaturing cathodic PAGE  
 
Nondenaturing cathodic PAGE188 was performed with 15%-18% acrylamide gel. 
Protein migration was carried out in cathodic electrode buffer (0.35% β-
alanine/acetic acid buffer, pH 4.0) at a constant voltage of 200 V, for 90 min, in ice 
bath. The gel was subsequently transferred in 12% trichloroacetic acid (TCA) for 
90 min, stained with 0.1% Coomassie Brilliant Blue and destained in 10% 
CH3COOH, 20% EtOH solution.  
   
 
4.2.5 Circular dichroism spectroscopy and thermal denaturation 
analyses 
 
Far- and near-UV CD spectra of RNase A monomers were recorded at 25 °C from 
190 to 240 nm and from 240 to 340 nm, respectively, in 10 mM NaPi buffer, pH 
6.7, using a Jasco-J-810 spectropolarimeter. Near-UV data were recorded with a 
protein concentration ranging from 0.28 to 0.60 mg/ml, while far-UV data with a 
protein concentration comprised between 0.27 and 0.34 mg/ml. All spectra were 
normalized against concentration. The far-UV CD spectra deconvolution was 
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performed by means of DichroWeb Server 
(http://dichroweb.cryst.bbk.ac.uk/html/home.shtml), considering the range 190-
240 nm and using the CONTIN algorithm. 
The thermal denaturation of the monomers was followed by far-UV CD, at 218 nm, 
with a Jasco J-810 spectropolarimeter. Each sample, dissolved in 10 mM NaPi 
buffer, was subjected to a temperature increase of 1.5 °C/min, from 25 °C to 90 °C. 
The Tm of each monomer was hence derived from the 50% far-UV CD signal. 
 
 
4.2.6 1-Anilinonaphthalene-8-Sulfonic acid (1,8-ANS) fluorescence  
 
In order to measure the fluorescence of 1-Anilinonaphthalene-8-Sulfonic acid (1,8-
ANS)-protein complex, each differently treated monomer was incubated with 90 
µM ANS for 1 h, in 10 mM NaPi, at a protein concentration of 0.90 mg/ml, in 
parallel with the native monomer. The spectrum of each sample was then measured 
using a JASCO FP-750 spectrofluorimeter. Samples were excited at 365 nm, and 
emission was recorded from 380 to 550 nm. The bandwidth of both excitation and 
emission was 2 nm. Fluorescence data were obtained subtracting the ANS emission 
contribution from that of each ANS-monomer complex. 
 
 
4.2.7 Limited proteolysis with subtilisin  
 
RNase A monomers were proteolyzed with subtilisin in 0.2 M Tris-HCl pH 8.0, at 
a protein concentration of 0.8 mg/ml205. Subtilisin was added in a subtilisin:RNase 
A weight ratio of 1:1000. Eight µg of each sample were withdrawn at different times 
(0, 15, 30, 60, 120, 240, 480, 1500 min). In order to stop the reaction, PMSF (in 
ethanol solution) was added to each aliquot at a final concentration of 1.5 mM. 
Loading buffer was immediately added, and each sample analyzed with SDS-
PAGE. 
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4.3 Results 
 
4.3.1 RNase A oligomerization 
 
RNase A N- and C-dimers, obtained through lyophilization from 40% acetic acid 
and thermal treatments from 20 or 40% EtOH highly concentrated solutions, were 
purified through cation exchange chromatography, as described in section 4.2.2. 
Figure 4.1 shows the corresponding chromatograms.  
 
  
Figure 4.1 – Cation exchange chromatography of RNase A oligomers performed with a Source 15S 
HR 10/10 column. RNase A oligomers were obtained through A) lyophilization of 1.5 mg protein 
from acetic acid 40%, B) thermal treatment of 1.5 mg protein at 60 °C in EtOH 20% and C) thermal 
treatment of 1 mg protein at 60 °C in EtOH 40%. The separation of RNase A monomer, N-dimer 
and C-dimer was performed increasing NaPi buffer, pH 6.7, concentration from 70 to 90 mM, with 
a subsequent 1h linear gradient from 90 mM to 200 mM. M= RNase A monomer, ND = N-dimer, 
CD = C-dimer. The green line shows the NaPi buffer concentration.  
HAc	lyoph.	
EtOH	40%	
EtOH	20%	
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RNase A monomer, N-dimer and C-dimer elute at 70, 90 and about 120 mM 
phosphate concentration, respectively107. It is evident that the yield of C-dimer is 
higher when obtained through lyophilization from acetic acid or thermal treatment 
from 40% EtOH, in line with previous investigations79,107. On the other hand, N-
dimer is more abundant when obtained by thermal treatment from 40% EtOH 
solution. 
 
 
4.3.2 Enzymatic activity 
 
a) Kunitz assays 
 
Kunitz assays performed against yeast ss-RNA using each species produced by the 
different treatments described show, as expected, that the activity of the monomers 
was higher than that of both dimers, with C-dimers showing in turn a lower activity 
than N-dimers (Fig. 4.2). Assays showed no significantly different activities among 
the same RNase A species (monomers, N-dimers, or C-dimers) obtained under 
different solvent and treatment conditions. It has to be noticed here that RNase A 
monomer degradates yeast-RNA more efficiently with respect to N- and C-dimers.  
These results indicate that the catalytic activity of monomer and N- and C- dimer 
against yeast ss-RNA is not significantly compromised by solvents and/or 
temperatures used to induce RNase A oligomerization.  
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Figure 4.2 – Kunitz activities of monomers (black histograms), N-dimers (gray histograms) and C-
dimers (white histograms) obtained with different treatments. Single stranded yeast RNA was used 
as substrate. The enzymatic activity (Abs/µg*min) is plotted against each protein species. Activities 
are reported as the mean of five independent experiments. Red indicators represent standard 
deviations. M = RNase A monomer, ND = N-dimer, CD = C-dimer.  
 
 
b) RNase A - Poly(A):poly(U) enzymatic assays  
 
The activity values (Abs/µg*min) of monomers and dimers against synthetic ds-
RNA poly(A):poly(U) are reported in figure 4.3. 
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Figure 4.3 – Activities against synthetic Poly(A):poly(U) substrate of monomers (black 
histograms), N-dimers (gray histograms) and C-dimers (white histograms) obtained with different 
treatments. The enzymatic activity (Abs/µg*min) is plotted against each protein species. Activities 
are reported as the mean of five independent experiments. Red indicators represent standard 
deviations. M = RNase A monomer, ND = N-dimer, CD = C-dimer.  
 
 
Monomers obtained with different solvent exposure do not display different 
activities within one another and with respect to native, untreated monomer. On the 
other hand, N-dimers and C-dimers obtained from thermal treatments in 20% or 
40% ethanol are definitely more active against poly(A):poly(U) than the same 
species formed through lyophilization from 40% aqueous acetic acid. 
 
 
4.3.3 Nondenaturing cathodic PAGE  
 
In order to investigate if the different activities against poly(A):poly(U) of N- and 
C-dimers obtained with different treatments could be related to conformational 
changes induced by incubation in various solvents and/or temperatures, all the 
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species produced were analyzed through nondenaturing cathodic PAGE (Figure 
4.4). 
 
Figure 4.4 – Gel electrophoresis under nondenaturing conditions of A) RNase A monomers (M) 
and B) N- (ND) and C–dimers (CD) obtained through lyophilization from acetic acid and thermal 
treatments in 20 or 40% EtOH. 5 µg of each sample were loaded in a 15% polyacrilamide gel. 
 
 
As expected, mobility differences are visible among N-dimers and C-dimers, due 
to both different mass and basic charge exposure107. However, no significant 
mobility differences are detectable within the same oligomer type obtained after 
incubation with different solvents. 
 
 
4.3.4 CD-spectroscopy 
 
The study of the possible structural differences among monomers exposed to 
different treatments was deepened using far- and near-UV CD spectroscopy. Far-
UV spectra of each sample were recorded in 10 mM NaPi buffer, pH 6.7. Data 
derived from spectra deconvolutions are reported in Table 4.1. 
 
 
 
 
 
 
A	 B	
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Table 4.1 – Percentages of helix, β-strand and β-turn and unordered motives resulting from far-UV 
CD spectra deconvolutions of each type of monomer. The value of the normalized root-mean-square 
deviation (NRMSD) obtained by each fitting is reported. Each value is the mean of the two best 
results computed by the algorithm.  
 
 
Although the monomers recovered from acetic acid lyophilization and 20% EtOH 
thermal treatment display a slightly higher amount of helix with respect to the other 
monomeric samples, and considering that the RMSDs calculated for all monomers 
vary between 0.051 and 0.119, the modest differences detected cannot be 
considered significant. 
Near-UV spectra of the differently treated monomers were recorded from 240 to 
340 nm, in 10 mM NaPi buffer, pH 6.7, and are reported in figure 4.5. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5 – Near-UV spectra of native RNase A (green curve), and of RNase A lyophilized from 
40% acetic acid (red curve), or incubated at 60 °C in 20% (black curve) or 40% EtOH (cyan curve). 
Spectra were recorded from 240 to 340 nm in 10 mM NaPi, pH 6.7. The concentration of each 
sample is reported in the Material and Methods section. 
Samples	 Helix	(%)	 b-strand	(%)	 b-turn	(%)	 Unordered	(%)	 NRMSD	
Native	M	 17.8	 27.6	 21.7	 32.9	 0.101	
Liophylized	M	 18.4	 28.6	 22.6	 30.4	 0.075	
20%	EtOH	M	 18.5	 26.8	 22.4	 32.3	 0.119	
40%	EtOH	M	 16.7	 29.9	 22.5	 30.9	 0.051	
	
Ho	tenuto	le	due	diverse	strutture	beta	separ te	perché	è	più	rigoroso.	Tieni	pres nte	che	ciascun	valore	in	
tabella	è	la	media	dei	due	migliori	risultati	che	ha	generato	l’algoritmo.	Come	vedi	non	ci	sono	differenze	
che	si	possono	considerare	veramente	significative.		
PS:	Sistema	i	nomi	dei	campioni,	il	resto	dovrebbe	essere	a	posto.	Alla	precedente	legenda	della	tabella	
aggiungi	”The	value	of	the	normalized	root-mean-square	deviation	(NRMSD)	obtained	by	each	fitting	is	
reported”	
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The CD spectra are minimally affected by the tertiary structure, rather by the 
secondary structure. 
The thermal denaturation of each monomer was analyzed following the variation 
of its 218 nm far-UV CD signal as a function of temperature. Each sample was 
exposed to a temperature increase of 1.5 °C/min, starting from 25 to 90 °C. Figure 
4.6 reports the denaturation curves and the calculated Tm of each monomer.  
 
 
 
Figure 4.6 – Denaturation curves and calculated Tm of native RNase A (green curve), and of RNase 
A lyophilized from 40% acetic acid (red curve), or incubated at 60 °C in 20% (black curve) or 40% 
EtOH (cyan curve). Data were obtained following the denaturations with far-UV CD, at 218 nm, in 
10 mM NaPi, pH 6.7. The concentration of each sample is reported in the Material and Methods 
section.  
 
 
All monomers exposed to acetic acid or ethanol display a melting temperature of 
approximately 63 °C. On the other hand, the melting temperature of RNase A is 
higher (67.6 °C) when the protein is not treated with solvents. This indicates that 
both acetic acid and ethanol treatments and/or high temperatures partially 
destabilize RNase A monomer206. 
 
 
4.3.5 1-Anilinonaphthalene-8-Sulfonic Acid (1,8-ANS) fluorescence  
 
In order to study if different treatments could cause some conformational changes 
and a different exposure of hydrophobic regions, RNase A monomers (0.9 mg/ml) 
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recovered from different treatments were incubated with 90 µM 1,8-ANS 
fluorophore in 10 mM NaPi buffer, pH 6.7. Fluorescence spectra recorder after 1 h 
of incubation are shown in figure 4.7.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7 – ANS fluorescence emission after 1 h incubation with native RNase A monomer (green 
curve), or with monomers recovered from 40% acetic acid lyophilization (red curve), or thermally 
treated in 20% (black curve), or 40% (cyan curve) EtOH. Data were acquired from 450 to 540 nm 
in 10 mM NaPi, pH 6.7. 
 
 
When the monomer recovered from 40% EtOH is incubated with ANS, a 
hyperchromic effect is observed, together with a shifting of the peak from 490 to 
485 nm. This is different compared to other monomers and could be due to different 
local conformational changes, inducing a global major exposure of hydrophobic 
regions. 
 
 
4.3.6 Limited proteolysis with subtilisin 
 
Subtilisin is a non-specific serine protease that specifically hydrolizes RNase A 
peptide bonds between A20-S21 and S21-S22. Subtilisin reaction was performed 
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to investigate if a specific conformational change occured in the N-terminal region, 
or in the protein motives interacting with it. 
SDS-PAGE of the products deriving from monomeric RNase A samples subjected 
to proteolysis with subtilisin is shown in figure 4.8.  
 
 
Figure 4.8 – SDS-PAGE showing the products of limited proteolysis performed with subtilisin on 
A) native RNase A monomer, B) RNase A monomer lyophilized from 40% acetic acid, C) RNase 
A monomer thermally treated in 20% EtOH, D) RNase A monomer thermally treated 40% EtOH. 
Reaction was stopped after 0 (t0), 15, 30, 60, 120, 240, 480 and 1500 min, as reported in the labels 
of the lanes.  
 
 
No significative differences can be detected in the rate of reaction detected with the 
different species, even if the monomer incubated in 20% EtOH seems to be slightly 
more prone to subtilisin cleavage. This suggests that the different treatments do not 
significantly alter the conformation of the N-terminus of RNase A monomer.  
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4.4 Discussion 
 
3D-DS, the mechanism through which RNase A is able to oligomerize, has been 
detected to be one of the mechanisms of amyloid fibers formation. It was 
demonstrated that in the context of amyloid-related pathologies, the toxicity is due 
to the oligomers that are the precursor of amyloid fibers, and they can be toxic or 
not depending on the way they form. Even if there is not evidence that RNase A 
forms amyloid type fibrils, we studied the structural and functional differences of 
its oligomers obtained through different ways: 1) lyophilization from 40% acetic 
acid solution, 2) thermal treatment at 60 °C in 20% ethanol solution and 3) thermal 
treatment at 60 °C in 40% ethanol solution.  
Chromatographic experiments (Fig. 4.1) revealed that the C-dimer is more 
abundant when obtained through lyophilization from acetic acid or thermal 
treatment in 40% EtOH than the one deriving from thermal treatment in 20% EtOH. 
N-dimer, instead, is more aboundant after the treatment in 40% EtOH. Since 40% 
acetic acid lyophilization and thermal treatment at 60° in 40% EtOH solution 
generate a stronger denaturing environment than thermal treatment at 60 °C in 20% 
EtOH, they could favor the almost complete denaturation of RNase A monomer207, 
with the possibly consequent higher yield of C-dimer formed after the addition of 
phosphate buffer. Moreover, the 40% ethanol thermal treatment could somehow 
favor the swapping of RNase A N-terminal domain more than the other two 
incubation types, leading to the generation of more N-dimer. However, no 
significant structural differences are detectable with nondenaturing cathodic PAGE 
(Fig. 4.4) and with far- and near-UV CD spectroscopy (Fig. 4.5, 4.6 and Table 4.1), 
although acetic acid lyophilization and 20% EtOH thermal treatment seem to lead 
to a slightly higher helix content. Then, the overlapping of the near-UV spectra may 
be considered as a confirmation of the actual absence of differences in the 
secondary structure of the different monomers. Anyway, since the RNase A number 
of aromatic residues is low, and their distribution not uniform, an actual modest 
variation of the secondary structure could not be visible as a dichroic signal 
variation in the near-UV. 
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On the contrary, the calculated Tm of each monomer demonstrate that all treatments 
promote their destabilization. In fact, when not submitted to any type of treatment, 
RNase A monomer is more stable, with a Tm of 67.6 °C, that is about 4-5 °C higher 
than the Tm of the monomers that underwent the three different treatments (Fig. 
4.6). Despite the undetectable structural differences with CD analyses, ANS 
fluorescence showed that different treatments may cause a difference in 
hydrophobic residues exposure (Fig. 4.7). In fact, when incubated at 60°C in 40% 
EtOH, RNase A monomer exposes more hydrophobic residues than the native form 
and the same species treated in the other two ways. The combination of harsh 
conditions, i. e., relative high EtOH concentration and high temperature, could 
therefore cause some structural changes that may be accompanied with 
hydrophobic regions exposure. On the other hand, limited proteolysis with 
subtilisin did not show any significant conformational change at the N-terminus of 
the differently treated monomers (Fig. 4.8).  
Finally, lyophilization from acetic acid or thermal treatments in ethanol do not 
significantly affect the activity of RNase A monomer and dimers against ss-RNA 
(Fig. 4.2). On the contrary, both N- and C- dimers activities against ds-RNA are 
enhanced after thermal treatments in presence of EtOH. This indicates that EtOH 
could somehow alter the composed catalytic site region or environment that 
generates after the protein resuspension in NaPi buffer, favoring the increasing of 
dimeric activity (Fig.4.3).  
Thus, we show here how the same protein submitted to different oligomerization 
pathways may produce slightly structurally and functionally different oligomers. 
This is not in contraddiction wity amyloidogenic proteins even if it is well known 
that wt RNase A  does not form fibrils.
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5.1 Materials 
 
Recombinant ONC was produced and purified from E. coli. Aminopeptidase from 
Aeromonas proteolytica (AAP), yeast RNA, poly(A):poly(U) and divinyl sulfone 
(DVS) were purchased from Sigma-Aldrich. SOC medium was from Invitrogen. 
Gemcitabine (2′,2′-difluoro-2′-deoxycytidine; GEM) was provided by Accord 
Healthcare (Milan, Italy) and solubilized in sterile water. All other chemicals were 
used at the highest purity available. 
 
 
 
5.2 Experimental procedures 
 
 
5.2.1 wt ONC competent cells preparation 
 
The cDNA of ONC, inserted in the plasmidic vector pET-22b(+) between Nde 
I/Bam HI restriction sites, was kindly provided by prof. D. Picone and dr. E. 
Notomista (University of Naples, Federico II).  
BL21(DE3) cells were incubated with 100 ng of plasmidic DNA, transferred in ice 
for 30 min, and then immediately at 42 °C for two min. After other two min in ice, 
200 µl TB were added, and the mixture was incubated at 37 °C for 1 h. Then, 100 
µl of solution were transferred in a “Petri” plate containing 15 ml of LB-agar and 
15 mg ampicillin, and colonies were grown overnight. A colony was then collected, 
transferred in 5 ml LB containing 5 mg ampicillin, and grown at 37 °C, overnight. 
Subsequently, 500 µl of culture were mixed with 500 µl glycerol, and immediately 
frozen to -80 °C.  
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5.2.2 H10A ONC mutant construction and production 
 
Primers 5’-TCCAGAAAAAAGCTATCACTAACACTCGTG-3’ and 5’-
CACGAGTGTTAGTGATAGCTTTTTTCTGGA-3’ were used to produce the 
H10A mutant. The PCR was carried out using the QuikChangeII (Agilent) mutation 
kit, and containing 0.5 µl of 117 ng/µl plasmidic DNA, 5 µl of 10X Buffer, 1 µl of 
10 mM dNTPs mix, 1.25 µl of each 25 µM primer, 1 µl of PFU polymerase, 40 µl 
of ddH2O. PCR was performed with the following cycles: 30 sec at 95 °C, 16 x (30 
sec at 95 °C, 1 min at 57 °C, 12 min at 68 °C), 12 sec at 68 °C. The amplification 
product was detected through electrophoresis (100 V, 20 min) on a 0.8 % agarose 
gel, enriched with 1/10 SYBR® dye solution (Invitrogen). The amplification 
product was digested with DpnI at 37 °C, for 1h.  
TOP10 cells (Invitrogen) were incubated with 5 µl of PCR product, transferred in 
ice bath for 30 min, then 30 sec at 42 °C and again 2 min in ice bath. Successively, 
250 µl of SOC medium (Sigma-Aldrich) were added and the sample was incubated 
at 37 °C for 1 h. 80 µl of bacteria were than grown overnight on a “Petri” plate, in 
15 ml of LB-agar containing 15 mg ampicillin. Two colonies were separately 
collected, transferred in 5 ml LB containing 5 mg ampicillin, and grown at 37 °C. 
The plasmidic DNA was purified (PureLink Quick Plasmid Miniprep Kit, 
Invitrogen), sequenced, and the one extracted from a selected colony was used to 
transform BL21(DE3) cells following the same procedure described in section 
5.2.1. 
 
 
5.2.3 wt and H10A onconase expression and purification 
 
Competent cells were grown for 6 h in 5 ml LB and 5 mg AMP, at 37 °C, and then 
overnight in 150 ml of the same broth, at the same temperature. The inoculum was 
subsequently mixed with 1 L of TB, 1 g AMP, incubated at 37 °C, and induced with 
0.4 mM IPTG when the OD600 of 2.4 was reached. Then it was left at 37 °C, 
overnight, under agitation. Cell lysis was performed resuspending the pellet in 10 
ml of 0.1 M Tris-acetate pH 8.4, 5 mM protease inhibitor PMSF, and 2 mg of 
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lysozyme, for 20 min. Then, 32 mg of deoxycholic acid were added, and the 
solution was transferred at 37 °C, for 40 min. After that, 320 Kunitz Units of DNase 
and MgCl2 at the final concentration of 5 mM were added, and the solution was 
incubated 30 min at room temperature. The pellet was then solubilized in 0.1 M 
Tris-acetate, pH 8.4, 10 mM EDTA, 2% Triton X and 2M Urea. After 30 min 
incubation, the “washing” was repeated three times, one with the same buffer and 
two with only 0.1 M Tris-acetate, pH 8.4, plus 10 mM EDTA. The pellet was 
subsequently redissolved in 0.1 M Tris-acetate, pH 8.4, 10 mM EDTA, 6 M 
GdnHCl, and DTT was added at the concentration of 100 mM. A flow of nitrogen 
was used to avoid oxidizing conditions, and the pellet was incubated at 37 °C for 3 
h. The sample was then dialyzed twice against 2 L of 20 mM acetic acid, for 3 h, 
and finally against 5 L, overnight. After pellet removal, the solution was diluted in 
200 ml of 0.1 M Tris-acetate, 0.5 M L-arginine, pH 8.4. A mix of reduced and 
oxidized gluthatione (3 mM/0.6 mM) was added and the sample saturated of 
nitrogen for 22 h. At the end of the reaction, the solution containing the protein was 
transferred in 100 ml of 0.2 M potassium-phosphate pH 8.0, 20 mM ZnSO4, and 
aminopeptidase extracted from Aeromonas proteolytica (AAP) was added in a 
molar ratio AAP:ONC of 1:1000. The solution was incubated for four days at 37 
°C. Subsequently, EDTA was added at a final concentration of 10 mM. ONC was 
further purified using a Superdex 75 HR 10/300 column, connected to an AKTA-
FPLC system (GE-Healthcare), in 0.1 M Tris-acetate pH 8.4, 0.3 M NaCl, at a flow 
rate of 0.2-0.3 ml/min. After the final purification step, ONC quantity was 
spectrophotometrically determined at 280 nm, e1%280 = 8.84 M-1cm-1 (calculated 
with ProtParam tool), with a Jasco V-650 spectrophotometer, and the protein was 
lyophilized from ddH2O. 10 µg of protein sample were resuspended in 100 µl of 
0.1% HCOOH and were analyzed by a high-resolution mass spectrometry on a 
Xevo G2-S Q-TOF instruments (Waters, MA, USA). Experimental conditions: 
capillary potential, 1.5kV; source temperature, 100°C; desolvation gas temperature, 
350°C; collision energy, 20-30V. The mass versus charge signals, visualized as BPI 
(base peak intensity) by the program MassLynx V4.1, were deconvoluted by the 
software MaxEnt1 to achieve the peaks average masses. 
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5.2.4 Onconase oligomerization 
 
To induce its oligomerization, the ONC powder aliquots of 50 to 1000 µg were 
lyophilized from 40% acetic acid, following the procedure described by Crestfield 
& coll. for RNase A78. Some ONC samples were also lyophilized after incubation 
in 0.25-1 mM DTT, 40% acetic acid at 25 °C, for 24 h, or after incubation in 0.5 
mM DTT, 10 mM NaPi, pH 6.7, at 25 °C, for 24 h, before the acetic acid solution. 
The resulting powder was then suspended at concentrations ranging from 1 to 10 
mg/ml, in 0.4 M NaPi, pH 6.7, and separately analyzed through SEC, with a 
Superdex 75 HR 10/300 column attached to an ÄKTA-FPLC system (GE-
Healthcare). The column was equilibrated with the same NaPi buffer and mixtures 
were eluted at a flow rate of 0.10-0.15 ml/min. Chromatographic patterns and areas 
of the resulting peaks were analyzed with the Unicorn 5.01 Software (GE 
Healthcare).  
 
 
5.2.5 Enzymatic activity on single strand (ss-) RNA 
 
Kunitz assays were performed on 0.6 mg/ml (A300 » 0.6) yeast ss-RNA solubilized 
in 0.10 M sodium acetate buffer, pH 5.0, using a Jasco V-650 spectrophotometer. 
RNase A concentration was 0.75 ng/µl, while ONC monomer and dimer 
concentration was 12,5-25 ng/µl. The catalytic activity was determined at 300 nm 
in the linearity range, measuring the absorbance decrease over time per µg of 
enzyme. The blank measure was performed measuring the absorbance of 0.1 M 
sodium acetate buffer pH 5.0. Negative controls were performed by measuring the 
absorbance of the yeast-RNA solution without the addition of the enzyme, in order 
to exclude the presence of contaminant RNases. 
 
 
5.2.6 Nondenaturing cathodic PAGE 
 
Nondenaturing cathodic PAGE188 was performed using a 12.5-15% acrylamide gel, 
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in β-alanine (0.35%)/acetic acid buffer, pH 4.0. ONC samples were electrophoresed 
with a constant voltage of 200 V, for 90 min., in ice. Gels were subsequently 
transferred in 12.5% 2,2,2-trichloroacetic acid for 1.5 h, stained with 0.1% 
Coomassie Brilliant Blue, and destained in 10% CH3COOH, 20% EtOH solution.  
 
 
5.2.7 ONC dimer stability 
 
ONC dimer stability was studied incubating it at 37 °C, for 100 h, at a concentration 
of 0.8 mg/ml in 10 mM NaPi Buffer, pH 6.7, in parallel with RNase A N- and C-
dimers. 5 µg aliquots were withdrawn at different time intervals and run in a 15% 
cathodic nondenaturing PAGE. The stability of ONC dimer in sodium 
acetate/acetic acid buffer, pH 5.0, was studied incubating it at 25 °C, for 120 h. 5 
µg were withdrawn at different time intervals and analyzed in 15% cathodic 
nondenaturing PAGE. The stability of ONC dimer in RPMI 1640 containing 
glutamine, gentamicin sulfate, was studied incubating it at 37 °C, with or without 
the addition of FBS. At different time intervals, 5 µg were withdrawn and analyzed 
in a 15% cathodic nondenaturing PAGE. 
 
 
5.2.8 Cross-linking with divinyl sulfone (DVS) 
 
ONC dimer was cross-linked with DVS at a concentration of 0.25 mg/ml in 0.1 M 
sodium acetate/acetic acid buffer, pH 5.0, or at 0.6 mg/ml in 0.025, 0.05 and 0.1 M 
sodium acetate/acetic acid buffer, pH 5.0. 10% DVS in ethanol solution was added 
in a DVS/protein molar ratio of 1000. Reactions were carried out at 8 or 25 °C. 15 
µg aliquots were withdrawn at times comprised between 0 and 165 h, and the 
reaction was stopped with β-mercaptoethanol (0.2 M final concentration). The 
reaction time-course was electrophoretically analyzed with SDS-PAGE (15% 
polyacrylamide, Tris/glycine buffer, pH 8.3). Gels were run at 200 V, for 60 min.  
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5.2.9 Circular dichroism and fluorescence 
 
Near-UV and far-UV spectra were acquired between 350-240 and 260-190 nm, 
respectively, using a Jasco J-810 spectropolarimeter, performing five total scans for 
each experiment. The far-UV CD spectra deconvolution was performed by means 
of DichroWeb Server (http://dichroweb.cryst.bbk.ac.uk/html/home.shtml), 
considering the range 190-260 nm and using the CONTIN algorithm. 
Fluorescence spectra were acquired using a Jasco FP-750 spectrofluorimeter. The 
excitation wavelength were 280 and 295 nm, and emission was respectively 
recorded from 295 to 550 nm or from 315 to 550 nm.  
For all CD and fluorescence experiments ONC monomer and dimer concentration 
were 0.17 and 0.18 mg/ml, respectively. 
 
 
5.2.10 ONC dimer modeling 
 
Two models of N-swapped ONC dimer were obtained in collaboration with dr. A. 
Pica (University of Naples, Federico II), starting from two different 
crystallographic templates: i) the non-covalent N-swapped dimer (ND) of wild-type 
RNase A (pdb code 1A2W)81, and ii) the dimeric deletion mutant of human 
pancreatic ribonuclease des(16-20)-HP-RNase (pdb code 4KXH)208. They were 
called ND-like model and desHP-like model respectively. The two models were 
obtained superimposing the structure of monomeric ONC (pdb code 2I5S)169 onto 
each structural unit of the domain-swapped dimer templates RNase A-ND or des(16- 
20)-HP-RNase. Then, the eight residues located in the loop connecting His10 
(corresponding to His12 in RNase A) to Cys19 (Cys26 in RNase A) were manually 
modeled using the template structures as a guide.  
MD simulations were performed to compare the two protein models and evaluate 
their stability. The ND-like model was immersed in a box of 7.985x6.646x6.518 
nm3
 
volume and filled with 10203 water molecules. In order to neutralize the 
overall protein charge (+12) and simulate physiological conditions, sodium and 
chloride ions were added to the box at a concentration of 100 mM, corresponding 
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to 21 sodium cations and 33 chloride anions. The desHP-like model was immersed 
in a box of 5.900x7.492x7.687 nm3 filled with 10114 water molecules with the 
addition of 20 sodium cations and 32 chloride anions. Equilibration was conducted 
in two phases. The first phase was to stabilize the temperature of the systems to 300 
K, the second to equilibrate pressure to 1 atm. Before starting the MD simulation, 
energies were minimized by fixing the protein atoms and then without restraints.  
 
 
5.2.11 Cytotoxic activity of ONC oligomers: cell proliferation and 
apoptosis assays 
 
ONC cytotoxicity was measured against PaCa44 human pancreatic 
adenocarcinoma cell line grown in RPMI 1640 supplemented with 2 mM glutamine 
(Life Technologies, Milan, Italy), 10% FBS, and 50 µg/mL gentamicin sulfate 
(BioWhittaker, Lonza, Bergamo, Italy), at 37 °C with 5% CO2.  
Cells were then seeded in 96-well plates (2.5 x 103
 
cells/well) and, the day after, 
incubated with 5, 10 and 25 µg/mL of ONC monomer or dimer, supplemented, or 
not, with 50 nM gemcitabine (GEM)178. After 96 h, cells were stained with a Crystal 
Violet solution (Sigma, Milan, Italy) and the dye was solubilized in PBS containing 
1% SDS to spectrophotometrically analyse the cell growth at 595 nm.  
In apoptosis assays, cells were seeded in 96-well plates (2.5 x 103
 
cells/well) and, 
the day after, treated for 96 h with 10 µg/ml of the mentioned compounds. At the 
end of the treatment, cells were fixed for 30 min with 2% paraformaldehyde in PBS 
solution at RT, then washed twice with PBS and stained for 10 min in the dark at 
RT with annexinV/FITC (Bender MedSystem, Milan, Italy) in the binding buffer 
10 mM HEPES/HCl pH 7.4, 140 mM NaCl, and 2.5 mM CaCl2. Finally, cells were 
washed with a binding buffer solution and fluorescence was measured with a 
multimode plate reader (λexc 485 nm and λem 535 nm) (GENios Pro, Tecan, Milan, 
Italy). Values were normalized on cell proliferation with a Crystal Violet assay.  
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5.3 Results 
 
 
5.3.1 wt ONC expression and purification 
 
Figure 5.1 displays a 18% SDS-PAGE performed after the expression and 
purification steps of wt ONC. 
 
 
 
 
 
       
 
 
Figure 5.1 – 18% SDS-PAGE analysis of the total (T), soluble (S) and insoluble (I) fractions 
deriving from the lysis of BL21(DE3) cells. ONC is detectable in the insoluble fraction (red arrow), 
and moves in the soluble fraction after the dialysis (A. D.). RNase A was used as a MW control. 
 
 
As expected, ONC is detectable in the insoluble fraction, since it is incorporated in 
inclusion bodies, like RNase A. After dialysis against 20 mM acetic acid, all the 
undesidered proteins precipitate, but the ONC monomer moves in the soluble 
fraction. The additional N-terminal residue N-Met was removed by incubating the 
protein for 96h in 0.2 M potassium-phosphate buffer, pH 8.0, containing 
Aeromonas proteolytica Aminopeptidase (AAP), with an AAP/protein molar ratio 
		RNase	A																			T																								S																										I																									A.	D. 
ONC	
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of 1:1000, at 37 °C. After the reaction, the protein was transferred in 0.1 M acetic 
acid pH 8.4, 0.3 M NaCl, and further purified through SEC, in order to remove AAP 
traces. Fig. 5.2 shows that ONC elutes slightly after RNase A, as expected. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2 – Superimposed SEC patterns of ONC monomer (blue curve) after the N-terminal Met 
removal performed with AAP and of RNase A monomer (grey curve). Chromatographies were 
carried out with a Superdex 75 HR 10/300 column equilibrated with 0.1 M acetic acid, pH 8.4, 0.3 
M NaCl buffer. Patterns were normalized on the RNase A monomer area with the Unicorn 5.01 
Software (GE Healthcare). 
 
 
The peak was collected and its content spectrophotometrically quantified, 
transferred in ddH2O and lyophilized. 10 µg of sample were analyzed by a high-
resolution mass spectrometry on a Xevo G2-S Q-TOF instruments (Waters, MA, 
USA). The N-term-Met cleavage occurred successfully for the 78% of the protein, 
while the 22% maintained the N-Met (Data not shown). Mass spectrometry 
confirmed that ONC monomer was correctly expressed. Moreover, ONC catalytic 
activity was tested against yeast ss-RNA, with Kunitz assays and the results are in 
line with those reported in literature209 (Table 5.2). 
RNase A										 ONC	
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5.3.2 ONC oligomers production, purification and characterization 
 
In order to obtain ONC oligomers, ONC monomer was lyophilized from 40% acetic 
acid acqueus solution. The resulting powder was resuspended in 0.4 M NaPi buffer 
pH 6.7, at a concentration ranging from 1 to 10 mg/ml, and analyzed through SEC. 
Figure 5.3 shows the chromatographic pattern of ONC oligomers purification. The 
presence of two peaks before ONC monomer indicates the increasing yield of a 
peak that could be supposed as to be a dimer (eluting at about 13 ml) and the 
formation of a trace of a larger oligomer (eluting at about 12.3 ml). The elution 
volumes of the most abundant species, in fact, is similar the one of RNase A N-
dimer (gray dotted pattern in Fig. 5.3). Moreover, the higher the concentration of 
ONC after the resolubilization in NaPi buffer, the higher the yield of the dimer 
obtained. In fact, we noticed that dimer yield increases from 9.5 to about 13.5% if 
the powder was resuspended at a concentration increasing from 1 to 10 mg/ml 
(Table 5.1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3 – SEC purification of ONC before (dashed line) and after (continuous line) the induced 
oligomerization through lyophilization from 40% acetic acid solution. Traces of ONC dimer are 
constitutively present (dashed line), but after the induction of oligomerization, the yield of the dimer 
increases. Traces of a larger oligomer are also detectable. The RNase A pattern is superimposed in 
grey (dotted line). Patterns were normalized on the RNase A monomer area with the Unicorn 5.01 
Software (GE Healthcare). 
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Table 5.1 – Yields (%) of dimer and larger oligomers obtained after lyophilizing ONC from 40% 
acetic acid buffer and resuspending it in 0.4 M NaPi buffer, pH 6.7 at concentration ranging from 1 
to 10 mg/ml. The quantity of each species was calculated as the area of each peak eluted with SEC 
purifications and the percentage calculated as ratio of (each peak area/total peak area)×100%. The 
values reported are the mean of three or more different experiments. 
 
 
Since it is known that the C-terminus of ONC is blocked by the disulfide bond that 
links Cys87 to Cys104, and that RNase A disulfide bonds are not affected by acetic 
acid207, some ONC fractions were lyophilized after incubation in 0.25-1 mM DTT, 
40% acetic acid at 25 °C, for 24 h, or after incubation in 0.5 mM DTT, 10 mM 
NaPi, pH 6.7, at 25 °C, for 24 h, before the acetic acid solution, in order to try to 
make the C-terminal residues available for the swapping. However, no traces of an 
additional ONC dimer are detected in SEC after these treatments (Fig 5.4). 
 
 
 
 
 
 
 
 
 
 
ONC species Monomer % Dimer % Larger oligomers % 
No HAc lyophilization 96.9 ± 0.4 3.1 ± 0.3 ----- 
1 mg/mL 89.8 ± 0.2 9.7 ± 0.2 0.6 ± 0.2 
2 mg/mL 87.7 ± 0.8 11.4 ± 0.5 0.9 ± 0.3 
4 mg/mL 85.6 ± 0.2 12.8 ± 0.3 1.5 ± 0.2 
10 mg/mL 85.0 ± 0.4 13.4 ± 0.4 1.7 ± 0.6 
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Figure 5.4 – SEC purification of ONC: untreated (light blue curve), lyophilized from 40% acetic 
acid solution (black curve), lyophilized after incubation in 40% acetic acid with the addition of 0.25 
(green curve), 0.5 (red curve) and 1 mM (violet curve) DTT at 25 °C, for 24 h, and lyophilized from 
40% acetic acid solution after incubation with 0.5 mM DTT, 10 mM NaPi, pH 6.7, at 25 °C, for 24h. 
Each sample was resuspended in 0.4 M NaPi buffer, pH 6.7, before the SEC analysis. Patterns were 
normalized on the monomer area with the Unicorn 5.01 Software (GE Healthcare). 
 
 
5.3.3 Comparison of the catalytic activities of ONC monomer and 
dimer against ss-RNA 
 
Kunitz assays were performed in order to measure the enzymatic activity of ONC 
dimer against ss-RNA and compare it to that of the monomer (Table 5.2). 
 
 
 
 
 
 
 
Table 5.2 – Kunitz activity of RNase A monomer, ONC monomer and ONC dimer. The activities 
of all the species are reported as percentages of RNase A monomer activity (100%). Data shown are 
the average of five different assays. 
Species %Kunitz activity 
RNase A  100.0 
ONC monomer 3.5 
ONC dimer 1.4 
0.0
10.0
20.0
30.0
40.0
50.0
mAU
12.0 12.5 13.0 13.5 14.0 14.5 ml
Native ONC
HAc lyoph.
HAc + DTT 0.25 mM
DTT + HAc
HAc + DTT 0.5 mM
HAc + DTT 1 mM
M
D
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Recombinant refolded ONC is less active than RNase A, in line with previous 
results209, and ONC dimer displays about 3.5% activity compared to ONC 
monomer. This result recalls the behavior of RNase A oligomers, whose formation 
leads to the loss of about 40% catalytic activity against ss-RNA79,83,107,112.  
 
 
5.3.4 Nondenaturing cathodic PAGE 
 
In order to analyze the electrophoretic behavior of ONC dimer under nondenaturing 
conditions, the samples collected from SEC were desalted to lower NaPi 
concentration to 50 mM, and 4 µg of ONC monomer and dimer were separately 
subjected to a 12.5 % acrylamide gel electrophoresis under nondenaturing 
conditions188. 
Monomeric ONC maintains the same electrophoretic mobility before and after the 
lyophilization treatment, indicating that harsh conditions do not affect the overall 
protein structure (Fig. 5.5, lane 3 and 4). The dimeric sample obtained after ONC 
lyophilization from 40% acetic acid (Fig. 5.5, lane 2) displays a lower mobility with 
respect to that of ONC monomer. Moreover, it maintains the same mobility of the 
corresponding species present before treatment (Fig. 5.5, lane 1), demonstrating 
that dimer traces are actually constitutively present after ONC purification. Finally, 
the presence of a single band demonstrates that the peak corresponding to ONC 
dimer is not a mixture of different dimeric conformers, but it contains only one 
isoform. 
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Figure 5.5 – 12.5% acrylamide cathodic nondenaturing PAGE of: ONC dimer isolated before (lane 
1) and after 40% acetic acid lyophilization (lane 2), ONC monomer before (lane 3) and after (lane 
4) 40% acetic acid lyophilization. 
 
 
5.3.5 ONC dimer stability  
 
The stability of ONC dimer in 10 mM NaPi buffer, pH 6.7, was studied incubating 
ONC dimer or N- or C-dimers of RNase A at 37 °C, at a concentration of 0.8 mg/ml. 
5 µg aliquots were withdrawn at different times (0, 1, 2, 4, 10, 24, 48, 72, 100 h), 
and run in a cathodic nondenaturing PAGE (Fig. 5.6). Under these conditions, 
traces of ONC dimer are detectable until 72 h, whereas C-dimer and N-dimer persist 
until 24 and 48h, respectively. This indicates that ONC dimer is a more stable 
species than N- and C-dimers of RNase A. 
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Take Home Message 
Onconase (ONC), secreted by Rana Pipiens oocytes [1], is a strongly 
cytotoxic member of the ‘pancreatic-type’ RNase super-family. Although being 
monomeric, its particular structure allows it to evade the cytosolic RNase 
inhibitor [1]. Even though to date no ONC aggregates had been unvealed, we 
induced ONC oligomerization following the protocols used with RNase A [2], 
and we detected definite amounts of ONC dimer that we structurally and 
functionally characterized. 
Recombinant ONC was lyophilized from 40% acetic acid [2]. The resulting 
powder was dissolved in 0.4 M sodium phosphate (NaPi), pH 6.7, and 
analyzed by SEC [2]. 
Native PAGE, SDS-PAGE after cross-linking with divynilsulfone (DVS), and in  
vitro cytotoxic assays [3] were performed with the species isolated by SEC. 
Modeling of the dimer was performed with the AMBER03 force field 
implemented in the program GROMACS. 
We found for the first time that ONC natively forms 
dimeric traces (Fig. 1, dashed line), but the dimer 
yield definitely increases of about four times after acid 
lyophilization [2] (continuous line). The dimer is eluted 
at the same volume of the well-known RNase A ND  
[4] (dotted line). 
Differently from the N- and C-swapped conformers of 
RNase A (Fig. 1, dotted line), ONC forms only one 
dimer, D, also after acidic lyophilization, as it is shown 
also in Fig. 2. 
DVS cross-links the His residues 
located in RNases termini and 
involved in the active site [5]. The 
presence of high MW species after 
SDS-PAGE indicates that ONC 
dimer forms through 3D-domain 
swapping (Fig. 3). 
 
-ONC oligomerization was unexpected for three reasons: i) protein rigidity, 
ii) lack of key-loops, iii) C-terminal Cys forming a locking disulfide. 
-We found that ONC can oligomerize, although to an extent definitely lower 
than bovine RNases [2,6]. 
-Being the C-terminus blocked, the sole dimer forming is N-terminus-
swapped an  odeling suggests to be similar to RNase A N-dimer, ND [4]. 
-ONC dimer resulted to be more cytotoxic and pro-apoptotic than native 
monomer, at low concentrations, also in combination with chemotherapeutic 
agents. 
-Construction f mutants possibly endowe  with higher oligomerization 
tendency and/or cytotoxicity than wt are planned. 
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The ONC dimer was modeled 
starting from the crystallographic 
structure of RNase A-ND [4]. The 
ND-like model seems to be a good 
candidate to represent the structure 
of dimeric ONC, because it has a 
high interface area and it displays a 
high number of stabilizing contacts 
(details not shown). 
Finally, ONC dimer displays to be more cytotoxic than the 
native monomer at low concentrations, either when 
administered alone or with chemotherapeutics [3] (Fig. 5). 
ONC induced to oligomerize by lyophilizing it from 40% aqueous HAc solutions and 
dissolving the powder in the elution column buffer at 4 mg/mL (continuous line). 
Analyses were performed in a Superdex 75 10/300 column equilibrated with 0.4 M NaPi, 
pH 6.7. The representative pattern is reported together with the one of native ONC 
(dashed line) and of oligomerized RNase A (dotted line) [2]. M, monomer; D, dimer; N- & 
C-dimer, N- & C-swapped RNase A dimers [2]. 
Nondenaturing cathodic PAGE of ONC dimer (D) and monomer (M) before (lanes 1 and 3) 
and after (lanes 2 and 4) acid lyophilization.  
SDS-PAGE of ONC dimer after cross-linking with DVS [5]. If 
domain swapping occurred, the His residues of the active 
site were covalently linked to form an undisassociable 
species detectable with a higher MW than the one of ONC 
monomer (t0). This is clearly visible for the ONC dimer. 
Molecular modeling of the N-swapped ONC dimer. A) RNase A N-dimer ND structure [4]; B) ND-like ONC 
dimeric model. MD simulations were performed to test the validity of the model. 
Chemotherapeutic effect of ONC and its dimer. Cell growth (A) and apoptosis (B) were determined 
with Crystal Violet colorimetric and annexinV/FITC binding assays, respectively. Panc1 and PaCa44 
pancreatic adenocarcinoma cells were treated with 10 µg/mL monomer and dimer of ONC, in 
association or not with 50 nM gemcitabine, for 72 h. Values are means (±SD) of three independent 
biological replicates, each performed with three technical replicates. *p< 0.05. 
Onconase (ONC) can produce a domain-swapped dimer, whose structure 
was modeled starting from RNase A N-dimer. Being the ONC dimer more 
cytotoxic than the monomer at low concentration, expecially when 
administrated in combination with gemcitabine, it could become involved in 
fruitful therapeutic implications. 
! 10!
Cys104, while His10 is located in a free N-terminus. It is therefore reasonable that the 
ONC dimer is a N-term-swapped species.!
On the other hand, the absence of a band with a MW larger than the monomer in the 
SDS-PAGE of the trimer indicates that it is not possible to state if 3D-DS occurs or 
not. In fact, even if it occurred, the trimer demonstrates to be too labile to resist under 
the conditions (temperature, pH, buffer) necessary to allow the cross-linking to take 
plac . 
 
Figure 3 – SDS-PAGE analysis of a cross-linking reaction products of ONC dimers (A) and trimers (B) incubated for 24, 50 and 
95 h ith DVS. M = monomer, D = di er. 
 
 
3.4 Modeling of a domain-swapped ONC dimer 
!
The 3D structures of ONC dimer were modeled in collaboration with dr. Andrea Pica 
(University of aples), considering firstly that the protein is free to swap only its 
amino-terminus. Indeed, the C-terminal swapping is precluded by the disulfide 
involving ONC C-terminal cysteine. Models were obtained starting from the structure 
of monomeric ONC (pdb code 2I5S) [28] using two different dimeric templates that 
display different relative orientations between the two subunits: a) the N-swapped 
dimer of RNase A-ND, (pdb code: 1A2W) [6] and b) the dimer of des(16-20)-HP-
RNase (desHP, pdb code: 4KXH) [27], as detailed in the Materials and Methods 
section. Like ONC, both crystallographic structures of dimers retain the standard 
folding of pancreatic-type RNases. The two dimeric ONC models are reported in Fig. 
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6 A and B, paralleled in Fig. 6 C and D by the structures of their parent templates, i.e., 
RNase A-ND and des(16-20)-HP-RNase, respectively. 
In the ND-like model, several interactions contribute to form the open interface [30] 
between the two ONC subunits and stabilize the quaternary structure. In particular, as 
reported in Fig. 7, four strong H-bonds form between the backbones of NH and CO of 
Leu79 of subunit A and Lys81 of subunit B, and vice-versa. It has to be underlined, 
then, that only two H-bonds are present in the same region of the parent RNase A-ND 
[6]. In addition, three extra H-bonds (between Asp18A and Thr14B, Asp18B and 
Tyr64A, Lys81A and Arg15B) and two symmetric salt bridges between Arg73A and 
Glu62B, and vice-versa, are present in the ND-like dimeric ONC model with respect 
to the parent template of RNase A. Accordingly, the interface area between the two 
subunits in the ND-like model is 2121 Å2, about 10% higher than that of the RNase A-
ND (1963 Å2) [6]. !
As far as the other desHP-like model is concerned (panel 6B), its quaternary structure 
is less compact. Indeed, the open interface is stabilized by only two H-bonds 
occurring between the two subunits. Consequently, the interface area is 1573 Å2, thus, 
definitely smaller than the one of the ND-like model. 
 
 
 
 !
  
 
 
 
 
 
 
 
 
 
 
 
Figure 6 -  Molecular modeling of the N-swapped ONC dimer.  A) RNase A ND-like ONC dimeric model; B) desHP-like ONC 
dimeric model; C) RNase A N-dimer, ND  [6]; D) des(16-20)-HP RNase dimer [27]. MD simulations were performed to compare 
the models and test their validity. 
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In the ND-like model, several interactions contribute to form the open interface [30] 
between the two ONC subunits and stabilize the quaternary structure. In particular, as 
reported in Fig. 7, four strong H-bonds form between the backbones of NH and CO of 
Leu79 of subunit A and Lys81 of subunit B, and vice-versa. It has to be underlined, 
then, that only two H-bonds are present in the same region of the parent RNase A-ND 
[6]. In addition, three extra H-bonds (between Asp18A and Thr14B, Asp18B and 
Tyr64A, Lys81A and Arg15B) and two symmetric salt bridges between Arg73A and 
Glu62B, and vice-versa, are present in the ND-like dimeric ONC model with respect 
to the parent template of RNase A. Accordingly, the interface area between the two 
subunits in the ND-like model is 2121 Å2, about 10% higher than that of the RNase A-
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Figure 6 -  Molecular modeling of the N-swapped ONC dimer.  A) RNase A ND-like ONC dimeric model; B) desHP-like ONC 
dimeric model; C) RNase A N-dimer, ND  [6]; D) des(16-20)-HP RNase dimer [27]. MD simulations were performed to compare 
the models and test their validity. 
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As expected, ONC monomer displays higher electropho tic mobility than RNase A 
monomer and the ONC dimer displays higher mobility than the RNase A C-dimer 
(Fig. 2B).   
 
 
Figure 2 – 12.5% acrylamide cathodic nondenaturing PAGE of: A) ONC dimer isolated before (lane 1) and after 40% acetic acid 
lyophilization (lane 2), ONC monomer before (lane 3) and after (lane 4) 40% acetic acid lyophilization and B) RNase A 
monomer (lane1), C-dimer (lane 2), ONC monomer before (lane 3) and after (lane 4) 40% acetic acid lyophilization, ONC dimer 
before (lane 5) and after 40% acetic acid lyophilization (lane 6).  
  
 
3.3 DVS cross-linking 
 
The reactio  of pancreatic-type RNases with DVS, allows to covalently link the two 
His residues of the active site that belong to the two N- and C-termini [29]. This 
reaction allows to assess if the oligomers form through 3D-DS, because if 3D-DS 
took place, an SDS PAGE performed after DVS reaction would reveal a covalently 
stabilized dimer formed by the swapping of one terminus, or both. !
In order to investigate the presence of 3D DS in the dimer and in the supposed trimer 
formed, the two species were separately incubated with DVS, in a protein 
subunit/cross-linker molar ratio of about 1/1000 (1nM/1µM). The reaction was 
stopped at 24, 50, 92, 163 h, adding β-mercaptoethanol, and 6 ug of each sample were 
analyzed through SDS-PAGE (Fig. 3). As shown in Fig. 3A, the presence of two 
bands demonstrates that the 3D-DS mechanism occurs in the ONC dimer. In ONC, 
His97 belongs to the C-terminus blocked by the disulfide involving the terminal 
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Figure 5.6 – A) ONC dimer, B) RNase A N-dimer and C) C-dimer stability until 100 h at 37 °C, 
assayed with cathodic nondenaturing PAGE. 5 µg of each species were withdrawn at 0, 1, 2, 4, 10, 
24, 48, 72 and 100 h and run on the gel. ONC M = ONC monomer, M = RNase A monomer.  
 
 
5.3.6 Far- and near-UV circular dichroism and fluorescence 
analyses 
 
The differences of secondary and tertiary structure detectable among ONC 
monomer and dimer were studied also through circular dichroism. Far-UV CD 
spectra were measured from 190 to 260 nm (Fig. 5.7A). The results of far-UV 
spectra deconvolution are reported in Table 5.3. No significant differences among 
the secondary structures of ONC monomer and dimer were detected through far-
UV CD analysis, as they display about the same amounts of a-helices, b-sheets and 
random coils. 
Near-UV CD data were measured from 240 to 350 nm (Fig. 5.7B), while 
fluorescence was measured exciting at 280 and 295 nm, and recording the emission 
spectra from 300 to 450 nm and from 315 to 450 nm, respectively (Fig. 5.7C/D). 
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Near-UV CD spectra of ONC monomer and dimer do not show significant 
differences, indicating that dimerization does not compromise the global tertiary 
fold of ONC, and therefore that the swapped N-terminal domains would re-establish 
the same contacts present in the monomer (closed interface) with the other subunit, 
as the 3D-DS mechanism foresees88. Fluorescence experiments (lem of 280 and 295 
nm) reveal a 2-3 nm maximum intensity shift of ONC dimer with respect to the 
monomer, in	 dicating a slightly lower exposition to the solvent of the dimer’s 
aromatic side chains. On the other hand, the similar fluorescence intensities shown 
by ONC monomer and dimer confirm that no significant conformational changes 
occur as a consequence of dimerization. 
 
Table 5.3 – Percentages of helix, β-strand and β-turn and unordered motives resulting from far-UV 
CD spectra deconvolutions of ONC monomer and dimer. The value of the normalized root-mean-
square deviation (NRMSD) obtained by each fitting is reported. Each value is the mean of the two 
best results computed by the algorithm.  
 
 
 
 
 
 
 
 
 
	
	
	
Verde	Dimero,	Blu	monomero	
Samples	 Helix	(%)	 b-Strand	(%)	 b-Turn	(%)	 Unordered	(%)	 NRMSD	
ONC	monomer	 18.1	 32.8	 19.6	 29.5	 0.243	
ONC	dimer	 19.4	 27.6	 21.8	 31.2	 0.223	
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Figure 5.7 – A) Far-UV and B) near-UV CD spectra of ONC monomer (M, continuous line) and 
dimer (D, dashed line). Far- and near-UV CD spectra were measured from 190 to 240 nm and from 
240 to 350 nm, respectively. C) Fluorescence at lex = 280 nm, lem = 300-450 nm and D) fluorescence 
at lex = 295 nm, lem = 315-450 nm of ONC monomer (M, continuous line) and dimer (D, dashed 
line). All spectra were measured in 50 mM NaPi buffer, pH 6.7. The concentrations of the samples 
are reported in the Materials and Methods section. 
 
 
5.3.7 DVS cross-linking: investigating the presence of 3D-DS  
 
The reaction of pancreatic-type RNases with DVS allows to covalently link the two 
His residues of the active site that belong to the two N- and C-termini. This reaction 
allows to assess if the oligomers form through 3D-DS because if 3D-DS took place, 
an SDS-PAGE performed after DVS reaction would reveal a covalently stabilized 
dimer formed by the swapping of one terminus, or both.  
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Onconase (ONC), secreted by Rana Pipiens oocytes [1], is a strongly cytotoxic member
of the ‘pancreatic-type’ RNase super-family. Although being monomeric, its particular
structure allows it to evade the cytosolic RNase inhibitor [1]. Even though to date no
ONC aggregates had been unvealed, we induced ONC oligomerization following the
protocols used with RNase A [2] and we detected definite amounts of ONC dimer that we
structurally and functionally characterized.
Recombinant ONC was lyophilized from 40% acetic acid [2]. The resulting powder was dissolved in 0.4
M sodium phosphate (NaPi), pH 6.7, and analyzed by SEC [2].
Native PAGE, SDS-PAGE after cross-linking with divynilsulfone (DVS), Far- and near-UV CD analyses,
fluorescence at !ex of 280 nm and in vitro cytotoxic assays [3] were performed with the species isolated
by SEC.
Modeling of the dimer was performed with the AMBER03 force field and the TIP3P water model
implemented in the program GROMACS.
We found for the first time that ONC spontaneously
forms dimeric traces (Fig. 1, dashed line). The dimer
yield definitely increases of about four times after acid
lyophilization [2] (continuous line) and is eluted at the
same volume of the known RNase A ND [4] (dotted line).
Differently from N- and C-swapped RNase A dimers
(Fig. 1, dotted line), ONC forms only one dimer (D)
also after acid lyophilization, as shown also in Fig. 2.
DVS cross-links the His residues located in the RNases
termini and involved in the active site [5]. The presence
of high MW species after SDS-PAGE indicates that ONC
dimer forms through 3D-domain swapping (Fig. 3).
-ONC oligomerization was somehow unexpected for three reasons: i) prot in rigidity, ii)
lack of favorable key-loops, iii) C-terminal Cys forming a locking disulfide.
-We found that ONC can definitely oligomerize through 3D domain swapping, as
confirmed by DVS cross-linking, although to a lower extent than bovine RNases [2,7].
-Being the C-terminus locked, the unique dimer forming is N-terminus-swapped and its
modeling suggests it to be similar to RNase A N-dimer, ND [4]. This has been indirectly
confirmed by the fact that an ONC H10A mutant is not able to generate the dimer.
-ONC dimer cytotoxicity, higher than the native monomer, also in combination with
chemotherapeutic agents, needs to be further investigated starting from previous data [3].
-Construction and production of mutants possibly endowed with higher oligomerization
tendency and/or cytotoxicity than wt has already been started.
1. Ardelt W. & al. 2008, Curr. Ph. Biotech. 9, 215-25
2. Libonati M. & Gotte G. 2004, Bioch. J. 380, 311-27
3. Fiorini C. & al. 2015, BBA-MCR 1853, 549-60
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The structure of the ONC dimer has been modeled
starting from the crystallographic structure of RNase A-
ND [4]. The ND-like model seems to be the best candidate
to represent the structure of dimeric ONC because it has
a high interface area and it displays a high number of
stabilizing contacts (details not shown).
Finally, ONC dimer displays to be more cytotoxic than the
native monomer [3] at low concentrations, either when
administered, alone or with chemotherapeutics, against
a pancreatic cancer cell line (Fig. 7).
ONC induced to oligomerize by lyophilizing it from 40% aqueous HAc
solutions, dissolving the powder at 4 mg/mL in the Superdex 75 10/300 elution
column buffer, 0.4 M NaPi, pH 6.7, and eluting it in the same column (solid
line). The representative pattern is reported together with the one of native
ONC (dashed line) and of oligomerized RNase A (grey dotted line) [2]. M & M,
monomers; D, ONC dimer; ND & CD, N- & C-swapped RNase A dimers [2].
Nondenaturing cathodic
PAGE of ONC dimer (D) and
monomer (M), before (lanes
1 and 3) and after (lanes 2
and 4) acid lyophilization.
SDS-PAGE of ONC dimer after
cross-linking with DVS [5]. If
domain swapping occurred, the
His residues of the active site
would be covalently linked to
form an indissociable species
detectable with a higher MW
than the one of ONC monomer
(t0). This is clearly visible for the
ONC dimer.
Molecular modeling of the N-swapped ONC dimer. A) RNase A N-dimer ND structure
[4]; B) Blue ND-like ONC dimeric model. MD simulations were performed to test the
validity of the model.
Onconase (ONC) can produce a N-terminus domain-swapped dimer, whose
structure was modeled on that of RNase A N-dimer. The ONC dimer is more
cytotoxic than the monomer at low concentration, expecially in combination
with gemcitabine. This suggests potential new therapeutic implications
based on the use of ONC oligomers.
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As expected,  monomer displays higher electrophoretic mobility than RNase A 
monomer and the ONC dimer displays higher mobility than the RNase A C-dimer 
(Fig. 2B).   
 
 
Figure 2 – 12.5% acrylamide cathodic nondenaturing PAGE of: A) ONC dimer isolated before (lane 1) and after 40% acetic acid 
lyophilization (lane 2), ONC monomer before (lane 3) and after (lane 4) 40% acetic acid lyophilization and B) RNase A 
monomer (lane1), C-dimer (lane 2), ONC monomer before (lane 3) and after (lane 4) 40% acetic acid lyophilization, ONC dimer 
before (lane 5) and after 40% acetic acid lyophilization (lane 6).  
  
 
3.3 DVS cross-linking 
 
The reaction of pancreatic-type RNases with DVS, allows to covalently link the two 
His residues of the active site that belong to the two N- and C-termini [29]. This 
reaction allows to assess if the oligomers form through 3D-DS, because if 3D-DS 
took place, an SDS PAGE performed after DVS reaction would reveal a covalently 
stabilized dimer formed by the swapping of one terminus, or both. !
In order to investigate the presence of 3D DS in the dimer and in the supposed trimer 
formed, the two species were separately incubated with DVS, in a protein 
subunit/cross-linker molar ratio of about 1/1000 (1nM/1µM). The reaction was 
stopped at 24, 50, 92, 163 h, adding β-mercaptoethanol, and 6 ug f each sample were 
analyzed through SDS-PAGE (Fig. 3). As shown in Fig. 3A, the presence of two 
bands demonstrates that the 3D-DS mechanism occurs in the ONC dimer. In ONC, 
His97 belongs to the C-terminus blocked by the disulfide involving the terminal 
2  &  4: after ONC lyophil. from 40%HAc solutions 
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6 A and B, paralleled in Fig. 6 C and D by the structures of their parent templates, i.e., 
RNase A-ND and des(16-20)-HP-RNase, respectively. 
In the ND-like model, several interactions contribute to form the open interface [30] 
between the two ONC subunits and stabilize the quaternary structure. In particular, as 
reported in Fig. 7, four strong H-bonds form between the backbones of NH and CO of 
Leu79 of subunit A and Lys81 of subunit B, and vice-versa. It has to be underlined, 
then, that only two H-bonds are present in the same region of the parent RNase A-ND 
[6]. In addition, three extra H-bonds (between Asp18A and Thr14B, Asp18B and 
Tyr64A, Lys81A and Arg15B) and two symmetric salt bridges between Arg73A and 
Glu62B, and vice-versa, are present in the ND-like dimeric ONC model with respect 
to the parent template of RNase A. Accordingly, the interface area between the two 
subunits in the ND-like model is 2121 Å2, about 10% higher than that of the RNase A-
ND (1963 Å2) [6]. !
As far as the other desHP-like model is concerned (panel 6B), its quaternary structure 
is less compact. Indeed, the open interface is stabilized by only two H-bonds 
occurring between the two subunits. Consequently, the interface area is 1573 Å2, thus, 
definitely smaller than the one of the ND-like model. 
 
 
 
 !
  
 
 
 
 
 
 
 
 
 
 
 
Figure 6 -  Molecular modeling of the N-swapped ONC dimer.  A) RNase A ND-like ONC dimeric model; B) desHP-like ONC 
dimeric model; C) RNase A N-dimer, ND  [6]; D) des(16-20)-HP RNase dimer [27]. MD simulations were performed to compare 
the models and test their validity. 
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6 A and B, paralleled in Fig. 6 C and D by the structures of their parent templates, i.e., 
RNase A-ND and des(16-20)-HP-RNase, respectively. 
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reported in Fig. 7, four strong H-bonds form between the backbones of NH and CO of 
Leu79 of subunit A and Lys81 of subunit B, and vice-versa. It has to be underlined, 
then, that only two H-bonds are present in the same region of the parent RNase A-ND 
[6]. In addition, three extra H-bonds (between Asp18A and Thr14B, Asp18B and 
Tyr64A, Lys81A and Arg15B) and two symmetric salt bridges between Arg73A and 
Glu62B, and vice-versa, are present in the ND-like dimeric ONC model with respect 
to the parent template of RNase A. Accordingly, the interface area between the two 
subunits in the ND-like model is 2121 Å2, about 10% higher than that of the RNase A-
ND (1963 Å2) [6]. !
As far as the other desHP-like model is concerned (panel 6B), its quaternary structure 
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Far-(not shown) and Near-UV (Fig. 4) CD spectra
show that not significant differences in the secondary
and tertiary structures are present in the ONC
m nomer d dimer. This suggest that ONC dimer
reconstitutes the correct closed interface [6] present
in the monomer
Fig. 3
D
M
Fluorescence at !ex = 280 nm
and !em = 300-450 nm of ONC
monomer (M, continuous line)
and dimer (D, dashed line) in 50
mM NaPi buffer, pH 6.7.
Fluorescence shows a 2-3 nm maximum intensity
shift of ONC dimer with respect to the monomer (!ex=
280 nm), indicating a slightly different exposition to
the solvent of the aromatic side chain, probably of
Trp3, of the two ONC species (Fig. 5).
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Near-UV CD spectra
of ONC monomer
(M, continuous line)
and dimer (D,
dashed line). The
spectra were
acquired in 50 mM
NaPi buffer, pH 6.7,
from 240 to 350 nm.
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The swapping occurs at the N-terminal domain, since
the C-terminal Cys is involved in a disolfide bond. In
order to prove it, H10A mutant was planned,
expressed and purified.
However, this species is not able to oligomerize (data
not shown), indirectly demonstrating that ONC dimer
forms through the N-terminal swapping.
In vivo effects of ONC monomer and dimer associated to chemotherapy. Cell
growth (A and B), and apoptosis (C) of PaCa44 pancreatic adenocarcinoma cells
determined with Crystal Violet colorimetric assay and annexinV/FITC binding
assay, respectively. Cells were seeded in 96-well plates, incubated overnight, and
treated with native ONC monomer and dimer, at the indicated concentrations in the
absence or presence of 50 nM GEM for 96 h. Values are means (SD) of three
independent biological replicates, each performed using three technical replicates.
Statistical analysis: * p < 0.05.
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Take Home Message
Onconase (ONC), secreted by Rana Pipiens oocytes [1], is a strongly cytotoxic member
of the ‘pancreatic-type’ RNase super-family. Although being monomeric, its particular
structure allows it to evade the cytosolic RNase inhibitor [1]. Even though to date no
ONC aggregates had been unvealed, we induced ONC oligomerization following the
protocols used with RNase A [2] and we detected definite amounts of ONC dimer that we
structurally and functionally characterized.
Recombinant ONC was lyophilized from 40% acetic acid [2]. The resulting powder was dissolved in 0.4
M sodium phosphate (NaPi), pH 6.7, and analyzed by SEC [2].
Native PAGE, SDS-PAGE after cross-linking with divynilsulfone (DVS), Far- and near-UV CD analyses,
fluorescence at !ex of 280 nm and in vitro cytotoxic assays [3] were performed with the species isolated
by SEC.
Modeling of the dimer was performed with the AMBER03 force field and the TIP3P water model
implemented in the program GROMACS.
We found for the first time that ONC spontan ously
forms dimeric traces (Fig. 1, dashed line). The dimer
yield definitely increases of about four times after acid
lyophilization [2] (continuous line) and is eluted at the
same volume of the known RNase A ND [4] (dotted line).
Differently from N- and C-swapped RNase A dimers
(Fig. 1, dotted line), ONC forms only one dimer (D)
also after acid lyophilization, as shown also in Fig. 2.
DVS cross-links the His residues located in the RNases
termini and involved in the active site [5]. The presence
of high MW species after SDS-PAGE indicates that ONC
dimer forms through 3D-domain swapping (Fig. 3).
-ONC oligomerization was somehow unexpected for three reasons: i) protein rigidity, ii)
lack of favorable key-loops, iii) C-terminal Cys forming a locking disulfide.
-We found that ONC can definitely oligomerize through 3D domain swapping, as
confirmed by DVS cross-linking, although to a lower extent than bovine RNases [2,7].
-Being the C-terminus locked, the unique dimer forming is N-terminus-swapped and its
modeling suggests it to be similar to RNase A N-dimer ND [4]. This has been indirectly
confirmed by the fact that an ONC H10A mutant is not able to generate the dimer.
-ONC dimer cytotoxicity, higher than the native monomer, also in combination with
chemotherapeutic agents, needs to be further investigated starting from previous data [3].
-Construction and production of mutants possibly endowed with higher oligomerization
tendency and/or cytotoxicity than wt has already been started.
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The structure of the ONC dimer has been modeled
starting from the crystallographic structure of RNase A-
ND [4]. The ND-like model seems to be the best candidate
to represent the structure of dimeric ONC because it has
a high interface area and it displays a high number of
stabilizing contacts (details not shown).
Finally, ONC dimer displays to be more cytotoxic than the
native monomer [3] at low concentrations, either when
administered, alone or with chemotherapeutics, against
a pancreatic cancer cell line (Fig. 7).
ONC induced to oligomerize by lyophilizing it from 40% aqueous HAc
solutions, dissolving the powder at 4 mg/mL in the Superdex 75 10/300 elution
column buffer, 0.4 M NaPi, pH 6.7, and eluting it in the same column (solid
line). The representative pattern is reported together with the one of native
ONC (dashed line) and of oligomerized RNase A (grey dotted line) [2]. M & M,
monomers; D, ONC dimer; ND & CD, N- & C-swapped RNase A dimers [2].
Nondenaturing cathodic
PAGE of ONC dimer (D) and
monomer (M), before (lanes
1 and 3) and after (lanes 2
and 4) acid lyophilization.
SDS-PAGE of ONC dimer after
cross-linking with DVS [5]. If
domain sw pping occurred, the
His residues of the active site
would be covalently linked to
form an indissociable species
detectable with a higher MW
than the one of ONC monomer
(t0). This is clearly visible for the
ONC dimer.
Molecular modeling of the N-swapped ONC dimer. A) RNase A N-dimer ND structure
[4]; B) Blue ND-like ONC dimeric model. MD simulations were performed to test the
validity of the model.
Onconase (ONC) can produce a N-terminus domain-swapped dimer, whose
structure was modeled on that of RNase A N-dimer. The ONC dimer is more
cytotoxic than the m nom r at low concentration, expecially in combination
with gemcitabine. This suggests potential new therapeutic implications
based on the use of ONC oligomers.
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As expected,  monomer displays higher electrophoretic mobility than RNase A 
monomer and the ONC dimer displays higher mobility than the RNase A C-dimer 
(Fig. 2B).   
 
 
Figure 2 – 12.5% acrylamide cathodic nondenaturing PAGE of: A) ONC dimer isolated before (lane 1) and after 40% acetic acid 
lyophilization (lane 2), ONC monomer before (lane 3) and after (lane 4) 40% acetic acid lyophilization and B) RNase A 
monomer (lane1), C-dimer (lane 2), ONC monomer before (lane 3) and after (lane 4) 40% acetic acid lyophilization, ONC dimer 
before (lane 5) and after 40% acetic acid lyophilization (lane 6).  
  
 
3.3 DVS cross-linking 
 
The reaction of pancreatic-type RNases with DVS, allows to c valently link e two 
His residues of the active site that belong to the two N- and C-termini [29]. This 
reaction allows to assess if the oligomers form through 3D-DS, because if 3D-DS 
took place, an SDS PAGE performed after DVS reaction would reveal a covalently 
stabilized dimer formed by the swapping of one terminus, or both. !
In order to investigate the presence of 3D DS in the dimer and in the supposed trimer 
formed, the two species were separately incubated with DVS, in a protein 
subunit/cross-linker molar ratio of about 1/1000 (1nM/1µM). The reaction was 
stopped at 24, 50, 92, 163 h, adding β-mercaptoethanol, and 6 ug f each sample were 
analyzed through SDS-PAGE (Fig. 3). As shown in Fig. 3A, the presence of two 
bands demonstrates that the 3D-DS mechanism occurs in the ONC dimer. In ONC, 
His97 belongs to the C-terminus blocked by the disulfide involving the terminal 
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6 A and B, paralleled in Fig. 6 C and D by the structures of their parent templates, i.e., 
RNase A-ND and d s(16-20)-HP-RNase, respectively. 
In the ND-like model, several interactions contribute to form the open interface [30] 
between the two ONC subunits and stabilize the quaternary structure. In particular, as 
reported in Fig. 7, four strong H-bonds form between the backbones of NH and CO of 
Leu79 of subunit A and Lys81 of subunit B, and vice-versa. It has to be underlined, 
then, that only two H-bonds are present in the same region of the parent RNase A-ND 
[6]. In addition, three extra H-bonds (between Asp18A and Thr14B, Asp18B and 
Tyr64A, Lys81A and Arg15B) and two symmetric salt bridges between Arg73A and 
Glu62B, and vice-versa, are present in the ND-like dimeric ONC model with respect 
to the parent template of RNase A. Accordingly, the interface area between the two 
subunits in the ND-like model is 2121 Å2, about 10% higher than that of the RNase A-
ND (1963 Å2) [6]. !
As far as the other desHP-like model is concerned (panel 6B), its quaternary structure 
is less compact. Indeed, the open interface is stabilized by only two H-bonds 
occurring between the two subunits. Consequently, the interface area is 1573 Å2, thus, 
definitely smaller than the one of the ND-like model. 
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Figure 6 -  Molecular modeling of the N-swapped ONC dimer.  A) RNase A ND-like ONC dimeric model; B) desHP-like ONC 
dimeric model; C) RNase A N-dimer, ND  [6]; D) des(16-20)-HP RNase dimer [27]. MD simulations were performed to compare 
the models and test their validity. 
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6 A and B, paralleled in Fig. 6 C and D by the structures of their parent templates, i.e., 
RNase A-ND and des(16-20)-HP-RNase, respectively. 
In the ND-like model, several interactions contribute to form the open interface [30] 
between the two ONC subunits and stabilize the quaternary structure. In particular, as 
reported in Fig. 7, four strong H-bonds form between the backbones of NH and CO of 
Leu79 of subunit A and Lys81 of subunit B, and vice-versa. It has to be underlined, 
then, that only two H-bonds are present in the same region of the parent RNase A-ND 
[6]. In addition, three extra H-bonds (between Asp18A and Thr14B, Asp18B and 
Tyr64A, Lys81A and Arg15B) and two symmetric salt bridges between Arg73A and 
Glu62B, and vice-versa, are present in the ND-like dimeric ONC model with respect 
to the parent template of RNase A. Accordingly, the interface area between the two 
subunits in the ND-like model is 2121 Å2, about 10% higher than that of the RNase A-
ND (1963 Å2) [6]. !
As far as the other desHP-like model is concerned (panel 6B), its quaternary structure 
is less compact. Indeed, the open interface is stabilized by only two H-bonds 
occurring between the two subunits. Consequently, the interface area is 1573 Å2, thus, 
definitely smaller than the one of the ND-like model. 
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Figure 6 -  Molecular modeling of the N-swapped ONC dimer.  A) RNase A ND-like ONC dimeric model; B) desHP-like ONC 
dimeric mo el; C) RNase A N-dimer, ND  [6]; D) des(16-20)-HP RNase dimer [27]. MD simulations were performed to compare 
the models and test their validity. 
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Far-(not shown) and Near-UV (Fig. 4) CD spectra
show that not significant differences in the secondary
and tertiary structures are present in the ONC
monomer and dimer. This suggest that ONC dimer
reconstitutes the correct closed interface [6] present
in the monomer
Fig. 3
D
M
Fluorescence at !ex = 280 nm
and !em = 300-450 nm of ONC
monomer (M, continuous line)
and dimer (D, dashed line) in 50
mM NaPi buffer, pH 6.7.
Fluorescence shows a 2-3 nm maximum intensity
shift of ONC dimer with respect to the monomer (!ex=
280 nm), indicating a slightly different exposition to
the solvent of the aromatic side chain, probably of
Trp3, of the two ONC species (Fig. 5).
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Near-UV CD spectra
of ONC monomer
(M, continuous line)
and dimer (D,
dashed line). The
spectra were
acquired in 50 mM
NaPi buffer, pH 6.7,
from 240 to 350 nm.
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The swapping occurs at the N-terminal domain, since
the C-terminal Cys is involved in a disolfide bond. In
order to prove it, H10A mutant was planned,
expressed and purified.
However, this species is not able to oligomerize (data
not shown), indirectly demonstrating that ONC dimer
forms through the N-terminal swapping.
In vivo effects of ONC monomer and dimer associated to chemotherapy. Cell
growth (A and B), and apoptosis (C) of PaCa44 pancreatic adenocarcinoma cells
determined with Crystal Violet colorimetric assay and annexinV/FITC binding
assay, respectively. Cells were seeded in 96-well plates, incubated overnight, and
treated with native ONC monomer and dimer, at the indicated concentrations in the
absence or presence of 50 nM GEM for 96 h. Values are means (SD) of three
independent biological replicates, each performed using three technical replicates.
Statistical analysis: * p < 0.05.
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Figure 5.7 – A) Near-UV CD spectra of ONC monomer (M, continuous line) and dimer (D, dashed 
line). The spectra were measured from 240 to 350 nm. B) Fluorescence at lex = 280 nm and lem = 
300-450 nm and at lex = 295 nm and lem = 315-450 nm of ONC monomer (M, continuous line) and 
dimer (D, dashed line). All spectra were measured in 50 mM NaPi buffer, pH 6.7. 
 
 
Near-UV CD spectra of ONC monomer and dimer do not show significant 
differences, indicating that dimerization does not compromise the global tertiary 
fold of ONC, and th ref re that the swapp d N-terminal d mains would re-establish 
the sam  co tacts present in th  monomer (closed interface) with the other subunit, 
as the 3D-DS mechanism foresees89. On the contrary, fluorescence experiments 
(lem of 280 and 295 nm) reveal a 2-3 m maxi um intensity shift of ONC dimer 
with respect to the monomer, indicating a slightly lower xposition to the solvent 
f the dimer’s aromat c side chains. On the other hand, the similar fluorescence 
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Take Home Message
Onconase (ONC), secreted by Rana Pipiens oocytes [1], is a strongly cytotoxic member
of the ‘pancreatic-type’ RNase super-family. Although being monomeric, its particular
structure allows it to evade the cytosolic RNase inhibitor [1]. Even though to date no
ONC aggregates had been unvealed, we induced ONC ligom rization following the
protocols used with RNase A [2] and we detected definite amounts of ONC dimer that we
structurally and functionally characteriz .
Recombinant ONC was lyophilized from 40% acetic acid [2]. The resulting powder was dissolved in 0.4
M sodium phosphate (NaPi), pH 6.7, and analyzed by SEC [2].
Native PAGE, SDS-PAGE ft r cross-li king with divynil ulfone (DVS), Far- and near-UV CD analyses,
fluorescence at !ex of 280 nm and in vitro cytotoxic assays [3] w re performed with the species isolated
by SEC.
Modeling of the dimer was performed with the AMBER03 force field and the TIP3P water model
impleme ed in the program GROMACS.
We found for the first time that ONC spontaneously
forms dimeric traces (Fig. 1, dashed line). The dimer
yield definitely incre ses of about four times after acid
lyophilization [2] (continuous line) and is eluted at the
same volume of the known RNase A ND [4] (dotted line).
Differently from N- and C-swapped RNase A dimers
(Fig. 1, dotted line), ONC forms only ne imer (D)
also after acid lyophilization, as shown also in Fig. 2.
DVS cross-links the His residu s located in h R ases
termini and involved in the active site [5]. The prese ce
of high MW species after SDS-PAGE indicates that ONC
dimer forms through 3D-domain swapping (Fig. 3).
-ONC oligomerization w s som how unexpected for three reas ns: i) protein rigidity, ii)
lack of favorable key-loops, iii) C-terminal Cys forming a locking disul ide.
-We found that ONC can definitely oligomerize through 3D domain swapping, as
confirmed by DVS cross-linking, although to a lower extent than bovine RNases [2,7].
-Being the C-terminus locked, the unique dimer forming is N-terminus-swapped and its
modeling suggests it to be similar to RNase A N-dimer, ND [4]. This has been indirectly
confirmed by the fact that an ONC H10A mutant is not able to generate the dimer.
-ONC dimer cytotoxicity, higher than the native monomer, also in combination with
chemotherapeutic agents, needs to be further investigated starting from previous data [3].
-Construction and production of mutants possibly endowed with higher oligomerization
tendency and/or cytotoxicity than wt has already been started.
1. Ardelt W. & al. 2008, Curr. Ph. Biotech. 9, 215-25
2. Libonati M. & Gotte G. 2004, Bioch. J. 380, 311-27
3. Fiorini C. & al. 2015, BBA-MCR 1853, 549-60
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The structure of the ONC dimer has been modeled
starting from the crystallographic structure of RNase A-
ND [4]. The ND-like model seems to be the best candidate
to represent the structure of dimeric ONC because it has
a high interface area and it displays a high number of
stabilizing contacts (details not shown).
Finally, ONC dimer displays to be more cytotoxic than the
native monomer [3] at low concentrations, either when
administered, lone or with chemotherapeutics, against
a pancreati cancer cell line (Fig. 7).
ONC induced to oligomerize by lyophilizing it from 40% aqueous HAc
solutions, dissolving the powder at 4 mg/mL in the Superdex 75 10/300 elution
column buffer, 0.4 M NaPi, pH 6.7, and eluting it in the same column (solid
line). The representative pattern is reported together with the one of native
ONC (dashed line) and of oligomerized RNase A (grey dotted line) [2]. M & M,
monomers; D, ONC dimer; ND & CD, N- & C-swapped RNase A dimers [2].
Nondenaturing cathodic
PAGE of ONC dimer (D) and
monomer (M), before (lanes
1 and 3) and after (lanes 2
and 4) acid lyophilization.
SDS-PAGE of ONC dimer after
cross-linki g with DVS [5]. If
domain swapping ccurred, the
His residues of the active site
would be covalently linked to
form an indissociable species
detectable with a higher MW
than the one of ONC monomer
(t0). This i clearly isible for th
ONC dimer.
Molecular modeling of the N-swapped ONC dimer. A) RNase A N-dimer ND structure
[4]; B) Blue ND-like ONC dimeric model. MD simulations were performed to test the
validity of the model.
Onconas (ONC) can produce a N-terminus domain-swapped dimer, whose
structure was modeled on that of RNase A N-dimer. The ONC dimer is more
cytotoxic than the monomer at low concentration, expecially in combination
with gemcitabine. This suggests potential new therapeutic implications
based on the use of ONC oligomers.
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As expected,  monomer displays higher electrophoretic mobility than RNase A 
monomer and the ONC dimer displays higher mobility than the RNase A C-dimer 
(Fig. 2B).   
 
 
Figure 2 – 12.5% acrylamide cathodic nondenaturing PAGE of: A) ONC dimer isolated before (lane 1) and after 40% acetic acid 
lyophilization (lane 2), ONC monomer before (lane 3) and after (lane 4) 40% acet c acid lyophilization and B) RNase A 
monomer (lane1), C-dimer (lane 2), ONC monomer before (lane 3) and after (lane 4) 40% acetic acid lyophilization, ONC dimer 
before (lane 5) and after 40% acetic acid lyophilization (lane 6).  
  
 
3.3 DVS cross-linking 
 
The reaction of pancreatic-type RNases with DVS, allows to covalently link the two 
His residues of the active site that belong to the two N- and C-termini [29]. This 
reaction allows to assess if the oligomers form through 3D-DS, because if 3D-DS 
took place, an SDS PAGE performed after DVS reaction would reveal a covalently 
stabilized dimer formed by th  swappi g of one terminus, or both. !
In order to investigate the presence of 3D DS in th  dimer and in the supposed trimer 
formed, the two species were separately incubated with DVS, in a prot in 
subunit/cross-linker molar ratio of about 1/1000 (1nM/1µM). The reaction was 
stopped at 24, 50, 92, 163 h, adding β-mercaptoethanol, and 6 ug f each sample were 
analyzed through SDS-PAGE (Fig. 3). As shown in Fig. 3A, the presence of two 
bands demonstrates that the 3D-DS mechanism occurs in the ONC dimer. In ONC, 
His97 belongs to he C-terminus blo ked by the disulfide involv ng the ter inal 
2  &  4: after ONC lyophil. from 40%HAc solutions 
    D          D                                  M        M   
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6 A nd B, paralleled in Fig. 6 C and D by the structures of their parent templates, i.e., 
RNase A-ND and des(16-20)-HP-RNase, respectively. 
In the ND-like model, several interactions contribute to form the open interface [30] 
between the two ONC subunits and stabilize the quaternary structure. In particular, as 
reported in Fig. 7, four strong H-bonds form between the backbones of NH and CO of 
Leu79 of subunit A and Lys81 of subunit B, and vice-versa. It has to be underlined, 
then, that only two H-bonds are present in the same region of the parent RNase A-ND 
[6]. In addition, three extra H-bonds (between Asp18A and Thr14B, Asp18B and 
Tyr64A, Lys81A and Arg15B) and two symmetric salt bridges between Arg73A and 
Glu62B, and vice-versa, are pres nt in the ND-like dimeric ONC mod l with respec  
to the parent templat  of RNase A. Accordingly, the int rface area b tween the two 
subunits in the ND-like model is 2121 Å2, about 10% higher than that of the RNase A-
ND (1963 Å2) [6]. !
As far as the other desHP-like model is concerned (panel 6B), its quaternary structure 
is less compact. Indeed, the open interface is stabilized by only two H-bonds 
occurring between the two subunits. Consequently, the interface area is 1573 Å2, thus, 
definitely smaller than the one of the ND-like model. 
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Figure 6 -  Molecular modeling of the N-swapped ONC dimer.  A) RNase A ND-like ONC dimeric model; B) desHP-like ONC 
dimeric model; C) RNase A N-dimer, ND  [6]; D) des(16-20)-HP RNase dimer [27]. MD simulations were performed to compare 
the models and test their validity. 
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6 A and B, paralleled in Fig. 6 C and D by the structures of their parent templates, i.e., 
RNase A-ND and des(16-20)-HP-RNase, respectively. 
In the ND-like model, several interactions contribute to form the open interface [30] 
between the two ONC subunits and stabilize the quaternary structure. In particular, as 
reported in Fig. 7, four strong H-bonds form b tween he backbones of NH and CO of 
Leu79 of subunit A and Lys81 of subunit B, an  vice-versa. It has to be u erlined, 
then, that only two H-bonds are present in the same region of the parent RNase A-ND 
[6]. In addition, three extr  H-bonds (b tween Asp18A and Thr14B, Asp18B and 
Tyr64A, Lys81A and Arg15B) and two symmetric salt bridges between Arg73A and 
Glu62B, and vice-versa, are present in the ND-like dimeric ONC odel with respect 
to the parent template of RNase A. Accordingly, the interface area between the two 
su units in the ND-like od l is 2121 Å2, about 10% higher than that of the RNase A-
ND (1963 Å2) [6]. !
As far as the other desHP-like model is concerned (panel 6B), its quaternary structure 
is less compact. Indeed, the open interfa e is stabilized by only two H-bonds 
occurring betw en the two subunits. Consequently, the interface area is 1573 Å2, thus, 
definitely smaller than the one f the ND-like model. 
 
 
 
 !
  
 
 
 
 
 
 
 
 
 
 
 
Figure 6 -  Molecular modeling of the N-swapped ONC dimer.  A) RNase A ND-like ONC dimeric model; B) esHP-like ONC 
dimeric mo el; C) RNase A N-dimer, ND  [6]; D) des(16-20)-HP RNase dimer [27]. MD simulations were p rformed to compare 
the models and test their validity. 
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Far-(not shown) and Near-UV (Fig. 4) CD spectr
show that not significant differences in the secondary
and tertiary structures are present in th ONC
mon mer and d mer. This suggest that ONC dimer
reconstitutes the correct closed interface [6] present
in the monomer
Fig. 3
D
M
Fluorescenc at !ex = 280 nm
and !em = 300-450 nm of ONC
onomer (M, continuous line)
and dimer (D, dashed line) in 50
mM NaPi buffer, pH 6.7.
Fluorescence shows a 2-3 nm maximum intensity
shift of ONC dimer with respect to the monomer (!ex=
280 nm), indicating a slightly different exposition to
the solvent of the aromatic side chai , probably of
Trp3, of the two ONC spec es (Fig. 5).
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Fig. 5
Near-UV CD spectra
of ONC monomer
(M, continuous line)
and dimer (D,
dashed line). The
spectra were
acquired in 50 mM
NaPi buffer, pH 6.7,
from 240 to 350 nm.
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The swapping occurs at the N-terminal domain, since
the C-terminal Cys is involved in a disolfide bond. In
order to prove it, H10A mutant w s planned,
expressed and purifi d.
However, this species is not able to oligomerize (data
t shown), indirectly demonstrating that ONC dimer
forms through the -terminal swapping.
In vivo effects of ONC monomer and dimer associated to chemotherapy. Cell
growth (A and B), and apoptosis (C) of PaCa44 pancreatic adenocarcinoma cells
det mine with Crystal Violet colorimetric assay and annexinV/FITC binding
assay, respectively. Cells were seeded in 96-well plates, incubated overnight, and
treated with native ONC monomer and dimer, at the indicated concentrations in the
absence or presence of 50 nM GEM for 96 h. Values are means (SD) of three
independent biological replicates, each performed using three technical replicates.
Statistical analysis: * p < 0.05.
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Take Home Message
Onconase (ONC), secreted by Rana Pipiens oocytes [1], is a strongly cytotoxic member
of the ‘pancreatic-type’ RNase super-family. Although being monomeric, its particular
structure allows it to evade the cytosolic RNase inhibitor [1]. Even though to date no
ONC aggregates had been unvealed, we induced ONC oligomerization following the
protocols used with RNase A [2] and we detected definite amounts of ONC dimer that we
structurally and functionally characterized.
Recombinant ONC was lyophilized from 40% acetic acid [2]. The resulting powder was dissolved in 0.4
M sodium phosphate (NaPi), pH 6.7, and analyzed by SEC [2].
Native PAGE, SDS-PAGE after cross-linking with divynilsulfone (DVS), Far- and near-UV CD analyses,
fluorescence at !ex of 280 nm and in vitro cytotoxic assays [3] were performed with the species isolate
by SEC.
Modeling of the dimer was performed with the AMBER03 force field and the TIP3P water model
implemented in the program GROMACS.
We found for the first time that ONC spontaneously
forms dimeric traces (Fig. 1, dashed line). The dimer
yield definitely increases of about four times after acid
lyophilization [2] (continuous line) and is eluted at the
same volume of the known RNase A ND [4] (dotted line).
Differently from N- and C-swapped RNase A dimers
(Fig. 1, d tted line), ONC forms only one dimer (D)
also after acid lyophilization, as shown also in Fig. 2.
DVS cross-links the His r si u s l cated in the RNases
termini and involved in the active site [5]. The presence
of high MW species after SDS-PAGE indicates that ONC
dimer forms through 3D-domain swapping (Fig. 3).
-ONC oligomerization was somehow un xpected for three reasons: i) protein rigidity, ii)
lack of fav rable key-loops, iii) C-termi al ys forming a locking disulfide.
-We found that ONC can definitely oligomerize through 3D domain swapping, as
confirmed by DVS cross-linking, although to a lower extent tha bovine RNases [2,7].
-Being the C-terminus locked, the unique dimer forming is -terminus-swapped and its
modeling suggests it to be similar to RNase A N-dimer, ND [4]. This has been indirectly
confirmed by the fact that an ONC H10A mutant is not able to generate the dimer.
-ONC dimer cytotoxicity, higher than the native onomer, also in combination with
chemotherapeutic agents, needs to be further investigated starting from previous data [3].
-Construction and production of mutants possibly endowed with higher oligomerization
tendency and/or cytotoxicity than wt has already been started.
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The structure of the ONC dimer has been modeled
starting from the crystallographic structure of RNase A-
ND [4]. The ND-like model seems to be the best candid te
to r pr sent the structure of dimeric ONC because it has
a high interface area and it displays a high number of
stabilizi g contacts (details not shown).
Finally, ONC dimer displays to be more ytotoxic than the
native monomer [3] at low concentrations, either when
administered, alone or with chemotherape tics, against
pancreatic cancer cell line (Fig. 7).
ONC induced to oligomerize by lyophilizing it from 40% aqueous HAc
solutions, dissolving the powder at 4 mg/mL in the Superdex 75 10/300 elution
column buffer, 0.4 M NaPi, pH 6.7, and eluting it in the same column (solid
line). The representative pattern is reported together with the one of native
ONC (dashed line) and of oligomerized RNase A (grey dotted line) [2]. M & M,
monomers; D, ONC dimer; ND & CD, N- & C-swapped RNase A dimers [2].
Nondenaturing cathodic
PAGE of O C dimer (D) and
monomer (M), before (lanes
1 and 3) and after (lanes 2
and 4) acid lyophilization.
SDS-PAGE of ONC dimer after
cr ss-linking wi h DVS [5]. If
domain swapping occurred, th
Hi residu s of the active site
would be covalently linked to
form an indissociable species
detectable with a higher MW
than the one of ONC monomer
(t0). This is clearly visible for the
ONC dimer.
Molecular modeling of the N-swapped ONC dimer. A) RNase A N-dimer ND structure
[4]; B) Blue ND-like ONC dimeric model. MD simul tions were performed to test the
validity of the model.
Onconase (ONC) can produce a N-terminus domain-swapped dimer, whose
structure was odeled n that of RNase A N-dimer. The ONC dimer is more
cytotoxic than the mo omer at low concentration, expecially in combination
with gemcitabine. This suggests potential ne therapeutic implications
based on the use of ONC oligomers.
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As expected,  monomer displays higher electrophoretic mobility than RNase A 
monomer and the ONC dimer displays higher mobility than the RNase A C-dimer 
(Fig. 2B).   
 
 
Figure 2 – 12.5% acrylamide cathodic nondenaturing PAGE of: A) ONC dimer isolated before (lane 1) and after 40% acetic acid 
lyophilization (lane 2), ONC monomer before (lane 3) nd after (lane 4) 40% acetic acid lyophilization and B) RNase A 
monomer (lane1), C-dimer (lane 2), ONC monomer before (lane 3) and after (lane 4) 40% acetic acid lyophilization, ONC dimer 
before (lane 5) and after 40% acetic acid lyophilization (lane 6).  
  
 
3.3 DVS cross-linking 
 
The reaction of pancreatic-type RNases with DVS, allows to covalently link the t o 
His residues of the active site that belong to the two N- and C-termini [29]. T is 
reaction allows to assess if the oligomers form through 3D-DS, because if 3D-DS 
took place, an SDS PAGE performed after DVS reaction would reveal a covalently 
stabilized dimer formed by the swapping of one terminus, or both. !
In order to investigate the presence of 3D DS in the dimer and in the supposed trimer 
formed, the two species were separately incubated with DVS, in  protein 
subunit/cross-link r molar ratio of about 1/1000 (1nM/1µM). The reacti n was 
stopped at 24, 50, 92, 163 h, adding β-mercaptoethanol, and 6 ug f each sample were 
analyzed through SDS-PAGE (Fig. 3). As shown in Fig. 3A, the presence of two 
bands demonstrates that the 3D-DS mechanism occurs in the ONC dimer. In ONC, 
His97 belongs to the C-terminus blocked by the disulfide involving the terminal 
2  &  4: after ONC lyophil. from 40%HAc solutions 
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6 A and B, paralleled in Fig. 6 C and D by the structures of their parent templates, i.e., 
RNase A-ND and des(16-20)-HP-RNase, respectively. 
In the ND-like model, several interactions contribute to form the open interface [30] 
between the two ONC subunits and stabilize the quaternary structure. In particular, as 
reported in Fig. 7, four strong H-bonds form between the backbones of NH and CO of 
Leu79 of subunit A and Lys81 of subunit B, and vice-versa. It has to be underlined, 
then, that only two H-bonds are present in the same region of the parent RNase A-ND 
[6]. In addition, three extra H-bonds (between Asp18A and Thr14B, Asp18B and 
Tyr64A, Lys81A and Arg15B) and two symmetric salt bridges between Arg73A and 
Glu62B, and vice-versa, re present in the ND-like dimeric ONC model with respect 
to the parent template of RNase A. Accordingly, the interface area between the two 
subunits in the ND-like model is 2121 Å2, about 10% higher than th t of he RNase A-
ND (1963 Å2) [6]. !
As far as the other desHP-like model is concerned (panel 6B), its quaternary structure 
is less compact. Indeed, the open interface is stabilized by only two H-bonds 
occurring between the two subunits. Consequently, the interface area is 1573 Å2, thus, 
definitely smaller than the one of the ND-like model. 
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Thus, the ONC dimer was incubated with DVS at different protein and buffer 
concentrations. Reaction aliquots were collected up to 165 h, adding β-
mercaptoethanol, and four µg of each sample were analyzed in SDS-PAGE. As 
shown in fig. 5.8A-E, the presence of two bands demonstrates that the 3D-DS 
mechanism occurs in the ONC dimer formation. In ONC, the two His residues 
composing the active site are His97, which belongs to the C-terminus, blocked by 
the disulfide involving Cys104, and His10, which is located in the N-terminus. It is 
therefore reasonable that ONC dimer forms through the swapping of ONC N-
terminus. 
In order to ensure that the dimer did not dissociate during the DVS reaction, ONC 
dimer stability was tested incubating it in the same buffer of the DVS experiment, 
at 25 °C (Fig. 5.8F). ONC dimer results to be stable at least for 120 h. 
 
 
5.	Onconase	oligomerizes	producing	a	cytotoxic	3D	domain	swapped	dimer	
	
		
92	
	
 
 
Figure 5.8 – 15% SDS-PAGE analysis of the cross-linking reactions obtained with divinyl sulfone 
on ONC dimer (0.6 mg/ml) in 0.10 M sodium acetate/acetic acid buffer, pH 5.0 at A) 8 °C and B) 
25 °C, C) in 0.05 M sodium acetate/acetic acid buffer, pH 5.0, at 25 °C, D) in 0.025 M sodium 
acetate/acetic acid buffer, pH 5.0, at 25 °C, and E) on ONC dimer (0.25 mg/ml) in 0.10 M sodium 
acetate/acetic acid buffer, pH 5.0. At different times (0, 12, 24, 48, 74, 118, 165 h), 15 µg aliquots 
were withdrawn and 4 µg were analyzed in SDS-PAGE. M = monomer, D = dimer. F) Stability of 
ONC dimer in sodium acetate/acetic acid buffer, pH 5.0, at 25 °C. 5 µg were withdrawn at different 
times (0, 12, 24, 48, 72, 96, 120 h) and analyzed in 15% cathodic nondenaturing PAGE. 
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reaction with DVS (165 h), in line with the covalent modifications of the active site 
His induced by the cross-linking reaction. In fact, the two His of the active site, 
linked by DVS, are not available for the catalytic reaction anymore.  
However, beyond the two His of the active site, a third histidine, His29, is present 
in ONC. In order to exclude the possibility of the cross-linking between His29 and 
His97 during the DVS reaction, that would lead to the formation of a dimer in 
absence of 3D-DS, the H10A mutant was hence constructed and produced (Section 
5.2.2). If the formation of ONC dimer occurred through 3D-DS, then the cross-
linking with DVS performed on H10A ONC would not produce a covalent dimer, 
due to the absence of one of the two His involved in the reaction. The H10A ONC 
was purified with Superdex 75 HR 10/300, and its CD and fluorescence analyses 
showed that it was correctly folded. Moreover, as expected, no catalytic activity 
against ss-RNA was detected, in line with the substitution of His10. However, we 
did not obtain analyzable quantity of dimer after the lyophilization of H10A ONC 
monomer from 40% acetic acid. A possible explanation could be the lack of a 
stabilizing interaction formed by a phosphate ion that links the two histidines of the 
composed active site of ONC dimer, in the first phases of its folding. In fact, the 
product yield of RNase A oligomerization through 3D-DS depends also by the 
presence of phosphate ions in the buffer, which would allow the interaction between 
His12 and His119 of two different subunits, favoring the swapping. This is 
supported by the fact that when ONC powder derived from lyophilization from 40% 
acetic acid is resuspended in ddH2O, the yield of the dimer is significantly lower 
compared to that obtained with resuspension in phosphate buffer (Fig. 5.9).  
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Figure 5.9 – SEC patterns superimposition of wt ONC after lyophilization from 40% acetic acid 
buffer and resuspension in 0.4 M NaPi buffer, pH 6.7 (blue curve) or ddH2O (green curve) and of 
H10A ONC after lyophilization from 40% acetic acid buffer and resuspension in 0.4 M NaPi buffer, 
pH 6.7 (red curve). Patterns were normalized on the monomer area with the Unicorn 5.01 Software 
(GE Healthcare). 
 
 
Due to the lack of His10, H10A ONC dimerization could be hindered even after its 
resuspension in phosphate buffer. This demonstrates that His10 is essential for the 
dimer formation, and that dimerization occurs through the formation of new 
interactions involving ONC N-terminal domain. DVS demonstrated that these 
interactions produce a 3D N-terminal domain-swapped ONC dimer. 
 
 
5.3.8 Modeling of the domain-swapped ONC dimer 
 
The 3D structure of ONC dimer was modeled firstly assuming that the protein is 
free to swap only its amino-terminus. Indeed, the C-terminal swapping is precluded 
by the disulfide involving ONC C-terminal cysteine. Models were obtained starting 
from the structure of monomeric ONC (pdb code 2I5S)169 using two different 
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dimeric templates that display different relative orientations between the two 
subunits: a) the N-swapped dimer of RNase A-ND, (pdb code: 1A2W)81 and b) the 
dimer of des(16-20)-HP-RNase (desHP, pdb code: 4KXH)208, as detailed in the 
Materials and Methods section. Like ONC, both the crystallographic structures of 
RNase A dimers retain the standard folding of pancreatic-type RNases. The two 
dimeric ONC models are reported in Fig. 5.10A and B, paralleled in Fig. 5.10C and 
D by the structures of their parent templates, i.e., RNase A-ND and des(16-20)-HP-
RNase, respectively.  
 
 
Figure 5.10 – Molecular modeling of the N-swapped ONC dimer. A) RNase A ND-like ONC 
dimeric model; B) desHP-like ONC dimeric model; C) RNase A N-dimer, ND81; D) des(16-20)-HP 
RNase dimer208. MD simulations were performed to compare the models and test their validity. 
 
 
In the ND-like model, several interactions contribute to form the open interface88 
between the two ONC subunits and stabilize the quaternary structure. In particular, 
as reported in Fig. 5.11, four strong H-bonds form between the backbones of NH 
and CO of Leu79 of subunit A and Lys81 of subunit B, and vice-versa. It has to be 
underlined, then, that only two H-bonds are present in the same region of the parent 
RNase A-ND81. In addition, three extra H-bonds (between Asp18A and Thr14B, 
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Asp18B and Tyr64A, Lys81A and Arg15B) and two symmetric salt bridges 
between Arg73A and Glu62B, and vice-versa, are present in the ND-like dimeric 
ONC model with respect to the parent template of RNase A. Accordingly, the 
interface area between the two subunits in the ND-like model is 2121 Å2, about 10% 
higher than that of the RNase A-ND (1963 Å2)81.  
As far as the other desHP-like model is concerned (panel 5.10B), its quaternary 
structure is less compact. Indeed, the open interface is stabilized by only two H-
bonds occurring between the two subunits. Consequently, the interface area is 1573 
Å2, thus, definitely smaller than the one of the ND-like model. 
 
 
 
 
 
 
 
 
Figure 5.11 – In the ND-like model, four strong H-bonds form between the backbones of NH and 
CO of Leu79 of subunit A and Lys81 of subunit B, and vice-versa, in addition to the hydrogen bonds 
between Asp18A and Thr14B, Asp18B and Tyr64A, Lys81A and Arg15B, and two symmetric salt 
bridges between Arg73A and Glu62B. 
 
 
5.3.9 Cell proliferation and apoptosis assays 
 
In order to test if ONC dimer was active against PaCa44 cell line, cells were treated 
with 5,10 and 25 µg/ml of each ONC species, both in presence and in absence of 
gemcitabine. The experiment was made in collaboration with prof. M. Donadelli. 
Fig. 5.12 shows the results obtained with Crystal Violet assay. 
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Figure 5.12 – Effects of ONC monomer and dimer on cell growth of PaCa44 pancreatic 
adenocarcinoma cells determined with Crystal Violet colorimetric assay. Cells were seeded in 96-
well plates, incubated overnight, and treated with native ONC monomer and dimer, at the indicated 
concentrations, in the absence A) or presence B) of 50 nM GEM for 96 h. Values are means (±SD) 
of three independent biological replicates, each performing three technical replicates. Statistical 
analysis: * p < 0.05. 
 
 
Both ONC monomer and dimer resulted to induce cell death of PaCa44 cell line, 
and the effect of the dimer is higher with respect to that of the monomer. The 
difference in cytotoxicity detected between monomer and dimer is strengthened 
when the two species are combined with the addition of gemcitabine (GEM). The 
higher cytotoxicity of ONC dimer could be ascribed to the higher amount of its 
positive net charge with respect to the monomer108, that causes a stronger 
interaction with cancer cell membranes, promoting cell death after its 
endocytosis108,210. 
Apoptosis induction by ONC monomer and dimer was measured against the same 
cell line and the results are shown in Fig. 5.13. 
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Figure 5.13 – In vivo effects of ONC monomer and dimer associated to chemotherapy. Apoptosis 
of PaCa44 pancreatic adenocarcinoma cells was determined with annexinV/FITC binding assay. 
Cells were seeded in 96-well plates, incubated overnight, and treated with 10 µg/ml native ONC 
monomer and dimer, in the absence or presence of 50 nM GEM for 96 h. Values are means (±SD) 
of three independent biological replicates, each performed using three technical replicates. 
Statistical analysis: * p < 0.05. 
 
 
ONC monomer and dimer demonstrated to be able to induce apoptotis on PaCa44 
cell line. The dimer is more pro-apoptotic with respect to the monomer. The 
apoptotic effect is further increased in presence of gemcitabine (GEM). 
In order to ensure that ONC dimer did not dissociate during the 96 h of incubation 
with Paca44 cells, it was incubated at 37 °C with or without the addition of FBS in 
RPMI 1640 containing glutamine, gentamicin sulfate. At different time intervals (0, 
12, 24, 48, 72, 96 h), 5 µg of each sample were withdrawn and analyzed in cathodic 
nondenaturing PAGE (Fig. 5.14). The presence of the band corresponding to ONC 
dimer in both cathodic nondeanturing PAGEs demonstrates that a certain amount 
of ONC dimer survived after 96 hours of incubation. 
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Figure 5.14 – Stability of ONC dimer in RPMI 1640 containing glutamine, gentamicin sulfate, with 
A) or without B) the addition of FBS. At different time intervals (0, 12, 24, 48, 72, 96 h), 5 µg of 
each sample were withdrawn and analyzed in 15% cathodic nondenaturing PAGE. M = ONC 
monomer. 
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4.4 Discussion 
 
In this study we demonstrated that ONC is able to oligomerize, even if at lower 
extent compared to RNase A and BS-RNase. As expected, in fact, ONC forms only 
a type of dimer (Fig. 5.3 - 5.6), due to the fact that a disulfide bond blocks its C-
terminal, preventing its swapping211, and few traces of larger oligomers, with a 
residual monomer never decreasing below 83-84%. Moreover, 3% of dimer, more 
than the 1-2% of RNase A N-dimer141, is natively formed by ONC (Table 5.1). The 
yield of ONC dimer is substantially increased after lyophilizing ONC from 40% 
acetic acid and resuspending it in NaPi buffer, and the increased concentration of 
the solubilized powder allows an augment, although not dramatic, of the dimeric 
species up to 13% (Table 5.1). 
The ONC dimer formed after lyophilization from acetic acid is identical to the one 
spontaneously formed by the protein (Fig. 5.5), and DVS cross-linking reaction 
demonstrated that it forms through the swapping of the N-terminus of ONC 
monomer (Fig. 5.8). This result is not in contrast with what was previously 
envisaged to explain ONC partial unfolding occurring at the N-terminus212. These 
conclusions are also supported by the almost identical volume of ONC dimer and 
N-dimer of RNase A, that is in turn different from that of RNase A C-dimer80 (Fig. 
5.3). 
The overall structure of the proposed ONC dimer model is more compact than the 
parent RNase A ND, because of the wider contact area of the former (2121 Å2 versus 
1963 Å2) and the higher number of H-bonds and other stabilizing interactions (Fig. 
5.10, 5.11). In particular, two strong and symmetrical salt bridges (Arg73A-Glu62B 
and Arg73B-Glu62A) located at the edges of the open interface lock the dimer and 
stabilize the compact quaternary structure. This is supported by the stability 
analysis in 10 mM NaPi buffer, pH 6.7, at 37 °C, in which ONC dimer resulted to 
be more stable with respect to RNase A N-dimer (and also to C-dimer) (Fig 5.6). 
ONC dimer is also stable for 96 h in RPMI 1640 containing glutamine, gentamicin 
sulfate, with or without the addition of FBS (Fig. 5.14) and is even more stable 
when incubated in 0.1 M sodium acetate/acetic acid buffer, pH 5.0, until 120 h (Fig. 
5.8F). Anyway, since 3D-DS oligomer stability depends on several factors such as 
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temperature, ionic strength, buffer nature, protein concentration92,93,95, further 
analyses could be performed to deepen the knowledge of the factors affecting ONC 
dimer stability. All these results, also considering that only a single ONC species is 
detectable in nondenaturing cathodic PAGE, suggest that the proposed RNase A 
ND-like model could represent the real ONC dimer structure. 
As a consequence of dimerization, ONC increases its cytotoxic activity at low 
concentrations (from 5 to 25 µg/ml) against PaCa44 pancreatic cancer cell line (Fig. 
5.12). The ability to induce an antiproliferative effect in presence of gemcitabine, 
that is higher with respect to the monomeric form, suggests a possible future 
therapeutic implication of ONC dimer, that could decrease both ONC and GEM 
concentration and side effects. The increased cytotoxicity induced by ONC 
dimerization is not only ascribable to the cytosolic RNase inhibitor (RI) evasion, as 
it is for many pancreatic-type RNases186, since also ONC monomer is able to avoid 
it57. It could rather derive by its higher basic charge density, that would cause a 
higher affinity for cancer cell membrane and/or target substrates, with respect to 
the monomer210,213–215. It was demonstrated that ONC monomer is able to cause 
Panc1 pancreatic cancer cell line apoptosis through an autophagy-mediated 
pathway induced by LC3 and Beclin1 expression and by UCP2 and MnSOD 
inhibition178. A similar mechanism may be proposed for the treatment of PaCa44 
cells with ONC monomer and dimer, but further studies are certainly needed to 
further explain the cause of their different cytotoxicity. 
Besides the production and the structural and functional characterization of a 
dimeric form of ONC, this study can set the basis for future developments with the 
aim of enhance the oligomerization capacity of ONC, that could produce new 
species with possible therapeutic applications. 
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